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 Synthetic vascular grafts have rarely been proved successful in small-diameter 
(inner diameter < 6 mm) blood vessel replacements due to thrombosis and subsequent 
intimal hyperplasia, which could be alleviated by providing an anti-thrombogenic 
endothelial cells (ECs) monolayer onto the lumen surface of the grafts to mimic the 
situation in natural blood vessels. Electrospun nanofiber scaffolds, simulating 
extracellular matrix (ECM) below ECs, might well support ECs growth. This study 
was to construct nanofiber scaffolds with the objective of achieving effective 
endothelialization and final goal of constructing blood vessel-like tubular nanofiber 
scaffolds for tissue engineered small-diameter vascular grafts. The nanofiber 
scaffolds in this study were prepared from synthetic poly(L-lactic acid)-co-poly(ε-
caprolactone) P(LLA-CL) and natural collagen type I by electrospinning. The 
diameters of nanofibers in the scaffolds ranged between 100 to 800 nm. Moreover, 
the nanofiber scaffolds were porous with the porosity around 70%.  
 
 Firstly, collagen-blended P(LLA-CL) nanofiber meshes (NFM) were 
constructed by electrospinning a mixture of collagen and P(LLA-CL) dissolved in 
1,1,1,3,3,3-hexafluro-2-propanol (HFP). In vitro Human coronary artery endothelial 
cells (HCAECs) culture showed that the blended NFM has improved viability and 
attachment of HCAECs compared with the P(LLA-CL) NFM. HCAECs adopted a 
spreading polygonal shape on the blended NFM. Moreover, HCAECs maintained 
 xiii
Summary  
phenotypic expression of cell adhesion molecules such as PECAM-1 (platelet 
endothelial cell ad adhesion molecule-1), ICAM-1 (intercellular adhesion molecule-1), 
VCAM-1 (vascular cell adhesion molecule-1), E-Selectin, and vWF by RT-PCR 
(reverse transcription-polymerase chain reaction) analysis.  
 
P(LLA-CL) NFM were also modified by collagen coating method. P(LLA-CL) 
NFM were treated by inductive coupled radiofrequency glow discharge plasma, 
followed by collagen coating. Collagen was found to be evenly coated throughout the 
surface of nanofibers. Collagen coating improved the viability and attachment of 
HCAECs on P(LLA-CL) NFM. Immunostaining and RT-PCR analysis showed that 
HCAECs maintained the phenotypic expression of PECAM-1, fibronectin, and 
collagen IV. cDNA microarray analysis further indicated that HCAECs kept the 
expressions of 112 function-related genes. Particularly, aligned collagen-coated 
P(LLA-CL) NFM were constructed. The aligned NFM have higher mechanical 
strength and modulus than the random NFM. HCAECs grew along the direction of 
nanofiber alignment and showed elongated morphology. 
 
Based on above studies, 3-D tubular P(LLA-CL) nanofiber scaffolds (inner 
diameter 3 mm) were fabricated by electrospinning onto a rotating metallic mandrel, 
followed by collagen coating in the above mentioned method. Expanded PTFE (Gore-
Tex®) 3 mm vascular grafts were used as a control to study the mechanical properties 
and biocompatibility. Tensile properties of the tubular scaffold were closer to that of 




seeded onto the lumen of the scaffolds and rotated at the speed of 6 rpm for 4 hours, 
followed by a static culture. It was found that HCAECs spread evenly on the lumen of 
the scaffolds and reached sub-confluence immediately after seeding. After 10 day’s 
culture, HCAECs possessed the phenotypic expression of PECAM-1 and existed as a 
thin layer covering the lumen of the scaffolds. On the Gore-Tex® grafts, there were 
few HCAECs present after seeding. 
   
Finally, to prove the basic concept of using the tubular nanofiber scaffolds as 
vascular grafts, the tubular P(LLA-CL) nanofiber scaffolds without collagen coating 
and without ECs seeding were implanted in vivo into a rabbit model to replace the 
inferior superficial epigastric vein. Results showed the scaffolds could sustain the 
suturing during the implantation process and there was no blood leaking from the 
scaffolds. Further, the scaffolds kept the structure integrity and showed patency for up 







ANF: aligned nanofiber meshes  
 
ATR-FTIR: attenuated total reflectance Fourier transform infrared  
 
BM: basement membrane  
 
BNF: collagen-blended P(LLA-CL) nanofiber meshes 
 
BSA: bovine serum albumin 
 
CAMs: cell adhesion molecules  
 
CMFDA: 5-chloromethyl fluorescein diacetate 
 
DCM: Dichloromethane  
 
DMF: N,N-dimethylformamide  
 
ECs: endothelial cells  
 
ECM: extracellular matrix  
 
EPCs: endothelial progenitor cells  
 
E-selectin: endothelial leucocyte adhesion molecules-1  
 
FBS: fetal bovine serum  
 




HCAECs: human coronary artery endothelial cells  
 
HCASMCs: human coronary artery smooth muscle cells 
 
 xvi
List of Tables  
 
List of Tables 
 
Table 2.1. Synthetic material requirements for tissue engineered vascular grafts 
 
Table 2.2. Comparison between the three methods of constructing tissue 
engineered vascular grafts (TEVG) 
 
 
Table 2.3. Comparison between synthetic and natural polymers 
 
 
Table 2.4. Summary of different combinations of biomolecules and polymers in 
blended nanofibers and their applications in tissue engineering 
 
 
Table 2.5. Composite nanofibers fabricated through blended electrospinning  
 
 
Table 2.6. Blended nanofibers containing heparin through blended electrospinning 
 
 
Table 2.7. Summary of the three graft copolymerization methods applied to 
modify nanofiber surface  
 
 




Table 3.1. PCR primers for RT-PCR analysis  
 
 
Table 3.2. Diameter, thickness, apparent density, and porosity of collagen-blended 
P(LLA-CL) NFM with various weight ratios of P(LLA-CL) to collagena 
 
 
Table 3.3. Atomic ratios of carbon (C), nitrogen (N), and oxygen (O) on the 
surface of P(LLA-CL) NFM, collagen-blended P(LLA-CL) NFM with various 
 xix
List of Tables  
 xx




Table 3.4. Tensile properties of collagen-blended P(LLA-CL) NFM, with the 




Table 4.1. PCR primers for RT-PCR analysis 
 
 
Table 4.2. Diameter, thickness, apparent density, porosity, and pore size of the 
random and aligned collagen-coated P(LLA-CL) NFMa 
 
 
Table 4.3. Water contact angles of the P(LLA-CL ) NFM and films before and 
after plasma treatment for various timea 
 
 
Table 4.4. Atomic ratio of C, N, and O on the surface of the P(LLA-CL) NFM, the 




Table 4.5. Tensile properties of the random and aligned P(LLA-CL) NFMa  
 
 
Table 4.6. Percentage (%) of genes with over-expressed, similar-expressed, and 
less-expressed levels between HCAECs grown on TCPS, random (RNF) and 
aligned (ANF) collagen-coated P(LLA-CL) NFM 
 
 
Table 5.1. Comparison between the Gore-Tex® vascular grafts and the tubular 




Table 5.2. Tensile properties of the collagen-coated P(LLA-CL) tubular nanofiber 
scaffolds in both longitudinal and circumferential directionsa 
 
 
Table 5.3. Longitudinal and circumferential tensile strength of the tubular 
nanofiber scaffolds, Teflon® (TF-208), and natural abdominal aorta 
Abbreviations  
H&E: Hematoxylin & Eosin 
 
hEGF: human epidermal growth factor 
 




ICAM-1: intercellular adhesion molecule-1 
 
IGF-I: insulin-like growth factor type I 
 
IH: intimal hyperplasia 
 
LSCM: laser scanning confocal microscope 
 
MSCs: mesenchymal stem cells  
 
NF: nanofibers   
 
NFM: nanofiber meshes  
 
PBS: phosphate-buffered saline  
 
PCL: polycaprolactone  
 
PCR: Polymerase Chain Reaction 
 
PECAM-1: platelet endothelial cell ad adhesion molecule-1  
 
PEG: poly(ethylene glycol) 
 
PEO: poly(ethylene oxide) 
 
PES: polyethersulfone  
 
PET: poly(ethylene terephthalate) 
 









P(LLA-CL): poly(L-lactic acid)-co-poly(ε-caprolactone) 
 




ePTFE: expanded polytetrafluoroethylene 
 
PU: polyurethane  
 
PVA: poly(vinyl alcohol) 
 
RBITC: rhodamine B isothiocyanate  
 
RNF: random nanofiber meshes  
 
RT-PCR: reverse transcription-polymerase chain reaction 
 
SD: standard deviation 
 
SEM: scanning electron microscope 
 
SMCs: smooth muscle cells  
 
TCPS: tissue culture polystyrene  
 
TEM: transmission electron microscopy 
 
TEVGs: tissue engineered vascular grafts  
 
VCAM-1: vascular cell adhesion molecule-1 
 
VEGF: vascular endothelial growth factor 
 
vWF: von Willebrand Factor 
 
XPS: x-ray photoelectron spectroscopy 
List of Figures  
 
List of Figures 
 
Figure 1.1. Schematic outline for the study: step 1, fabrication of nanofiber 
meshes (NFM); step 2, evaluation of the in vitro endothelialization on the flat 
NFM; step 3, constructing the blood vessel-like 3-D tubular nanofiber scaffolds 
with the lumen seeded with ECs.  
 
Figure 2.1. Schematic graph of the basic tri-lamellar structure of blood vessels.  
 
Figure 2.2. Elastic fibers. These scanning electron micrographs show (A) a 
low-power view of a segment of a dog's aorta and (B) a high-power view of the 
dense network of longitudinally oriented elastic fibers in the outer layer of the 
same blood vessel. All the other components have been digested away with 
enzymes and formic acid. Reprint with permission from (Alberts et al., 2002).  
 
Figure 2.3. The basal lamina in the cornea of a chick embryo. In this scanning 
electron micrograph, some of the epithelial cells (E) have been removed to expose 
the upper surface of the matlike basal lamina (BL). A network of collagen fibrils 
(C) in the underlying connective tissue interacts with the lower face of the lamina. 
Reprint with permission from (Alberts et al., 2002). 
 
Figure 2.4. A model of the molecular structure of a basement membrane (basal 
lamina). Reprint with permission from (Alberts et al., 2002). 
 
Figure 2.5. Pathway of thrombus formation (A) and EC antithrombogenic 
signaling (B). Reprint with permission from (Mitchell and Niklason, 2003).  
 
Figure 2.6. Schematic representations of a collagen-based construct. The most 
general configuration contains an adventitia-like layer, a media-like layer, a 
monolayer of ECs, and DacronTM sleeves for structural reinforcement. Reprint 
with permission from (Nerem and Seliktar, 2001). 
 
 xxi
List of Figures  
Figure 2.7. Schematic representation of the cell self-assembly model. Vascular 
cells are cultured to form a continuous sheet of cells and extracellular matrix and 
then rolled over a central mandrel. The construct is matured over 10 weeks, 
allowing the cell to organize into a mechanically stable tubular construct. Reprint 
with permission from (Nerem and Seliktar, 2001). 
 
Figure 2.8. Schematic representation of a cell-seeded polymeric scaffold. Vascular 
cells are cultured on a woven PGA mesh. The construct is matured over 8 weeks 
of dynamic culture, allowing the cells to proliferate and produce and organize 
extracellular matrix as the PGA degrades. Reprint with permission from (Nerem 
and Seliktar, 2001). 
 
Figure 2.9. Electrospinning basic principles (Ramakrishna et al., 2006). 
 
Figure 2.10. Similarity between the native ECM protein structure and the 
electrospun polymer nanofiber scaffold. (a) Fibroblasts grown in vivo on collagen 
fibrils of rat cornea (Nishida et al., 1988); (b) ECs cultured in vitro on the 
electrospun PCL nanofiber scaffold. Reprint with permission from (Ma et al., 
2005b). 
 
Figure 2.11. Similarity between (a) the natural collagen bundles of the connective 
stroma of the small intestine (Ottani et al., 2001) and (b) the electrospun collagen 
nanofibers. Reprint with permission from (Teo et al., 2006).  
 
Figure 2.12. General scheme of graft copolymerization on polymer surfaces. 
 
Figure 2.13. Surface modification scheme for galactose conjugation to PCLEEP 
nanofibers. Reprint with permission from (Chua et al., 2005). 
 
 
Figure 2.14. Reaction scheme of the surface modification process for PCL 
nanofiber. RFGD, Radio-frequency glow discharge. Reprint with permission from 
(Ma et al., 2005a). 
 
Figure 2.15. Schematic representation of the surface modification process of PET 
nanofibers. Reprint with permission from (Ma et al., 2005c). 
 xxii
List of Figures  
Figure 3.1. Schematic setup and optimized operation parameters for fabrication of 
the collagen-blended P(LLA-CL) NFM. 
 
 
Figure 3.2. SEM (A-D) and TEM (E and F) micrographs of collagen-blended 
P(LLA-CL) NFM with various weight ratios of P(LLA-CL) to collagen. Weight 
ratios of P(LLA-CL) to collagen: (A) 4:1; (B) 2:1; (C and E) 1:1; (D and F) 0:1 
Total concentration of the electrospinning solution is 5 wt%. 
 
 
Figure 3.3. Diameter distributions of the collagen-blended P(LLA-CL) NFM with 
various weight ratios of P(LLA-CL) to collagen. 
 
 
Figure 3.4. ATR-FTIR spectra of (A) P(LLA-CL) NFM, (B) collagen NFM, and 




Figure 3.5. Typical stress-strain curves of the P(LLA-PCL ) NFM and 
collagen-blended P(LLA-CL) NFM with the weight ratio of P(LLA-CL) to 
collagen 1:1 under tensile loading. 
 
 
Figure 3.6. Total viability of HCAECs cultured on TCPS, collagen NFM, 
collagen-blended P(LLA-CL) NFM (BNF) with various weight ratios of 
P(LLA-CL) to collagen( BNF 1:1, BNF 2:1, BNF 4:1), P(LLA-CL) NFM, and 
collagen-blended P(LLA-CL) film (Blended film). 
 
 
Figure 3.7. Viability of HCAECs on day 3 and 7 shown in Figure 3.6 were 
summarized here for clearness. 
 
 
Figure 3.8. LSCM [original magnification: (a): × 400; (b and c): × 200] and SEM 
[original magnification: (d-f): × 500] images of HCAECs cultured on (a and d) 




Figure 3.9. Higher magnification of SEM micrographs (original magnification, × 
3000), showing the detailed interactions between HCAECs and (a) the P(LLA-CL) 
NFM and (b) the collagen-blended P(LLA-CL) NFM at 5 days of culture. 
 
 xxiii
List of Figures  
Figure 3.10. Attachment of HCAECs on the TCPS, P(LLA-CL) NFM, and 
collagen-blended P(LLA-CL) NFM. 
 
 
Figure 3.11. Expression of ECs-characteristic genes from HCAECs cultured on 
TCPS and collagen-blended P(LLA-CL) NFM (BNF) for 10 days. On day 10, 
total RNA was extracted and RT-PCR was performed with gene-specific primer 
pairs shown in Table 3.1, including E-Selectin (E-SEL, CD62E), VCAM-1 
(CD106), ICAM-1 (CD54), won Willebrand factor (vWF), PECAM-1 (CD31), 
and β-actin as a housekeeping gene. 
 
 
Figure 4.1. Experimental setups for fabricating the random and aligned P(LLA-CL) 




Figure 4.2. Schematic representation of the plasma treatment and collagen coating 
of the electrospun P(LLA-CL) nanofiber mesh.  
 
 
Figure 4.3. SEM pictures of the cross section (a and d), 3-dimensional structure (b 
and e), and top view (c and f) of the random (a-c) and aligned (d-f) 
collagen-coated P(LLA-CL) NFM. 
 
 
Figure 4.4. (a) Diameter distribution of the random and aligned collagen-coated 




Figure 4.5. 3-D laser scanning confocal microscopy (LSCM) (original 
magnification, × 600) of the collagen-coated random (a) and aligned (b) 




Figure 4.6. Stress-strain curves for the random and aligned P(LLA-PCL) NFM 
under tensile loading. 
 
 
Figure 4.7. LSCM (original magnification, × 400) and SEM (original 
magnification, × 1000) images of HCAECs cultured on (a, d) TCPS, (b, e) 
P(LLA-CL) NFM, and (c, f) collagen-coated P(LLA-CL) NFM. 
 xxiv
List of Figures  
Figure 4.8. Immunofluorescent staining of PECAM-1 from HCAECs cultured on 
TCPS (a) and the collagen-coated P(LLA-CL) NFM (b). Existence of 
rhodamine-labeled collagen was identified by its red fluorescence in (b). White 
arrows indicate strong PECAM-1 expression at cell-cell interfaces. 
 
 
Figure 4.9. Viability of HCAECs on the TCPS, P(LLA-CL) NFM, and 




Figure 4.10. Attachment of HCAECs on the TCPS, P(LLA-CL) NFM, and 




Figure 4.11. (A) Fluorescent microscopy (original magnification, × 600) and SEM 
(original magnification, × 1000) images from HCAECs on TCPS, random NFM 
(RNF) and aligned (ANF) collagen-coate P(LLA-CL) NFM. (B) LSCM images of 
fibronectin and collagen type IV expressions from HCAECs on the TCPS, RNF, 
and ANF. (C) RT-PCR analysis of expressions of PECAM-1, fibronectin, and 
collagen type IV from HCAECs on the TCPS, RNF, and ANF. 
 
 
Figure 4.12. (A) Gene expression profiles of HCAECs on TCPS, random (RNF), 
and aligned (ANF) collagen-coated P(LLA-CL) NFM by cDNA microarray 
analysis. Expression of each gene is represented by the fluorescence of a tetra-spot. 
(B) Scatter plots showing the relative gene expression of (B1) RNT versus TCPS, 
(B2) ANF versus TCPS, and (B3) ANF versus RNF. (C). RT-PCR analysis of 
integrin α5 (ITGA5), αV (ITGAV), and β1 (ITGB1) expression from HCAECs 




Figure 5.1. (A) Setup and operation parameters for fabrication of the P(LLA-CL) 
tubular nanofiber scaffolds. (B) The electrospun tubular nanofiber scaffold 
collected on the mandrel.  
 
 
Figure 5.2. Schematic illustration of HCAECs seeding onto the lumen of the 
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Figure 5.3. Macroscopic and microscopic structures of the collagen-coated 
P(LLA-CL) tubular nanofiber scaffolds . (a, b) optical images of macroscopic 
structures. (c, d, e, f) SEM photographs: (c) whole structure; (d) enlarged 
cross-section of wall; (e) inner layer; (f) out layer. Original magnification: × 50, × 
2500, × 5000, × 5000 for c, d, e, f, respectively. 
 
 
Figure 5.4. Macroscopic and microscopic structures of the Gore-Tex® vascular 
grafts. (a, b) optical images of macroscopic structures. (c, d, e, f) SEM 
photographs: (c) cross section; (d) enlarged cross-section of wall; (e) inner layer; 
(f) out layer.  
 
 
Figure 5.5. (Left) 3-D LSCM (original magnification, × 600) image of the 
collagen-coated P(LLA-CL) tubular nanofiber scaffolds. (Right) Enlarged LSCM 




Figure 5.6. Typical uniaxial stress-strain curves for the collagen-coated 




Figure 5.7. HCAECs grew on the lumen of the tubular nanofiber scaffolds for 1 
day (a and b), 5 days (c and d), and 7 days (e and f) after seeding at the density of 
6 × 105 cells/cm3. (b, d, and f): higher magnification images of (a, c, and e) 
respectively. Original magnification: a, × 200, c, × 42, e, × 80, b, d and f, × 1000. 
 
 
Figure 5.8. HCAECs grew on the lumen of the tubular nanofiber scaffolds for 10 
days after seeding. (a, b) SEM images showing the overall structure of the 
HCAECs-scaffold constructs: (a) cross-section of wall of the constructs; (b) 
enlarged quadrangle in (a). (c) H&E staining of the cross-section of the constructs. 
(d) Immunostaining of PECAM-1 from HCAECs on the lumen of the tubular 
nanofiber scaffolds. Original magnification: a, × 80, b, × 2000, c, × 200, d, × 630. 
 
 




Figure 6.2. Image of the P(LLA-CL) tubular nanofiber scaffold (length: 1 cm, 
inner diameter: 1 mm). 
 xxvi
List of Figures  
 xxvii
Figure 6.3. Image of the replacement of the inferior superficial epigastric vein 
with the P(LLA-CL) tubular nanofiber scaffold. 
 
 
Figure 6.4. SEM images showing morphology of the P(LLA-CL) NFM 
biodegraded in 1 × PBS at 37 oC for (a and b) 0 month, (c and d) 3 month, and (e 
and f) 8 month. (b, d, and f) are magnified images of (a, c, and e) respectively. 
 
 
Figure 6.5. H&E staining image of the oblique-section of the explanted tubular 
nanofiber scaffold after 7 weeks’ implantation in the rabbit model. 
 
 
Figure 7.1. Experimental setup for electrospinning core-shell nanofibers (Zhang et 
al., 2004).  
 
 
Figure 7.2. Constructing tubular nanofiber scaffolds with hierarchical strructure: 
ECs-seeded NFM, SMC-contained aligned NFM, and fibroblasts-contained NFM 
can be used to construct the intima, media, and adventitia of blood vessels 
respectively.  
 





1.1 Background  
 
Cardiovascular diseases including blood vessel diseases such as coronary 
artery disease and peripheral vascular disease, and heart disease are the number one 
cause of death in USA and most European countries (Ross, 1993). Treatment of blood 
vessel diseases involves bypassing diseased blood vessels using various types of 
vascular grafts: autografts (grafts taken from a patient, e.g. saphenous veins or 
internal mammary arteries), allografts (grafts taken from other person, e.g. umbilical 
veins), xenografts (grafts taken from other species, e.g. bovine carotid arteries), and 
synthetic grafts (artificial grafts). Allografts and xenografts are rarely used now 
because of high failure rates resulting from immune rejections, aneurysms, and 
ruptures. With autografts, the problem is that as many as 30% of patients do not have 
suitable veins/arteries for grafting due to preexisting vascular diseases, vein stripping, 
or vein uses in prior procedures. Nowadays more than 600,000 vascular grafts bypass 
procedures are performed annually in USA. Thus there is a clear clinical need for 
synthetic grafts as alternatives to the use of autografts (Xue.L, 2000).  
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Although have being successfully used for large and medium blood vessel 
replacements, synthetic vascular grafts have rarely been proved successful in small-
diameter blood vessel replacements (inner diameter < 6 mm, e.g. peripheral vessels 
below the knee and coronary arteries etc). Only 15-30% of small-diameter synthetic 
vascular grafts remain open (or patent) after 5 years (Seal et al., 2001). The rate of 
thrombosis (static aggregation of blood factors) occurred in synthetic vascular grafts 
is greater than 40% in the early phase after 6 months followed by continuous intimal 
hyperplasia (excessive tissue ingrowth and plasma protein depositions) in the chronic 
phase (Sayers et al., 1998). Thrombosis and intimal hyperplasia are caused by host-
tissue foreign body responses, initiated first by plasma protein depositions, followed 
by leukocytes and platelets adhesion and migration of endothelial cells (ECs) and 
smooth muscle cells (SMCs) onto the lumen of vascular grafts. Effects of these 
factors will even be amplified in a low flow rate and high resistance small-diameter 
vascular graft, resulting in easier graft occlusion and subsequent failure. It is to this 
challenge that vascular tissue engineering is seeking to answer. One of the commonly 
accepted methods for developing tissue engineered small-diameter vascular grafts is 
to hybridize vascular grafts made from biodegradable materials with vascular cells 
(Ratcliffe, 2000;Thomas et al., 2003;Kakisis et al., 2005).  
 
1.1.1 ECs-seeded tissue engineered vascular grafts 
 
 As mentioned above, thrombosis is one of the main reasons for occlusion of 
small-diameter vascular grafts. One approach to solve this problem is seeding 
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vascular ECs onto the lumen of vascular grafts to allow the formation of a monolayer 
of ECs prior to implantation. The rationale behind this approach is that thrombosis 
could be prevented by providing a anti-thrombogenic ECs monolayer to mimic the 
situation in natural blood vessels (Luscher and Barton, 1997). Although the lumen of 
vascular grafts implanted in animal models will ultimately be covered with confluent 
host ECs, such a process has not been demonstrated to occur in humen with any 
currently available vascular grafts (Tomizawa, 2003). The observation of this 
“incomplete endothelialization” in human is an important limitation to the patency of 
small-diameter vascular grafts, leading to great research interests in the development 
of “ECs-seeded” vascular grafts. The endothelialization approach is regarded as the 
beginning of the application of tissue engineering principle in the cardiovascular 
system (Nerem and Seliktar, 2001). Results from a 7-year clinical studies of 
peripheral implants have shown that autologous ECs-seeded ePTFE (expanded 
polytetrafluoroethylene) synthetic vascular grafts possessed improved patency when 
implanted into 136 patients (Meinhart et al., 2001).  
 
 ECs seeding onto the lumen of vascular grafts have always been challenging 
because ECs show limited proliferation ability on synthetic graft materials (Sipehia et 
al., 1996). Moreover, ECs can be detached from the lumen of vascular grafts upon 
exposure to shear force and cyclic strain due to blood circulation (Mitchell and 
Niklason, 2003). Thus optimizing ECs attachment and improving EC proliferation on 
the lumen of synthetic vascular grafts has received much attention in recent literature 
(Nerem and Seliktar, 2001). In clinical practice, endothelialization of vascular grafts 
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can be obtained using high ECs seeding densities, or by creating a ECs-compatible 
surface on which ECs can adhere and grow to confluent (Sipehia et al., 1996). 
Extracellular matrix (ECM) proteins and peptides are commonly used biomolecules 
to modify the lumen surfaces of vascular grafts to promote EC adhesion and 
attachment via ligand-cell receptor interaction. For example, natural ECM proteins 
and their derivatives such as collagen (Lu and Sipehia, 2001), gelatin (Zhu et al., 
2004), and fibronectin (Unger et al., 2005;Seeger and Klingman, 2006) have been 
immobilized onto surfaces of synthetic grafts to obtain improved EC attachment and 
spreading. Similarly, peptide sequences derived from ECM proteins such as RGD 
(Arg Gly Asp) from collagen/fibronectin, YIGSR (Tyr Ile Gly Ser Arg) from laminin 
1, and REDV (Arg Glu Asp Val) from fibronectin have also been covalently bound 
onto surfaces of synthetic grafts. Mazzucotelli et al. reported coating of a 
recombinant adhesion factor containing the RGD peptide sequence onto the ePTFE 
graft surfaces. There was an increased adherence and survival of human saphenous 
vein endothelial cells on the coated surface for up to one week compared with the 
uncoated ePTFE surfaces (Mazzucotelli et al., 1994). In addition to modifications 
using ECM proteins or bioactive peptides, other chemical surface modification 
methods have also been reported to improve biocompatibility of synthetic vascular 
grafts such as ammonia plasma treatment (Sipehia et al., 1996) and hydroxylation 
(Mckeown et al., 1991) etc.  
 
Although ECM chemical cues (proteins and bioactive peptides) have been 
extensively studied, ECM physical cues such as 3-D geometry and porosity etc 
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should not be neglected. Since ECM plays an important role in cell development, 
organization, and function, it is important to emulate features of ECM as closely as 
possible in biomaterial design for optimized cell growth. Thus natural ECM around 
ECs can give hints on how to construct vascular grafts with good endothelialization. 
Natural ECM underlying ECs is called basement membrane (BM) which is mainly 
composed of EC-secreted collagen and laminin fibers embedded in heparin sulfate 
proteoglycan hydrogels. Further study of BM shows a nano- to submicron-scale 
topography of ECM macromolecules, including fiber mesh, pores, ridges, and 
grooves (Kwon et al., 2005). The 3-D structure of BM has been shown to be as 
important as its chemistry in its influence on cellular processes (Schmeichel and 
Bissell, 2003;Schindler et al., 2005).  
 
 Another important concern is cell function studies. It is not enough to 
characterize the normal status of ECs only in terms of cell morphology, proliferation, 
and attachment. It is quite possible that ECs may lose their phenotypic expression of 
anti-thrombogenic molecules, which is critical to the patency of ECs-seeded vascular 
grafts, and it can not be characterized only through cell morphology, proliferation, 
and attachment. Thus systematic investigations into ECs phenotype and gene 
expression level need to be carried out to understand the normal functional 
maintenance of ECs.  
 
 Finally, although flat sheet-like substrates have been extensively studied for 
endothelialization, tubular models which better represent the real environment where 
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ECs grow in the lumen of blood vessels should be paid more attention to. One big 
difference between EC growth on flat surfaces and tubular scaffolds is the seeding 
method. Seeding ECs onto the lumen of tubular scaffolds is more challenging since 
dynamically rotational seeding is required to achieve evenly distributed ECs. Thus, 
based on fundamental studies from ECs culture on flat sheet-like substrates, it would 
be helpful to go further into constructing tubular scaffolds and establishing the 
seeding technology in order to enable the development of ECs-seeded vascular grafts.  
 
1.2 Thesis objectives  
 
The purpose of this study was to construct biomimetic electrospun nanofiber 
scaffolds which mimic the extracellular matrix (ECM)/basemen membrane (BM) 
(step 1), with the objective of achieving effective endothelialization of the nanofiber 
scaffolds in terms of viability, attachment, as well as phenotypic and functional 
maintenance of ECs (step 2), and the final goal of constructing blood vessel-like 3-D 
tubular nanofiber scaffolds with the anti-thrombogenic lumen composed of ECs for 
tissue engineered small-diameter vascular grafts (step 3). The outline for this study is 
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Figure 1.1. Schematic outline for the study: step 1, fabrication of nanofiber meshes 
(NFM); step 2, evaluation of the in vitro endothelialization on the flat NFM; step 3, 
constructing the blood vessel-like 3-D tubular nanofiber scaffolds with the lumen 
seeded with ECs.  
 
Moreover we proposed to pursue the following specific aims in this study:  
 
1. To fabricate collagen-modified nanofiber meshes (NFM) with high levels of 
controllability and reproducibility. 
 
Hypothesis: Bulk and surface modification of pure polymer NFM by blending or 
coating with collagen could promote ECs attachment via ligand-cell receptor 
interaction. 
 
a To include collagen into polymer NFM by physical blending or coating.  
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b To characterize the morphology, surface chemistry, and mechanical 
properties of the collagen-modified polymer NFM. 
 
2. To evaluate in vitro endothelialization of the collagen-modified polymer NFM 
with respect to attachment, viability, as well as phenotypic and functional 
maintenance of ECs. Concurrently, NFM constructed from both random and 
aligned nanofiber will be studied. 
 
Hypothesis: Electrospun collagen-modified polymer NFM could support in vitro 
endothelialization since the NFM mimic the natural basement membrane.  
 
a To study ECs’ morphology, attachment, viability as the basic 
biocompatibility evaluation of the collagen-modified polymer NFM. 
 
b To analyze the phenotypic maintenance of ECs on the collagen-modified 
polymer NFM in terms of the expressions of cell adhesion molecules (CAMs) 
and EC-specific ECM proteins. 
 
c To study the functional maintenance of ECs on the collagen-modified 
polymer NFM by cDNA microarray technology to analyze the expression 
profiles of the function-related genes.   
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3. To construct 3-D tubular collagen-modified polymer nanofiber scaffolds which 
facilitate quick, stable, and effective endothelialization in the lumen.  
 
Hypothesis: By rotational seeding ECs onto the lumen of the tubular nanofiber 
scaffolds, evenly distributed ECs would be achieved. Also similar 
endothelialization would occur onto the lumen of the 3-D tubular nanofiber 
scaffolds as that on the collagen-modified polymer NFM. 
 
a To construct 3-D tubular nanofiber scaffolds.  
 
b To rotationally seed ECs onto the lumen of the tubular nanofiber scaffolds.  
 
c To establish an animal model to prove the basic concept of using the tubular 
nanofiber scaffolds as vascular grafts.  
 
1.3 Thesis scope 
 
As one of the pioneer studies in the application of electrospun nanofiber 
scaffolds in tissue engineered small-diameter vascular grafts, we focused on scaffold 
fabrication and primary in vitro cell culture study. In order to mimic the physical cues 
of ECM such as porosity and 3-D fiber network, polymer nanofiber scaffolds were 
constructed by electrospinning. A copolymer from biodegradable aliphatic polyester 
family, the random poly(L-lactic acid)-co-poly(ε-caprolactone) P(LLA-CL 70:30), 
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was chosen. Such a kind of copolymer has a potential to enable its degradation rate 
and mechanical property to be controlled. PLLA is a semi-crystallized hard and brittle 
material, while PCL is a semi-crystalline material with rubbery properties, thus the 
copolymer of PLLA and PCL can achieve an adjustable mechanical property via 
adjusting the ratio of the two components. In order to add the chemical cue, we chose 
type I collagen, which is the main type of collagen in connective tissue and is present 
throughout the arterial wall, to be included into the P(LLA-CL) nanofiber scaffolds 
either through electrospining the mixture of P(LLA-CL) and collagen, or through 
collagen coating during postprocessing of the P(LLA-CL) nanofiber scaffolds. The 
ECs we chose was human coronary artery endothelial cells (HCAECs). In vitro EC 
growth on the nanofiber scaffolds was studied in terms of phenotypic maintenance 
through RT-PCR analysis for CAMs and ECM proteins, and functional maintenance 
through cDNA analysis for function-related 112 genes. A rabbit epigastric free flap 
model was established to prove the basic concept of using the 3-D tubular collagen-
modified P(LLA-CL) nanofiber scaffolds as tissue engineered vascular grafts.  
 
1.4 Thesis values  
 
It is hope that this study would provide an approach to develop synthetic 
analogues of the natural ECM for improved ECs attachment and phenotype and 
functional maintenance, and ultimately approach the development of tissue 
engineered small-diameter vascular grafts for their clinical applications in the 
treatment of peripheral and cardiovascular disease. In addition to vascular graft 
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application, the nanofiber scaffold may also act as a new type of cell culture surface 
for different kinds of cell which can be incorporated into a variety of applications of 
tissue engineering and cell-based therapies.  
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2.1 Challenges of small-diameter vascular grafts  
 
 The first synthetic vascular grafts used clinically were made of the woven 
fabric Vinyon N by Voorhees in 1952 (Voorhees et al., 1952;Blakemore and 
Voorhees, 1954). From then on, a variety of materials including nylon, Orlon, PET 
(poly(ethylene terephthalate), Dacron®), ePTFE (expanded polytetrafluoroethylen, 
Teflon®), polyethylene, and polyurethane have been made into vascular grafts. For 
replacement of the abdominal aorta and iliac arteries, which have an inner diameter 
more than 6 mm, knitted Dacron® is the common choice, whilst for the 
femoropopliteal and femorotibial bypass, which have an inner diameter less than 6 
mm, ePTFE is used together with knitted Dacron (Hastings, 1992). Although very 
inert, those materials do evoke host-tissue foreign body responses, initiated first by 
plasma protein deposition known as the Vroman effect (Vroman and Adams, 1969), 
followed by leukocytes and platelets adhesion and the migration of endothelial and 
smooth muscle cell. These lead to thrombosis (static aggregation of blood factors) in 
the early phase followed by a continuous and intimal hyperplasia (excessive SMC 
ingrowth and plasma protein deposits) in the chronic phase. Thrombosis phenomenon 
will be more severe in small-diameter vascular grafts (inner diameter < 6 mm) 
 12
                                                                                                                         Chapter 2                              
(Niklason and Seruya, 2002). This is because in small-diameter vascular grafts, blood 
pressure, resistance of blood flow, shear stress, and surface-to-volume ratio are high, 
which result in increased contact time of blood components with grafts and increased 
activation of blood coagulation (thrombosis) (Matsuda, 2004). As a result, small-
diameter synthetic vascular grafts suffer thrombosis rates greater than 40% after 6 
months (Sayers et al., 1998) and only 15-30% of them remain patent after 5 years 
(Seal et al., 2001). The higher propensity of small-diameter vascular grafts to 
thrombosis has spurred the scientists to improve the standard materials and develop 
new materials. It is also to this challenge that tissue engineering approach is seeking 
to answer. 
 
2.2 Rationale of constructing tissue engineered vascular grafts  
 
2.2.1 Natural vascular structure   
 
 Current research on tissue engineered small-diameter vascular grafts focused 
more on the development of native blood vessel-like tubes (or conduits). The 
development of biomimetic vascular grafts relies on the understanding of the 
anatomical structure and the biological functions of blood vessels. Normal blood 
vessels (except capillaries) have tri-lamellar structures, with each layer having 
specific functional properties (Figure 2.1). The intima (tunica intima) contains the 
endothelium, which is a single layer of ECs functioning to prevent spontaneous blood 
coagulation. As an interface between dynamic blood flow and static blood vessel wall, 
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ECs are directly exposed to flow and the associated shear stress and blood pressure, 
which make ECs elongate in response to flow and orient their major axis with the 
direction of flow. Moreover ECs attach to a subendothelial layer which is a 
connective tissue bed, called the basement membrane (BM). This is adjacent to the 
internal elastic lamina which is a band of elastic fibers, found most prominently in 
larger arteries. The media layer (tunica media) is composed of smooth muscle cells 
(SMCs) and variable amount of connective tissues such as collagen, elastin, and 
proteoglycans. Specially, SMCs and collagen fibers have a marked circumferential 
orientation to withstand the higher pressures in the blood circulation, as well as their 
abilities to contract or relax in response to external stimulus. The adventitia layer 
(tunica adventitia) is composed primarily of fibroblasts and loose connective tissue 
fibers (Niklason and Seruya, 2002). In arteries with diameter greater than 1 mm, the 
innermost layer of the wall (intima) is nourished from blood flow in the lumen while 
the outer layers (the adventitia and part of the media) are supplied from small blood 
vessels called vasa vasorum (How, 1992).  
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Figure 2.1. Schematic graph of the basic tri-lamellar structure of blood vessels.  
 
 The ECM in the vascular tissues forms a network composed primarily of 
collagen (mainly type I and III), elastin fibers (Figure 2.2), proteoglycans (including 
versican, decorin, biglycan, lumican, and perlecan), hyaluronan, and glycoproteins 
(mainly laminin, fibronectin, thrombospondin and tenascin). The mechanical 
properties critical to blood vessels’ functions include tensile stiffness, compliance, 
elasticity and viscoelasticity. Collagen provides the tensile stiffness; elastin offer 
elastic properties; proteoglycans contribute to compressibility; the combination of all 
are responsible for the viscoelasticity property.  
 
 15
                                                                                                                         Chapter 2                              
 
Figure 2.2. Elastic fibers. These scanning electron micrographs show (A) a low-
power view of a segment of a dog's aorta and (B) a high-power view of the dense 
network of longitudinally oriented elastic fibers in the outer layer of the same blood 
vessel. All the other components have been digested away with enzymes and formic 
acid. Reprint with permission from (Alberts et al., 2002).  
 
One important ECM structure in human body is the basement membrane (also 
called basal lamina), which is a flexible thin (40-120 nm thick) mat that underlie all 
epithelial cells (Figure 2.3) or endothelial cell sheets to separate them from the 
underlying connective tissue. In blood vessels, the basement membrane under the EC 
layer is mainly composed of EC-secreted type IV collagen and laminin nanofibers 
embedded in heparin sulfate proteoglycan hydrogels. The basement membrane shows 
a nano- to submicron-scale topography of ECM macromolecules, including fiber 
mesh, pores, ridges, grooves, and peak valleys (Kwon et al., 2005) (Figure 2.4), 
which are also the features of the nanofiber scaffold. Therefore it makes sense to use 
the non-woven polymer nanofiber scaffold to construct the inner surface of vascular 
graft capable of quick endothelialization.  
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Figure 2.3. The basal lamina in the cornea of a chick embryo. In this scanning 
electron micrograph, some of the epithelial cells (E) have been removed to expose the 
upper surface of the matlike basal lamina (BL). A network of collagen fibrils (C) in 
the underlying connective tissue interacts with the lower face of the lamina. Reprint 
with permission from  (Alberts et al., 2002). 
 
 
Figure 2.4. A model of the molecular structure of a basement membrane (basal 
lamina). Reprint with permission from (Alberts et al., 2002). 
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Mimicing the three layer structure of native blood vessels has been the 
principle in tissue engineering approaches to design vascular grafts (Niklason and 
Seruya, 2002). Basically, three models have been used to construct the native-like 
tissue engineered vascular grafts using vascular cell types: 1) a mono-layer of EC-
seeded collagen gel (Miwa and Matsuda, 1994); 2) a bi-layer of EC-monolayered 
intimal and SMC-inoculated medial layer (Matsuda and Miwa, 1995); 3) a three-layer 
of EC, SMC, and fibroblasts (Ishibashi and Matsuda, 1994). Results showed that 
three-layered vascular grafts had the highest potential of vascular wall regeneration, 
followed by the bi-layer vascular grafts (Matsuda, 2004). Robert Langer gave another 
criterion for the ideal tissue engineered vascular grafts: confluent endothelium, 
differentiated SMCs, sufficient mechanical integrity, and elastic modulus (Niklason et 
al., 1999). It was found that the short-term patency of vascular grafts is highly 
dependent on the luminal surface properties while long-term patency depends on 
mechanical properties of the grafts (Dewey et al., 1981). 
 
2.2.2 Synthetic Materials  
 
As mentioned before, tissue engineered vascular grafts have the potential to 
resolve the problem which limits application of synthetic vascular grafts in small-
diameter blood vessel replacements. In order to do this, tissue engineered vascular 
grafts should have characteristics similar to those of healthy recipients’ blood vessels, 
and allow complete integration into the biological environment with low host-tissue 
reactivity. Furthermore, an active anti-thrombogenic inner surface is necessary 
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(Tomizawa, 2003). Synthetic material’s characteristics such as biocompatibility, 
biodegradability, porosity, mechanical properties, and surface chemistry etc affect 
independently or synergistically the patency of implanted vascular grafts (Table 2.1).  
 
Table 2.1. Synthetic material requirements for tissue engineered vascular grafts  
Requirements Explanation 
Biocompatibility Haemocompatible; lack of thrombogenicity; low-
inflammatory; nontoxic; non-carcinogenic; 
nonimmunogenic; resistant to infection 
 
Biodegradability By-products of polymer degradation are not toxic; 
degradation rate should match that of tissue regeneration 
 
Porosity Allowing cell infiltration from the adventitial; maintaining 




Enough burst strength to withstand the physiological blood 
pressure and cyclic loading; compliant; elastic; good 
suturability, kink resistance 
 
Surface chemistry Bioactivity for cell attachment, spread, and proliferation 
 
Others Off the shelf availability in various diameters and lengths; 
uncomplicated storage or preparation requirements; ease of 




2.2.3 Endothelialization  
 
Seeding ECs onto the lumen of vascular grafts is a promising method to 
improve the anti-thrombogenic property of vascular grafts, which is regarded as the 
beginning of tissue engineering approach applied to the cardiovascular system 
(Nerem and Seliktar, 2001). Credit for this concept goes to Herring et al in 1978 
(Herring et al., 1978). The rationale behind ECs seeding is to provide a ‘natural’ 
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interface between the circulating blood and the underlying vascular grafts, which can 
improve resistance of vascular grafts to thrombosis and intimal hyperplasia. The 
invasion of vascular grafts by fibrous tissues and the deposition of ECs on the lumen 
were observed in animal models but not in humans, where the deposition of 
compacted fibrin was observed (Tomizawa, 2003). The “incomplete 
endothelialization” in humans is an important limitation to the patency of small-
diameter vascular grafts, leading to great research interest in the development of 
“ECs-seeding” vascular grafts.  
 
In addition to acting as natural interface between the blood and subendothelial 
tissues, an intact and quiescent endothelium proactively inhibits thrombosis 
(Maruyama, 1998;Pearson, 1999;Gross and Aird, 2000;Mitchell and Niklason, 2003). 
Figure 2.5 shows the pathway of EC anti-thrombogenic signaling. Thrombomodulin, 
a receptor expressed on the surface of ECs, catalyzes activation of protein C by 
binding thrombin. ECs also produce the anticoagulant protein S, a cofactor for protein 
C. Activated protein C proteolytically inactivates factors Va and VIIIa, thereby 
counteracting the coagulation cascade. ECs also synthesize heparan sulfate 
proteoglycans that bind antithrombin III, which neutralizes and inhibits thrombin. 
Platelet adhesion to a quiescent endothelium is suppressed by release of nitric oxide 
and prostacyclin, and by the presence of negatively charged proteoglycans on the EC 
surface. If coagulation occurs, ECs will secrete tissue-type plasminogen activator (t-
PA), which lyses fibrin clots. Thus, in the development of tissue engineered vascular 
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grafts, an important goal should be to create a confluent and adherent ECs layer with 




Figure 2.5. Pathway of thrombus formation (A) and EC antithrombogenic signaling 
(B). Reprint with permission from (Mitchell and Niklason, 2003).  
 
Although ECs-seeding is effective to provide the anti-thrombogenic layer, 
however, endothelialization has always been limited because attached ECs can detach 
from the lumen of vascular grafts upon exposure to shear force and cyclic strain due 
to blood circulation (Xue.L, 2000). Other issues like source of ECs, seeding 
efficiency of ECs, and the functional maintenance of ECs are also challenging. For 
example, endothelial progenitor cells (EPCs) from the peripheral blood and 
genetically-modified fibroblasts were used as alternatives cell sources because of the 
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difficulty of harvesting ECs from patients and the lack of off-the-shelf availability, 
which is clinically important.  
 
One of the approaches to enhance EC attachment is to immobilize either ECM 
proteins or bioactive peptides onto vascular graft’s surface (Salacinski et al., 2001b). 
For example, ePTFE was coated with fibronectin and RGD (Arg Gly Asp) containing 
peptides to improve EC attachment. The coated ePTFE was seeded with saphenous 
vein ECs for 30 min and exposed to shear stress in an artificial flow circuit. Both cell 
attachment and retention were significantly increased by coating with fibronectin as 
well as immobilization RGD containing peptides (Walluscheck et al., 1996). 
However, some bioactive molecules and ECM proteins are not EC-specific, resulting 
in adhesions of other types of cells like activated platelets, which may lead to more 
thrombogenic surface. Thus it is critical to establish a confluence and stable ECs layer 
on the lumen of vascular grafts before implantation, which can completely cover 
vascular grafts’ inner surfaces from contacting with blood cells (Shin et al., 2003). 
Moreover, bioactive peptide like Arg-Glu-Asp-Val (REDV) sequence from III-CS 
domain of human plasma fibronectin was demonstrated to only interact with the 
receptor present in ECs. The surface modification with this peptide allowed EC 
attachment and spreading but limited adhesion of vascular SMCs and platelets 
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2.2.4 Mechanical properties  
 
Mechanical property is an important parameter to decide the long-term 
patency of vascular grafts (Dewey et al., 1981). One of the main failure modes of 
vascular grafts is intimal hyperplasia especially at the anastomosis regions, which is 
believed to be associated with shear stress disturbances due to the compliance 
mismatch of the compliant artery and the rigid graft at the end-to-end anastomosis 
(Salacinski et al., 2001a). Most of the commercialized vascular grafts made from PET 
(Dacron™) and PTFE (Teflon™) are much less compliant (or too stiff) compared 
with that of the native blood vessels. This is one of the reasons for their lack of 
patency when used as the small- diameter vascular grafts. Besides compliance, 
vascular grafts should have sufficient tensile stiffness to withstand forces from the 
initial wound contraction and later tissue remodeling (Hutmacher et al., 2004), as 
well as the physiological blood pressure (120 mmHg for typical systolic pressure) 
(Niklason et al., 1999). Although significant progress has been made, fabrication of 
vascular grafts with identical mechanical properties to those of native blood vessels 
remains an elusive goal. It should be highlighted, however, that a major advantage of 
tissue engineered vascular grafts is that they don’t need to have mechanical properties 
identical to those of native blood vessels at implantation. Being composed of viable 
tissues with the potential to remodel, repair, and grow, tissue engineered vascular 
grafts should be theoretically able to completely adapt to local dynamic conditions 
and acquire the structure and mechanical features of the blood vessels, for which they 
replace.  
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2.3 Current approaches  
 
Tissue engineering has been successfully used for repair of chronic wounds 
and burns, and at the experimental study level in repair of cartilage defects. It is 
believed that a biomimetic scaffold that degrades over time will allow natural tissue 
ingrowth and healing. Optimally, the breakdown of materials used will not create 
excessively toxic, allergenic, thrombogenic or carcinogenic by-products. 
Biodegradable scaffolds and vascular cells are vital constituents in the development 
of tissue engineered vascular grafts. The main approaches include collagen-based 
construct, cell self-assembly technologies (or cell-sheets), and biodegradable polymer 
vascular graft (Seal et al., 2001).  
 
One of the earliest methods was to construct collagen gel based vascular grafts. 
Weinberg et al reported in “Science” in 1986 the technique of fabricating a three layer 
vascular graft using vascular cells grown in a tubular collagen gel: an adventitia-like 
layer made from fibroblasts and collagen, a media-like layer made from SMC and 
collagen, and an intima-like EC monolayer constructed into a tubular configuration. 
The multilayered structure of the graft resembled that of an artery. However, in order 
to withstand physiological pressures, the graft required support sleeves made from 
non-biodegradable Dacron™ (Weinberg and Bell, 1986). Figure 2.6 illustrates the 
compositions and structure of this tubular construct. Improvements were mainly 
carried out to overcome the inherent mechanical weakness of the graft by enhancing 
the structure integrity (L'Heureux et al., 1993) and circumferential tensile strength 
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(Tranquillo et al., 1996). Dynamic culture was also used to improve its mechanical 
strength (Seliktar et al., 2000). However, a collagen gel based vascular graft with 
mechanical properties comparable to that of a native blood vessel has not been shown 
with these approaches.  
 
 
Figure 2.6. Schematic representations of a collagen-based construct. The most general 
configuration contains an adventitia-like layer, a media-like layer, a monolayer of 
ECs, and DacronTM sleeves for structural reinforcement. Reprint with permission 
from (Nerem and Seliktar, 2001). 
 
The second approach used cell-assembly (cell-sheet) technology to construct 
vascular grafts, which was developed by Auger’s group in 1998 (L'Heureux et al., 
1998). The cell self-assembly model is made with intact layers of human vascular 
cells grown to overconfluence to form viable sheets of cells and ECM (Figure 2.7). 
The monolayer cell sheets formed were rolled around a mandrel to form tissue layers 
within a tubular wall. After culture, ECs were seeded onto the inner surface. 
Therefore, a three layered vascular graft was formed which mimic the structure of a 
native blood vessel. The tubular structure made by this way could withstand 2000 
mmHg pressure, similar to native arteries. When grafted in vivo, these vessels 
performed modestly, with a 50% patency rate at 1 week after implantation. The 
 25
                                                                                                                         Chapter 2                              
advantage of this approach is that it can eliminate the immunological mismatch, 
provided autologous cells are used, which is unlike the collagen-gel based vascular 
grafts using reconstituted animal proteins. However, the main drawback of this 




Figure 2.7. Schematic representation of the cell self-assembly model. Vascular cells 
are cultured to form a continuous sheet of cells and extracellular matrix and then 
rolled over a central mandrel. The construct is matured over 10 weeks, allowing the 
cell to organize into a mechanically stable tubular construct. Reprint with permission 
from (Nerem and Seliktar, 2001). 
 
The third method, met with some success recently, was to hybridize 
biodegradable polymer materials with vascular cells. In one study, SMCs were seeded 
onto a porous poly(glycolic acid) (PGA) tubular scaffold and cultured for several 
weeks in a customized bioreactor applying pulsatile radial distention (Niklason et al., 
1999) (Figure 2.8). During this time, the cells produced large amounts of ECM 
proteins concurrently with the degradation of the PGA scaffold. The cells-PGA 
constructs were maintained in a culture medium that was supplemented with 
biochemicals to promote synthesis of ECM proteins.  After 8 week’s culture, the PGA 
scaffold had been replaced by a SMC medial layer. ECs were then seeded onto the 
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lumen of the construct to form a confluent monolayer. The initial findings 
demonstrated that the construct exhibited burst pressures greater than 2000 mmHg. 
When implanted into a swine, the construct was able to remain patent for up to 4 
weeks. The use of a biocompatible and biodegradable scaffold to provide a structural 
support, as well as the dynamic bioreactor to provide mechanical stimulation, are 
particularly important in the tissue regeneration.  
 
 
Figure 2.8. Schematic representation of a cell-seeded polymeric scaffold. Vascular 
cells are cultured on a woven PGA mesh. The construct is matured over 8 weeks of 
dynamic culture, allowing the cells to proliferate and produce and organize 
extracellular matrix as the PGA degrades. Reprint with permission from (Nerem and 
Seliktar, 2001). 
 
The comparison between these three methods is summarized in Table 2.2.  
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Table 2.2. Comparison between the three methods of constructing tissue engineered 
vascular grafts (TEVG) 
TEVG Materials Advantages Disadvantages Current Status 
Collagen Gel Collagen 























human in 2006 














 First clinical 
application on 
human in 1999  
using PCL-PLLA 
tube reinforced 
with woven  PGA 




It can be seen from Table 2.2 that biodegradable polymer scaffolds approach 
went faster into the clinical practice than the other two methods. This may be due to 
that synthetic scaffolds enable better control over physical properties such as 
mechanical properties. Also varieties of surface modification methods like protein 
and peptide immobilization, plasma treatment can provide better biocompatibility to 
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Methods to produce nanoscaled polymeric fibers include electrospinning, self-
assembly, and phase separation, among which electrospinning is the most simple and 
efficient one. Electrospinning has been known for over seventy years. The patent of 
electrospinning was granted in 1902 in the USA (William, 1902). Special needs in 
biomedical and other applications have stimulated renewed interests and studies on 
electrospinning since 1990s. Since then over 200 universities and research institutes 
worldwide have investigated various aspects of electrospinning. The number of 
patents applied for process and applications based on electrospinning are also 
growing over the years. Startups such as eSpin Technologies, NanoTechnics, and 
KATO Tech are just some companies that sought to reap the unique advantages 
offered by electrospinning while companies such as Donaldson have been using 
electrospun fibers in their air filtration products for the last two decades 
(Ramakrishna et al., 2006). 
 
A key advantage of electrospinning to prepare ultra-fine polymer fibers is that 
almost any polymer with sufficiently high molecular weight that forms solution can 
be electrospun. Nanofibers made of natural polymers, polymer blends, nanoparticles 
or drug impregnated polymers and ceramic precursors have been successfully 
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electrospun. Different fiber morphologies such as beaded fibers, ribbon fibers, porous 
fibers and core-shell, have also been spun (Ramakrishna et al., 2006).  
 
The principle of electrospinning is to use an electric field to draw polymer 
solution or melt from an orifice to a collector (Figure 2.9). High voltages (10-20 kV) 
are used to generate sufficient surface charge to overcome the surface tension of the 
solution and a jet then erupts from the tip of the spinneret. The jet is only stable near 
the tip of the spinneret, after which the jet undergoes bending instability (Yarin et al., 
2001). As the charged jet accelerates toward regions of lower potential, the 
entanglements of the polymer chain will prevent the jet from breaking up while the 
solvent evaporates resulting in fiber formation. Generally, a grounded plate is used to 
collect the fibers (Figure 2.9) (Ramakrishna et al., 2006). The diameters of the 
electrospun fibers are at least one order of magnitude smaller than those made by 
conventional extrusion techniques.  
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Figure 2.9. Electrospinning basic principles (Ramakrishna et al., 2006). 
 
Electrospinning usually produces non-woven sheet with a flat profile due to 
the ejection rate of the polymer solution through the orifice must be controlled at a 
low value if nanoscaled fiber diameter is desired. However, 3-D non-woven fibrous 
mesh can be obtained if the electrospinning time is long enough. Our experiences 
show that the thickness of the nanofiber increases with the electrospinning time at a 
typical speed of 20 μm/h. One effective method to increase the thickness of the non-
woven sheet is to use more than one orifice simultaneously, in which the 
electrospinning speed will be proportional to the number of the orifices. This method 
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2.4.2 Nanofiber scaffolds  
 
The principle of designing tissue engineered scaffolds is clear: the scaffold 
should mimic the structure and biological function of native extracellular matrix 
(ECM) as much as possible, both in terms of chemical compositions and physical 
structures. In terms of chemical compositions, ECM is mainly composed of three 
major classes of biomolecules: structural proteins like collagen and elastin, 
specialized proteins like fibronectin and laminin, and proteoglycans composed of a 
protein core and glycosaminoglycans (GAGs). In terms of physical structures, ECM 
is consisted of various protein fibrils interwoven within a hydrated network of GAG 
chains (Lutolf and Hubbell, 2005). The function of the ECM is far more than 
providing a physical support for cells. It also provides a substrate with specific 
ligands for cell adhesion and migration, and regulates cellular proliferation and 
functions by storing and presenting various growth factors (Alberts et al., 2002). It is 
reasonably expected that an ECM-mimic tissue engineered scaffold may play a 
similar role to promote tissue regeneration in vitro as the native ECM does in vivo.  
 
Polymer nanofiber scaffold is among the most promising biomaterials for 
native ECM analogues (Ma et al., 2005b). The potential of applying electrospinning 
in tissue engineered scaffolds is enormous since nanofiber scaffolds can mimic the 
nanoscaled dimension of the natural ECM and mesoscopic scale of ECM’s spatial 
organization by controlling fiber’s orientation and spatial placement. Moreover, 
nanofiber scaffolds can emulate chemical compositions of ECM by including 
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biomolecules into fibers. We found that there is a vivid similarity between the 
electrospun polycaprolactone (PCL) nanofiber scaffold and native ECM in rat cornea 
(Figure 2.10) (Nishida et al., 1988). Another example is the apparent similarity 
between the electrospun collagen nanofibers and the ECM of the small intestine, 
which is composed of collagen bundles, in terms of both physical structure and 
chemical composition (Figure 2.11) (Teo et al., 2006). In fact, non-woven 
microscaled polymer scaffolds have already been widely used in tissue engineering 
for a long time due to their high surface area and high porosity (Cao et al., 1997).  
 
 
Figure 2.10. Similarity between the native ECM protein structure and the electrospun 
polymer nanofiber scaffold. (a) Fibroblasts grown in vivo on collagen fibrils of rat 
cornea (Nishida et al., 1988); (b) ECs cultured in vitro on the electrospun PCL 
nanofiber scaffold. Reprint with permission from (Ma et al., 2005b). 
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  a                                                                   b 
Figure 2.11. Similarity between (a) the natural collagen bundles of the connective 
stroma of the small intestine (Ottani et al., 2001) and (b) the electrospun collagen 
nanofibers. Reprint with permission from (Teo et al., 2006).  
 
Most of widely used biomaterials have been fabricated into electrospun 
nanofiber scaffolds. Typical biodegradable polymers like PLGA or PCL and water 
soluble polymers like poly(ethylene oxide) (PEO) and poly (vinyl alcohol) (PVA) can 
be easily electrospun into nanofibers using organic or water solvent (Jaeger et al., 
1998;Li et al., 2002;Li et al., 2003;Drew et al., 2003). Natural occurred biomaterials 
like collagen (Huang et al., 2001;Matthews et al., 2002;Matthews et al., 2003;Rho et 
al., 2006;Chen et al., 2006;Yoo et al., 2006), silk protein (Jin et al., 2002;Kim et al., 
2003;Min et al., 2004;Jin et al., 2004;Kim et al., 2005b), elastin-mimic peptide 
(Huang et al., 2000), fibrinogen (Wnek et al., 2003), casein and lipase enzyme (Xie 
and Hsieh, 2003) and even DNA (Fang and Reneker, 1997) have also been 
electrospun into nanofibers. Electrospinning of the natural occurred biomaterials is 
much more challenging compared with the synthetic polymers for the difficulties in 
looking for appropriate solvent. 1,1,1,3,3,3-hexafluoro-2-propanol (HFP) is a 
commonly used solvent for electrospinning of proteins (Matthews et al., 2002;Wnek 
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et al., 2003). Electrospinning of silk fibroin has been performed with formic acid as 
the solvent (Kim et al., 2003;Min et al., 2004). The silk fibroin can also be mixed 
with PEO in water and electrospun, followed by washing with methanol to remove 
the PEO (Jin et al., 2002;Jin et al., 2004). Huang et al prepared polypeptides 
containing repeated elastomeric peptide sequence of elastin by genetic engineering 
method. The polypeptide was dissolved in water and electrospun into nanofibers with 
diameter from 200 to 300 nm under appropriate conditions (Huang et al., 2000). Fang 
X et al reported the electrospinning of calf thymus Na-DNA aqueous solutions with 
concentrations from 0.3% to 1.5% into nanofibers with diameters around 50 to 80 nm 
(Fang and Reneker, 1997). 
 
The simplicity and reproducibility of fabricating well-controlled polymer 
nanofiber scaffolds by electrospinning have invigorated big interests in the field of 
tissue engineering. In addition to the ECM-like architecture, polymer nanofibers have 
other desired features for tissue engineered scaffolds such as biocompatibility, high 
porosity for tissue ingrowth, high surface area-to-volume ratio, adjustable mechanical 
and biodegradable properties, capability of surface modification (Ma et al., 2005c), 
and flexibility of loading drugs or genes (Luu et al., 2003). Studies have been carried 
out in the application of polymer nanofiber scaffolds as tissue engineered bone 
(Yoshimoto et al., 2003), blood vessel (Mo et al., 2004;Xu et al., 2004a;Xu et al., 
2004b;Ma et al., 2005c), cartilage (Li et al., 2002;Li et al., 2005), cardiac tissue (Shin 
et al., 2004), peripheral nerve system (PNS) (Bini et al., 2004;Yang et al., 2005), 
ligament (Lee et al., 2005), liver (Chua et al., 2005), and skin  (Li et al., 2002) etc. 
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2.4.3 Surface modifications of polymer nanofibers 
 
It has been well known that the interactions between cells and their 
environments are meditated by the “bio-recognition processes”, the specific binding 
of the receptors on cell surfaces with their corresponding ligands (Elbert and Hubbell, 
1996). In native tissues in vivo, cell attachment on ECM is mediated by the binding 
between integrins (receptors on cell surfaces) and ECM adhesion proteins such as 
collagen, fibronectin, vitronectin, and laminin etc. On biomaterial surfaces in vitro, 
the same mechanisms also apply. When foreign materials come into contact with 
body fluids or cell culture mediums, the initial response is protein adsorptions atop 
material’s surfaces. Thus materials interact with cells through the adsorbed protein 
layer. The composition and structure of this protein layer play critical roles in 
determining subsequent cell behaviors (Elbert and Hubbell, 1996). A successful tissue 
engineering scaffold should have cell compatible surface to allow cell attachment and 
proliferation. 
 
There are advantages and disadvantages for both synthetic and natural 
polymers when used as tissue engineering scaffolds (Table 2.3). Synthetic polymers 
often do not possess surface properties needed for tissue engineering applications. 
Actually, most mechanically strong and chemically stable synthetic polymers often 
have inert surfaces both chemically and biologically. In contrast, those natural 
polymers having active surfaces usually do not possess excellent mechanical 
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properties which are critical for their successful applications as tissue engineering 
scaffolds.  
 
Table 2.3. Comparison between synthetic and natural polymers 
Polymers Advantages Disadvantages 
Synthetic  Easily synthesized with 
controlled molecular weight 
and other physical properties 
like mechanical properties 
 
Lack of intrinsic biological activity 
Natural  Possess intrinsic biological 
activity; enzymatically 
degradable 
Source-related variability and 
contamination; limited control over 
parameters such as molecular 
weight; the potential for adverse 
immunological responses; variation 
in degradation rates due to 
difference in host enzyme levels; 
inferior mechanical properties 
 
The same problem is also faced by electrospun synthetic polymer nanofibers 
when used as tissue engineering scaffolds. Thus surface modifications of synthetic 
polymer nanofibers were widely studied. Functionalization of polymer nanofibers is 
typically carried out either through direct incorporating biomolecules into the 
spinning solution during electrospinning process or through immobilizing 
biomolecules onto the surface of nanofibers during the postprocessing step (Pham et 
al., 2006). Special attentions are required to protect biodegradable polymer 
nanofibers from rapid degradation and destruction during surface modification 
process. Strong reaction conditions such as plasma, ultraviolet (UV), γ radiation, high 
temperature, and acidic or basic environments may destroy degradable nanofibers to 
some extent. Because of the high surface area-to-volume ratio, biodegradable 
polymer nanofibers may degrade much faster than bulk materials due to the larger 
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contact area between nanofibers and the environment. It was found that even 
poly(ethylene terephthalate) (PET) nanofibers showed considerable degradation in 
acidic or basic solutions. Some surface modification methods, such as physical 
coating and “layer by layer” electrostatic interaction, can immobilize biomolecules 
onto nanofiber surfaces under very moderate conditions, and thus may be the most 
ideal methods in future (Ma et al., 2005b).  
 
2.4.3.1 Physical methods 
 
The easiest and the most straightforward way to modify polymer surfaces is 
coating biomolecules onto polymer surfaces or just blending biomolecules into bulk 
polymers. Although the biggest limitation of this technique is the instability of the 
polymer surface compositions caused by the losing of biomolecules from polymers, it 
is still a good choice if this losing is too slow to be considered, or not fast enough to 
affect applications of surface modified polymers. For example, collagen, fibronectin 
and laminin have been coated onto the electrospun silk fibroin (SF) nanofiber 
surfaces to promote cell adhesion (Min et al., 2004). Human keratinocytes and 
fibroblasts showed spreading morphology and good attachment on the modified SF 
nanofibers. Similar results were also reported on collagen-coated poly(ε-caprolactone) 
(PCL) nanofibers, which showed improved smooth muscle cell growth and 
attachment (Venugopal et al., 2005). Similar to coating, blending is another physical 
method of modifying nanofiber surfaces. Differently, blending is carried out during 
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the electrospinning process, while coating is carried out in the postprocessing of 
electrospun nanofibers.   
 
Due to the simplicity and flexibility of blended electrospinning, different 
combinations of biomolecules and polymers were blended and electrospun into 
nanofibers for various tissue engineering applications (Table 2.4). For example, 
polyanifine (PANi)/gelatin and poly(lactide-co-glycolide)/gelatin/elastin blended 
nanofibers were investigated for the potential application of supporting rat cardiac 
myoblast growth (Li et al., 2006b;Li et al., 2006c). Results indicated that those 
blended nanofibers supported cell attachment and proliferation. In another study, 
human epidermal fibroblasts were cultured on poly(glycolic acid) (PGA)/chitin 
blended nanofibers and showed good cell attachment and spreading (Park et al., 
2006b). The same group also studied the behavior of human epidermal keratinocytes 
and fibroblasts on the chitin/silk fibroin blended nanofibers and observed an excellent 
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Table 2.4. Summary of different combinations of biomolecules and polymers in 
blended nanofibers and their applications in tissue engineering 
Combinations in blended nanofibers  Application Cells used 
Poly(L-lactide-co-epsilon-caprolactone) 
P(LLA-CL) / collagen and P(LLA-CL) /  
tri-n-butylamine salt of heparin (heparin-







Polyaniline (PANi) / gelatin 
 (Li et al., 2006b) 
 
Heart regeneration Rat cardiac 
myoblasts 
Poly (lactide-co-glycolide) (PLGA) /  
gelatin / elastin (Li et al., 2006c)  
 
Heart regeneration Rat cardiac 
myoblasts 
Poly(glycolic acid) (PGA) / chitin  
(Park et al., 2006b) 
 
Skin regeneration Human epidermal 
fibroblasts 




Poly lactide-co-glycolide (PLGA) / 





Collagen / elastin  






Collagen / PEO  






Collagen / chondroitin sulfate (CS)  
(Zhong et al., 2005) 




Poly (epsilon-caprolactone) (PCL) / 
collagen (Ekaputra et al., 2006)  




As the kind of special blended nanofibers, composite nanofibers containing 
both organic and inorganic elements were also fabricated through blended 
electrospinning (Table 2.5). 
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Table 2.5. Composite nanofibers fabricated through blended electrospinning  
Combination in composite nanofibers Application Cells used 
Polycaprolactone (PCL) / calcium 
carbonate (CaCO3) 





Silk fibroin / bone morphogenetic 
protein 2 (BMP-2) / nanoparticles of 
hydroxyapatite (nHAP) (Li et al., 2006a)
 
Bone regeneration Human bone marrow-
derived mesenchymal 
stem cells  
Poly(3-hydroxybutyrate-co-3-
hydroxyvalerate) (PHBV) / 




Cos-7 cells, originating 
from the kidney of an 
Africa green monkey 
Gelatin / hydroxyapatite (HA)  






Blended electrospinning also offer the flexibility of loading drugs into carrier 
polymers during electrospinning (Pham et al., 2006). But it is possible that 
bioactivities of drugs may be destroyed in organic solvents and under high electric 
field during electrospinning process. For example, Casper et al. incorporated heparin 
into nanofibers of PEO and PLGA by mixing it directly into the spinning solution 
(Casper et al., 2005). By labeling the heparin with a fluorescent dye, the heparin was 
found to be distributed both throughout individual fibers and the thickness of NFM. 
Incorporation of poly (ethylene glycol) PEG-heparin resulted in improved heparin 
retention in the nanofibers (Pham et al., 2006). Table 2.6 summarizes research on 
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Table 2.6. Blended nanofibers containing heparin through blended electrospinning 
Combination of blended 
nanofibers  
Application Release profile  
Heparin (or PEG-Heparin) / 
PEO / PLGA  
(Casper et al., 2005) 
 
Drug delivery, tissue 
engineering, wound 
healing 
Incorporation of PEG-heparin 
permits retention of the heparin 
for at least 14 days 
Heparin / PCL  
(Luong-Van et al., 2006) 
Drug delivery, blood 
vessel regeneration  
A total of approximately half of 
the heparin was released by 
diffusion from the nanofibers 
after 14 days.  
 
Tri-n-butylamine salt of 
heparin (Heparin-TBA) / 
poly(L-lactide-co-epsilon-
caprolactone) P(LLA-CL) 
(Kwon and Matsuda, 2005) 
Blood vessel 
regeneration 
The releasing rate, released 
amount, and surface content of 
heparin-TBA were increased 
with increasing heparin-TBA 
content in blended fibers 
 
 
Blended electrospinning was also used to overcome the disadvantage of un-
spinnabillity of some polymers due to their molecular weight/solubility. Polymers 
which are well-suited for electrospinning can be blended with the original polymers 
to facilitate the electrospinning process. For example, PEO was added into the 
aqueous solution of 3,3'-dithiobis(propanoic dihydrazide)-modified hyaluronic acid 
(HA-DTPH) at an optimal weight ratio of 1:1. The electrospun HA-DTPH/PEO blend 
scaffold was subsequently cross-linked through poly (ethylene glycol)-diacrylate 
(PEGDA) mediated conjugate addition. PEO was then extracted in DI water to obtain 
an electrospun HA-DTPH nanofibrous scaffold (Ji et al., 2006) .  
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 2.4.3.2 Chemical methods  
 
In addition to physical coating or blending, covalently grafting of ECM 
proteins like collagen and gelatin onto nanofiber surfaces is another choice with the 
ultimate goal of the development of biocompatible tissue engineering scaffolds. 
Grating is the simplified term of graft copolymerization. For initiation of graft 
copolymerization, radicals or groups which can produce radicals like peroxide groups 
must be introduced onto polymer surfaces first. For most of chemically inert 
polymers, this can be achieved via irradiation (γ-ray, electron beams, UV, etc), plasma 
treatment, and Ozone (O3) or hydrogen peroxide (H2O2) oxidization or Ce4+ 
oxidization. Then the polymer to be surface modified is usually immersed in a 
monomer solution, so that the radicals produced on the polymer surface can 
immediately initiate the copolymerization of the monomer (Figure 2.12).  
 
Figure 2.12. General scheme of graft copolymerization on polymer surfaces. 
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 The following are three typical examples of how grafting was applied to 
modify nanofiber surfaces through the initiation by irradiation, plasma and 
oxidization respectively (Table 2.7).  
 
Table 2.7. Summary of the three graft copolymerization methods applied to modify 
nanofiber surface  
Materials Application Methods 
Poly(e-caprolactone-co-ethyl 
ethylene phosphate) 
(PCLEEP) nanofiber surface 
grafted with Galactose 
 
Artificial liver Graft copolymerized of PMAA initiated
by UV irradiation, followed by 
immobilization of 1-O-(60-
aminohexyl)-D-galactopyranoside 
(AHG) on carboxyl groups in PMAA 
 
Poly(ε-carprolactone) (PCL) 




Air Plasma treatment to yield carboxyl 
groups, followed by immobilization of 
gelatin on the carboxyl groups 
 
Poly(ethylene terephthalate) 
(PET) nanofiber surface 
grafted with gelatin 
Blood vessel 
regeneration 
Graft copolymerized of PMMA 
initiated by Ce4+ oxidization, followed 
by immobilization of gelatin on 
carboxyl groups in PMMA 
 
 
Chua et. al., used radiation induced graft copolymerization to develop the 
biofunctional poly(ε-caprolactone-co-ethyl ethylene phosphate) (PCLEEP) nanofiber 
scaffold for hepatocyte culture (Chua et al., 2005). This was achieved by conjugating 
hepatocyte-specific galactose ligands onto the nanofiber surface. Poly(acrylic acid) 
was grafted onto the nanofiber scaffold via UV-induced graft copolymerization using 
acrylic acid (AAc) monomers. The COOH sites on the grafted scaffold was then used 
as immobilization sites to conjugate1-O- (6’-aminohexyl)-D-galactopyranoside 
(AHG) (Figure 2.13). The functionalized AHG-P(AAc)-grafted nanofiber scaffolds 
exhibited much higher hepatocyte attachment as compared to unmodified scaffold. 
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Figure 2.13. Surface modification scheme for galactose conjugation to PCLEEP 
nanofibers. Reprint with permission from (Chua et al., 2005). 
 
  For gelatin grafting on the poly(ε-carprolactone) (PCL) nanofiber surfaces, 
PCL nanofibers were first treated with air plasma to introduce -COOH groups on the 
surface followed by covalently grafting of gelatin molecules, using 1-ethyl-3-(3-
dimethylamino-propyl) carbodiimide hydrochloride (EDAC) as the coupling agent 
(Figure 2.14) (Ma et al., 2005a).  
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Figure 2.14. Reaction scheme of the surface modification process for PCL nanofiber. 
RFGD, Radio-frequency glow discharge. Reprint with permission from (Ma et al., 
2005a). 
 
One popular method to covalently attach protein molecules on polymer 
surface is to grafting poly(methacrylic acid) (PMMA) on the biomaterial surface to 
introduce carboxyl groups at first, followed by the grafting of the protein molecules 
using water soluble carbodiimide as coupling reagent (Steffens et al., 2002). 
Electrospun poly(ethylene terephthalate) (PET) nanofibers were grafted with gelatin 
on the surface. The PET nanofiber was first treated in formaldehyde to yield hydroxyl 
groups on the surface, followed by the grafting copolymerization of methacrylic acid 
(MAA) initiated by Ce4+ oxidization. Finally the PMAA grafted PET nanofiber was 
grafted with gelatin using water-soluble 1-ethyl-3-(3-dimethylamino-propyl) 
carbodiimide hydrochloride (EDAC) as coupling agent (Figure 2.15) (Ma et al., 
2005c). Both the gelatin modified PCL and PET nanofibers showed improved EC 
compatibility than the unmodified nanofibers.  
 
 46
                                                                                                                         Chapter 2                              
 
Figure 2.15. Schematic representation of the surface modification process of PET 
nanofibers. Reprint with permission from (Ma et al., 2005c).  
 
 
There are several other reports regarding the immobilization of biomolecules 
onto nanofiber surfaces. Bone morphogenetic protein-2 (BMP-2) immobilized 
chitosan nanofibers increased osteoblastic cell attachment, proliferation, alkaline 
phosphatase activity, as well as calcium deposition (Park et al., 2006c). Arg-Gly-Asp 
(RGD) immobilized poly(D,L-lactic-co-glycolic acid) (PLGA) nanofibers enhanced 
fibroblasst attachment, spreading, and proliferation (Kim and Park, 2006). Covalent 
modification of the polyamide nanofibers with neuroactive peptides derived from 
human tenascin-C significantly enhanced the ability of the nanofibers to facilitate 
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2.4.3 Cells-nanofiber scaffolds interactions 
 
  The reason why we need to study the interactions between cells and 
biomaterials in vitro is based on the theory that “macroscopic tissue-level events are 
ultimately derived from, and thus could be controlled by, cellular and molecular level 
events at the tissue-implant interface” (Giliberti et al., 2002). Thus any implant 
should be studied in vitro first before implantation in vivo for the interactions of cells 
and biomaterials in terms of cell adhesion, proliferation, phenotype maintenance, and 
functional development.  
 
 It has been well established that gross change in ECM affects cell behaviors. 
However little is known about how cell behaviors will be affected by fine changes at 
the nanometer scale in the synthetic ECM. Researchers as early as 1960s claimed that 
nanoscaled features influenced cell behaviors (Rosenberg, 1963). Cells attached and 
organized well around fibers with diameters smaller than size of cells (Laurencin et 
al., 1999). Nanoscaled surface roughness with dimensions ranging from 20 to 50 nm 
produced by chemical etching on Silicone wafer enhanced neural cell adhesion and 
hydroxylase activity (Fan et al., 2002). Nanoscaled surface topography has been 
found to promote osteoblast adhesions (Webster et al., 1999). Recent studies reported 
that osteoblast adhesion, proliferation, alkaline phosphatase activity, and ECM 
secretion on carbon nanofibers increased with deceasing fiber diameters in the range 
of 60-200 nm, while the adhesion of other cells like chondrocytes, fibroblasts, and 
smooth muscle cells was not affected (Elias et al., 2002;Price et al., 2003). It has been 
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postulated that the nanoscaled surface affects the conformation of the adsorbed 
adhesion proteins like vitronectin to affect the cell behaviors (Webster et al., 2001). 
In addition, the nanoscaled dimension of the cell membrane receptors like integrins 
should also be considered.  
 
Most of the works about in vitro cell culturing on nanofiber scaffolds was to 
evaluate cell adhesion, proliferation, gene expression and ECM secretion. Li et al  
cultured fibroblasts, cartilage and bone marrow derived mesenchymal stem cells on 
PLGA or PCL nanofibers (Li et al., 2002;Li et al., 2003;Li et al., 2005). It was found 
that the nanofiber scaffolds were capable of supporting cell attachment and 
proliferation. Fetal bovine chondrocytes were cultured on PCL nanofibers and their 
phenotype was evaluated. The chondrocytes seeded on the PCL nanofibers and 
cultured in serum-free medium continuously maintained their phenotype by 
expressing cartilage-specific ECM genes. In addition to promoting phenotypic 
differentiation, the PCL nanofibers also promoted chondrocyte proliferation when the 
cultures were maintained in serum-containing medium (Li et al., 2003). Adult bone 
marrow derived mesenchymal stem cells cultured in the PCL nanofibers were able to 
be induced to form chondrocytes in the presence of transforming growth factor (TGF-
β1), as evidenced by chondrocyte-specific gene expressions and synthesis of 
cartilage-associated ECM proteins. The chrondrogenic ability of the stem cells 
cultured in the PCL nanofibers was comparable to that observed for the stem cells 
maintained as cell aggregates or pellets (Li et al., 2005).  
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2.4.5 Current research of polymer nanofibers as tissue engineered 
vascular grafts 
 
 As we mentioned before, there are requirements on materials for tissue 
engineered vascular grafts applications, which is summarized in Table 2.1. 
Electrospun nanofiber scaffolds have shown the potential to fulfill most of those 
requirements. Most commonly, synthetic polymers were used to construct nanofiber 
scaffolds for the application of tissue engineered vascular grafts. Poly(L-lactide-co-ε-
caprolactone) (PLCL 50/50) were electrospun using 1,1,1,3,3,3-hexafluoro-2-
propanol (HFP) as the solvent. Human umbilical vein endothelial cells (HUVECs) 
were found to adhere well and proliferate on the small-diameter fiber fabrics (0.3 and 
1.2 μm in diameter) but not on the large-diameter fiber fabrics (7.0 μm in diameter) 
(Kwon et al., 2005). Surface modification of electrospun poly(ethylene terephthalate) 
(PET) and poly(ε-caprolactone) (PCL) nanofibers improved the spreading and 
proliferation of human coronary artery endothelial cells (HCAECs) (Ma et al., 
2005a;Ma et al., 2005c). Both random and aligned electrospun poly( -lactid-co- -
caprolactone) P(LLA-CL) nanofiber scaffolds supported human coronary artery 
smooth muscle cells (HCASMCs) attachment and proliferation. Also HCASMCs 
attached and migrated along the axis of the aligned nanofibers and expressed a 
spindle-like contractile phenotype (Xu et al., 2004a).  
 
Some researchers also made use of natural polymers to construct nanofiber 
scaffolds for the application of tissue engineered vascular grafts. Huang et al. used 
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recombinant protein based on repeating elastomeric peptide sequence of elastin (Val-
Pro-Gly-Val-Gly)4(Val-Pro-Gly-Lys-Gly) to electrospin a non-woven mesh of fibers. 
The ultimate tensile strength of the nonwoven fabrics was 35 MPa and the material 
modulus was 1.8 GPa (Huang et al., 2000). Natural collagen and elastin were also 
electrospun into nanofiber scaffolds as tissue engineered vascular grafts (Buttafoco et 
al., 2006). 
 
In order to combine advantages of both synthetic and natural polymers, 
blended nanofiber scaffolds containing synthetic and natural polymers were 
constructed as tissue engineered vascular grafts. Kwon and Matsuda reported the 
fabrication of two kinds of blended nanofibers. The first blended nanofibers consisted 
of PLCL and collagen fibers, and the second ones consisted of PLCL and tri-n-
butylamine salt of heparin (heparin-TBA) (Kwon and Matsuda, 2005). Human 
umbilical vein endothelial cells cultured on the first type of blended nanofibers 
containing 5 and 10 wt% collagen were highly elongated and well spread. With the 
second type of blended nanofibers containing the heparin, a burst release was 
observed in the first 12 h when they were soaked in PBS at 37oC. After then, 
relatively sustained release rate was observed for 4 weeks probably due to the 
degradation of the PLCL. By electrospinning both blends simultaneously on the same 
collector, it may be possible to fabricate a scaffold that is able to encourage cell 
adhesion and proliferation, and at the same time exhibit anti-thrombogenic properties. 
Stitzel et al. fabricated vascular grafts using blended nanofiber scaffolds which 
consisted of Type I collagen, elastin, and poly (D,L-lactide-co-glycolide). The 
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electrospun scaffold was biocompatible and did not elicit local or systemic toxic 
effects when implanted (Stitzel et al., 2006).  
 
There are also novel ways to design nanofiber scaffolds with a flexible 
hierarchical organization in terms of structure, topography and material composition, 
which may make it possible to better simulate the tri-layer structure of natural blood 
vessels. The group from Takehisa Matsuda developed the sequential multilayering 
electrospinning and mixing electrospinning (Kidoaki et al., 2005). By sequential 
electrospinning of collagen, styrenated gelatin, and segmented polyurethane (SPU) 
layer by layer, a tri-layered electrospun NFM was constructed. By simultaneous 
electrospinning of SPU and PEO onto the same collector with high-speed rotation and 
traverse movement, the mixed electrospun NFM composed of SPU and PEO was 
prepared. Furthermore, a bi-layered tubular scaffold composed of a thin inner layer of 
collagen and a thick outer layer of SPU was developed as a prototype of artificial 
vascular grafts. Similarly, Vaz et al. electrospun a bi-layered tubular scaffold 
composed of an inner layer of random and compliant PCL and a outer layer of 
oriented and stiff PLA through the sequential multilayering electrospinning  as a 
candidate tissue engineered vascular scaffold (Vaz et al., 2005).  
 
The most attractive option of using electrospinning to fabricate vascular graft 
is its ability to electrospin small-diameter tubes with uniform thickness and fiber 
distribution throughout the scaffold. The latest research is summarized in Table 2.8.  
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Table 2.8. Summary of constructing tubular tissue engineered vascular grafts through 
electrospinning 







2.3-2.5 50-340 (Inoguchi et 
al., 2006) 
 
Segmented polyurethane (PSU) 3 250 (Matsuda et 
al., 2005) 
 
Inner: collagen; outer: PSU 3 500 (Kidoaki et 
al., 2005) 
 
Collagen, elastin and poly (D,L-
lactide-co-glycolide)  (PLGA) 
4.75 N.A (Stitzel et al., 
2006) 
 
Inner: PCL; outer: polyurethane 
(PU) 




A very recent study by Prof. Li’s group in UC Berkeley showed that human 
bone marrow mesenchymal stem cells (MSC) inoculated nanofiber scaffolds 
displaced excellent long-term patency and exhibited well organized layers of ECs and 
SMCs when implanted to replace the common carotid artery in athymic rats for 60 
days. While acellular grafts (without MSCs) resulted in significant intimal thickening. 
These results demonstrate several favorable characteristics of nanofibrous scaffolds 
and the important role of seeded cells in the scaffolds towards in vivo patency of 
scaffolds (Hashi et al., 2007).  
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Chapter 3 
 
Collagen-Blended P(LLA-CL) Nanofiber Meshes (NFM) 
 
Many studies have been carried out to apply electrospun nanofibers as tissue 
engineered scaffolds. In most of these studies, synthetic polymers such as 
poly(caprolactone) (PCL), poly(L-lactide) (PLA), and poly(glycolide) (PGA) etc 
were widely used. In parallel, natural materials like collagen, silk protein, elastin-
mimic peptide, fibrinogen etc have also been used. The disadvantage for synthetic 
polymers is their lack of cell-recognition signals, which can be found in natural 
materials. This problem could be overcome by modification of synthetic polymer 
nanofibers with natural materials, either through blending natural materials into the 
spinning solution prior to electrospinning, or immobilizing natural materials onto the 
surface of polymer nanofibers after electrospinning (Pham et al., 2006).  
 
Although previous studies in our laboratory have demonstrated that human 
coronary artery smooth muscle cells (HCASMCs) cultured on the P(LLA-CL) NFM 
showed normal morphology and good proliferation, human coronary artery 
endothelial cells (HCAECs) were found not to be able to grow well on the P(LLA-CL) 
NFM (Xu et al., 2004b), which may be due to the lack of ECs recognition sites on 
pure polymer NFM. Collagen is a native adhesion protein, interacting through RGD 
domain with integrins receptors in cell membranes (Ruoslahti and Pierschbacher, 
1987). This interaction results in focal adhesion of cells on substrates, which benefits 
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cell attachment and movement. Therefore it is probable that inclusion of collagen into 
the P(LLA-CL) NFM would increase their bioactivity. In this chapter, collagen-
blended P(LLA-CL) NFM were fabricated by electrospinning a mixture of collagen 
and P(LLA-CL) dissolved in 1,1,1,3,3,3-hexafluro-2-propanol (HFP). Morphology, 
porosity, mechanical properties, and surface chemistry of the collagen-blended NFM 
were studied. Behaviors of HCAECs on the collagen-blended NFM were analyzed in 
terms of morphology, viability, attachment, and phenotype. 
 
3.1 Materials and methods  
 
3.1.1 Materials  
 
Poly(L-lactic acid)-co-poly(epsilon-caprolactone) random copolymer [P(LLA-
CL), 70:30] was bought from Boehringer (Ingelheim, Germany), with a molecular 
mass of 150 kDa. 1,1,1,3,3,3-hexafluro-2-propanol (HFP) and Collagen Type I from 
calf skin were purchased from Sigma-Aldrich (St. Louis, MO, USA). CMFDA 
fluorescent CellTracker probe was purchased from Molecular Probe (Eugene, OR, 
USA). CellTiter 96® AQueous One Solution assay was purchased from Promega 
(Madison, WI, USA)   
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3.1.2 Fabrication of collagen-blended P(LLA-CL) NFM  
 
P(LLA-CL) and collagen were dissolved in HFP with different weight ratios 
(4:1, 2:1, 1:1, 1:2) while maintaining the total weight concentration as 5 wt%. The 
solution was then filled in a syringe. With the aid of a syringe pump, the solution was 
ejected out through a needle tip with an inner diameter of 0.21 mm at a constant feed-
rate of 1.2 mL/h. A high DC voltage of 12 kV (Gamma High Voltage Research, 
Ormond Beach, FL, USA) was applied between the needle and a grounded aluminum 
plate which was 12cm below the needle. The electric field generated by the surface 
charge caused the solution drop at the tip of the needle to distort into a Taylor cone. 
Once the electric potential at the surface charge exceeded a critical value, the 
electrostatic forces would overcome the solution surface tension and a thin jet of 
solution would erupt from the surface of the cone. The schematic setup and the 
optimized parameters for fabrication of the collagen-blended P(LLA-CL) NFM are 
shown in Figure 3.1. The nanofibers were collected on an aluminum collector. For 
future cell culturing in 24-well tissue culture polystyrene (TCPS) plate, coverslips 
(Assistent, 15 mm in diameter; Karl Hecht, Sondheim, Germany) were placed on top 
of the aluminum foil to collect the NFM directly. Pure collagen NFM was fabricated 
by dissolving collagen in HFP and then electrospun into nanofibers.  
 
Uniform smooth films of the P(LLA-CL)-collagen (1:1 w/w) were prepared 
by a solvent casting method. Briefly, P(LLA-CL) and collagen were first dissolved at 
a concentration of 5 wt% in HFP. The resulting solution was then cast onto the 15 
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mm coverslips which were put into a 24-well TCPS plate. After solvent evaporation 
in open air, the P(LLA-CL)-collagen coated coverslips [hereafter referred to as 




Figure 3.1.Schematic setup and optimized operation parameters for fabrication of the 
collagen-blended P(LLA-CL) NFM. 
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3.1.3 Material characterization 
 
3.1.3.1 Physical properties  
 
Scanning electron microscopy (SEM) micrographs of the collagen-blended 
P(LLA-CL) NFM were obtained with a JSM-5800LV SEM (JEOL, Tokyo, Japan). 
Transmission electron microscopy (TEM) micrographs of the NFM were obtained 
with a JEM-2010F FasTEM field emission electron microscope (JEOL) operated at 
100 kV. The NFM for the TEM observation were prepared by directly depositing the 
as-spun NFM onto copper grids that had been coated with a supportive Formvar film 
(Structure Probe, SPI Supplies Division, West Chester, PA, USA). 
 
Diameter range of the fabricated NFM was measured using image analysis 
software (Image J, National Institutes of Health, Bethesda, MD, USA) by random 
counting of 60 nanofibers on the SEM images. The thickness of the collagen-blended 
P(LLA-CL) NFM was measured with a micrometer (Mitutoyo, Kawasaki, Japan) and 
its apparent density and porosity were calculated according to the following equations 

















cmgdensityapparentNFMporosityNFM   
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3.1.3.2 Surface chemistry  
 
 Attenuated total reflectance Fourier transform infrared (ATR-FTIR) spectra 
were obtained using an AVATAR 380 FTIR machine (Thermo Electron, Waltham, 
MA, USA). Surface chemistry analysis of the NFM was performed by X-ray 
photoelectron spectroscopy (XPS) (VG Escalab 2201-XL, Thermo VG 
Scientific/Thermo Electron, East Grinstead, UK) with a take off angle of 90o. The 
binding energy was referenced to the C1S of saturated hydrocarbon at 285.0 eV. 
 
3.1.3.3 Mechanical properties 
 
Tensile tests were carried out with a 5848 microtester (Instron, Norwood, MA, 
USA) at a stretching speed of 10 mm/min and with a 40 mm gauge length. NFM 
samples were cut into a rectangular (10 × 60 mm) shape. The NFM thickness 
measured by a micrometer and the NFM width (10 mm) was input into the computer 
to calculate the tensile strengh and strain. 
 
3.1.4 Characterization of cellular behaviors  
 
3.1.4.1 In vitro cell culture 
 
Collagen-blended P(LLA-CL) NFM were deposited on round 15 mm diameter 
coverslips, which fits nicely into the bottom of 24-well TCPS plate. A small amount 
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of implant-grade silicon adhesive (Silbione, MED ADH 4300 RTV; Rhodia, 
Boulogne-Billancourt, France) was applied along the edge of the NFM to immobilize 
them on the coverslip surface. The highly inert silicon adhesive has no toxic effects 
on cells (Ma et al., 2005c). Ethanol solution (75%) was used to sterilize samples and 
was removed by rinsing with phosphate buffered saline (PBS). 
 
Human coronary artery endothelial cells (HCAECs) obtained at passage 3 
from Biowhittaker (New Jersey, USA) were seeded into the 24-well plate containing 
NFM at given seeding densities. Cells were cultured in endothelial cell basal medium 
(CloneticsTM EBM®-2) supplemented with EC growth supplements (vascular 
endothelial growth factor [VEGF], human epidermal growth factor [hEGF], human 
fibroblast growth factor-B [hFGF-B] insulin-like growth factor type I [IGF-I], 
hydrocortisone, and ascorbic acid) purchased from Cambrex (North Brunswick, NJ, 
USA), 5% fetal bovine serum (FBS), penicillin (100 units/mL), and streptomycin 
(100 µg/mL). Medium was replaced every 4 days and cultures were maintained in a 
humidified incubator at 37°C with 5% CO2. When the cells reached 80-90% 
confluence (confluence density, 5 × 104 cells/cm2), they were trypsinized and sub-
cultured at a 1:3 ratio.  
 
3.1.4.2 Cellular morphology 
 
Cellular morphology was either studied by laser scanning confocal 
microscope (LSCM, Leica Microsystems, Wetzlar, Germany) or using a scanning 
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electron microscope (SEM) (JSM-5800LV, JEOL). For LSCM observation, live cells 
were stained with green fluorescent probe CMFDA (5-chloromethyl fluorescein 
diacetate). A stock solution of CMFDA (25 µM in dimethyl sulfoxide [DMSO]) was 
diluted with serum-free cell culture medium to obtain a 2.5 µM working solution. 
Prewarmed CMFDA working solution (200 µL) was added to cover the bottom of the 
wells of 24-well plate for 45 min. Cells were washed three times with 1 × PBS and 
incubated with 200 µL of EC culture medium for another 30 min. Subsequently, the 
culture medium was replaced with another 1 mL of culture medium, in which the 
cells were cultured further. Cells were observed by LSCM (excitation, 492 nm; 
emission, 517 nm). 
 
  SEM micrographs were taken for cell morphology studies on different 
substrates. Cells were washed with 1 × PBS to remove nonadherent cells and then 
fixed with 2.5% glutaraldehyde for 45 min at 4 °C. Thereafter, the samples were 
dehydrated in 75% alcohol solutions and dried under vacuum. The samples were 
sputter coated with gold (JFC-1200 Fine Coater, JEOL, Japan) and observed with an 
SEM at an accelerating voltage of 15 or 20 kV. 
 
3.1.4.3 Cellular attachment and viability  
 
Cellular attachment and viability on the NFM were determined by the 
colorimetric MTS assay (CellTiter 96® AQueous One Solution cell proliferation assay, 
Promega, USA). Briefly, cells were incubated with 20% 3-(4,5-dimethylthiazol-2-yl)-
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5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium) (MTS) reagent in 
cell culture medium for 4 h. Thereafter, 100μl aliquots were pipetted into the wells of 
a 96-well plate and placed into a spectrophotometric plate reader (FLUOstar 
OPTIMA, BMG Labtech, Offenburg, Germany), and the absorbance at 490 nm for 
each well was measured. 
For cellular viability test, cells were seeded onto the NFM at a density of 1.5 × 
104 cells/cm2 (30% confluence). On day 1, 3, 5, and 7 after cell seeding, unattached 
cells were washed out and the attached cells were quantified by MTS assay. For 
cellular attachment study, cells were seeded at the density of 3 × 104 cell/cm2 (60% 
confluence). At 1, 2, 4, 6 and 8 h after cell seeding, unattached cells were washed out 
and the attached cells were quantified by MTS assay. A lower seeding density was 
used for viability studies as compared with attachment studies. This is to provide 
more area for cells to proliferate to avoid reaching confluence prematurely. For both 
cellular viability and attachment test, TCPS was used as a control. Data are 
representative of three independent experiments and all data points are plotted as 
means ± SD (n=3) 
 
3.1.4.4 RT-PCR analysis  
 
Four typical cell adhesion molecules (CAMs) characteristic of ECs (platelet 
endothelial cell ad adhesion molecule-1 [PECAM-1 or CD31], intercellular adhesion 
molecule-1 [ICAM-1 or CD54], vascular cell adhesion molecule-1 [VCAM-1 or 
CD106], and E-selectin [or CD62E]) and the ECs universal marker, von Willebrand 
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Factor (vWF), were studied by reverse transcription-polymerase chain reaction (RT-
PCR) for gene expression analysis. Total RNA was extracted from 2.5 × 106 
subconfluent HCAECs cultured in a 75 cm2 TCPS flask or from NFM deposited on a 
petri-dish (86 mm in diameter, 58 cm2 in area) using an RNeasy Mini Kit (Qiagen, 
Hilden, Germany). Cells were lysed and homogenized in the guanidine isothiocyanate 
(GITC)-containing buffer, and then applied to a column where the total RNA bound 
to the silica-gel-based membrane and impurities were effectively washed away. 
Lastly, high-quality RNA was eluted in 30 µL RNase-free water and RNA yields 
were measured on the basis of absorbance at 260 nm. 
 
For reverse transcription (RT), cDNA was reverse transcribed from 1 µg of 
total RNA and then stored at -20 °C. Briefly, a 10.5 µL reaction mixture containing 1 
μg of total RNA, 0.5 µg of oligodeoxythymidine (oligo(dT)18, 1st BASE, Singapore) 
and distilled water was heated at 75 °C for 5 min and then put on ice for 5 min. Next, 
dNTPs (dATP, dTTP, dGTP, dCTP, 2mM each), 20 units of recombinant 
ribonuclease inhibitor (RNasin, Promega, USA), and 200 units of Moloney murine 
leukemia virus (M-MLV) reverse transcriptase (Promega, USA) were added in a final 
20 μL reaction mixture. This mixture was incubated for 1 h at 37 °C followed by 
heating for 5 min at 95 °C, and then put on ice for 5 min.  
 
For PCR, a 1 µL aliquot of the reaction mixture was subjected to PCR 
amplification in a final 20 μL reaction mixture that contained 20 pmol of each 
forward and reverse primer (Table 3.1), 1.5 mM MgCl2, a 0.3 mM concentration of 
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each of the four deoxynucleotides, and 1 unit of Taq polymerase (Promega, USA). 
Amplification of ECs specific genes by PCR was carried out in a PTC-100 Peltier 
Thermal Cycler (MJ Research, Waltham, USA) for 30 cycles. In each cycle, an initial 
denaturation at 94 °C for 1 min was carried out, followed with primers annealing at 
55 °C for 1 min and polymerization at 72 °C for 1 min. This was followed with a final 
extension step at 72 °C for 10 min and stored at 4 °C. The PCR products were 
analyzed by electrophoresis of 10 μL of each sample in a 1% agarose gel, with the 
bands visualized under ultraviolet light by ethidium bromide staining, using the Gel 
Doc 2000 gel documentation system (Bio-Rad, Hercules, CA, USA).  
 
Table 3.1. PCR primers for RT-PCR analysis  
Gene                          Genebank No.      size (bp)         Primer pair sequences 
β-actin                               BC002409             318                  5’ GAG TCC TGT GGC ATC CAC G 3’    
                                                                                                5’ GAA GCA TTT GCG GTG GAC G 3’ 
PECAM-1 (CD31)            BC051822             367                 5’ TCA TCG GAG TGA TCA TTG CTC 3’ 
                                                                                       5’ CTA GAG TAT CTG CTT TCC ACG 3’ 
von Willebrand Factor       BC022258            274                  5’ TGA GGC TGG GTA CTA CAA GC 3’ 
        (vWF)                                                                              5’ GGA GAT GTT GCA TGA GCT GC 3’ 
ICAM-1 (CD54)                J03132                  352                   5’ GCT TCG TGT CCT GTA TGG C 3’ 
                                                                                                 5’ CTG GCG GTT ATA GAG GTA CG 3’ 
VCAM-1 (CD106)            X53051                  297                  5’ TTC TGA GAG TGT CAA AGA AGG 3’ 
                                                                                                5’ AAG GAG GAT GCA AAA TAG AGC 3’ 
E-selectin (CD62E)           NM_000450         280                 5’ GCA CTG TGT GCA AGT TCG C 3’ 
         (E-SEL)                                                                           5’ GGC TTT TGG TAG CTT CCG TC 3’ 
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3.1.5 Statistical analysis 
 
Values (at least triplicate) were averaged and expressed as means ± standard 
deviation (SD). Each experiment was repeated three times. Statistical analysis was 
carried out for HCAECs viability and attachment studies using One-Way ANOVA 
testing by SPSS for Windows (SPSS Inc., Copyright 1989-2002) version 11.5.0. 
Significant difference between data groups was determined by the Student-Newman-
Keuls (SNK) post hoc test (p < 0.05). 
 
 3.2 Results and discussions 
 
3.2.1 Material characterization 
 
3.2.1.1 Physical properties 
 
SEM and TEM micrographs of the collagen-blended P(LLA-CL) NFM with 
various weight ratios of P(LLA-CL) to collagen (4:1, 2:1, 1:1, and 0:1) are shown in 
Figure 3.2, revealing the non-woven and interconnected-pore structure of the NFM. 
Similar morphologies of the NFM, with various weight ratios of P(LLA-CL) to 
collagen at the same total concentration (5 wt%), were observed, suggesting that the 
weight ratio did not affect the NFM’ morphology (Figure 3.2 A-D). Typical smooth 
nanofibers had diameters between 100-200 nm, as shown in Figure 3.2 E and F. 
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Figure 3.2. SEM (A-D) and TEM (E and F) micrographs of collagen-blended P(LLA-
CL) NFM with various weight ratios of P(LLA-CL) to collagen. Weight ratios of 
P(LLA-CL) to collagen: (A) 4:1; (B) 2:1; (C and E) 1:1; (D and F) 0:1 Total 
concentration of the electrospinning solution is 5 wt%. 
 
Diameter distributions of the collagen-blended NFM were determined by 
directly measuring nanofiber’s diameter from SEM images in Figure 3.2 by image 
analysis software (Image J), which is shown in Figure 3.3. It shows quite narrow 
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diameter distributions for the collagen-blended NFM at various weight ratios of 
P(LLA-CL) to collagen. Basically, more than 60% of nanofiber’s diameters ranged 
from 100 to 200 nm, with about 20% of nanofiber’s diameters ranging from 200 to 
300 nm, which was much smaller and better distributed than those of most nanofibers 
we had reported previously. This may be because that the high molecular weight of 
collagen (285k) could enhance the viscosity of spinning solution at a low 
concentration, facilitating the production of small nanofibers. Further, HFP is a polar 
solvent with a low boiling temperature (58.5 °C) and a high dielectric constant (17.8), 






















Figure 3.3. Diameter distributions of the collagen-blended P(LLA-CL) NFM with 
various weight ratios of P(LLA-CL) to collagen.  
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Diameter, thickness, apparent density, and porosity of the collagen-blended 
NFM with various weight ratios of P(LLA-CL) to collagen are summarized in Table 
3.2. Thickness of the collagen-blended NFM was mainly controlled by 
electrospinning time if operation parameters such as voltage, feed rate, and collector 
distance were fixed. Table 3.2 shows that the collagen-blended NFM [P(LLA-
C):Collagen, 1:1 (wt:wt)] deposited for 1 h were thicker than others deposited for 30 
min. Apparent density of all the collagen-blended NFM was in the range of 0.3-0.4 
g/cm3. No obvious relationship existed between the apparent density and weight ratio 
of P(LLA-CL) to collagen. This may be because that density of collagen (1.3-1.4 
g/cm3) is close to the density of the P(LLA-CL) (1.2-1.3 g/cm3). As the collagen-
blended P(LLA-CL) NFM are highly porous materials, with the known bulk density 
of the P(LLA-CL)-collagen blends, porosity of the collagen-blended NFM can be 
calculated based on the apparent density. The bulk density of the collagen-P(LLA-CL) 
blends were estimated to be in the range of 1.2-1.4 g/cm3 based on the bulk density 
range of the P(LLA-CL) and collagen, and the porosity of the collagen-blended NFM 
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Table 3.2. Diameter, thickness, apparent density, and porosity of collagen-blended 
P(LLA-CL) NFM with various weight ratios of P(LLA-CL) to collagena 
P(LLA-CL) : 
Collagen 











4:1 160 ± 68 9 ± 2 0.31 ± 0.01 74-78 
2:1 168 ± 40 6 ± 1 0.39 ± 0.05 68-72 
 1:1b 181 ± 47 15 ± 3 0.38 ± 0.08 68-73 
1:2 191 ± 63 9 ± 0 0.33 ± 0.06 73-76 
aData are representative of three independent experiments and represented as means ± 
SD (n=5). 
b Electrospinning deposition time is 60 min. For others, deposition time is 30 min. 
 
 3.2.1.2 Surface chemistry  
 
Surface chemistry of biomaterials mediates protein adsorption, which 
regulates cell adhesion, proliferation, and migration and affects tissue regeneration 
rate (Li et al., 2002). Regarding the collagen-blended P(LLA-CL) NFM, it is 
expected that some of the collagen would be present on the surface of the nanofibers, 
which could promote cell attachment and proliferation. Chemical compositions of 
the collagen-blended P(LLA-CL) NFM were studied by attenuated total reflectance 
Fourier transform infrared (ATR-FTIR) spectrometry (Figure 3.4). The spectra of 
the collagen-blended NFM (Figure 3.4C) revealed peaks characteristic of collagen at 
wave-numbers of 1651cm-1 (amide I band) and 1537 cm-1 (amide II band) (Figure 
3.4B), and a P(LLA-CL) peak at 1747 cm-1 (Figure 3.4A), together with a peak at 
3310 cm-1 (N-H stretch). ATR-FTIR is not a very surface specific characterization 
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method because it has a probe depth of about 1 μm. For the NFM with the diameters 
ranging from 100 to 200 nm, ATR-FTIR may show the compositions inside the 
nanofibers. Therefore x-ray photoelectron spectroscopy (XPS), which has a probe 
depth of only tens of nanometers, was used to check whether collagen was present 
on the surface of nanofibers. The XPS results are summarized in Table 3.3. 
Appearance of N1S peak represents the presence of collagen on the nanofiber 
surface. More collagen (higher N atomic ratio) was found to be present on the 
surface of the collagen-blended P(LLA-CL) NFM with increased collagen weight 
ratios. The pure collagen NFM showed the highest amount of surface collagen 
compared with other collagen-blended NFM. There was no collagen present on the 
surface of the pure P(LLA-CL) NFM.  
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Figure 3.4. ATR-FTIR spectra of (A) P(LLA-CL) NFM, (B) collagen NFM, and (C) 
collagen-blended P(LLA-CL) NFM with a 1:1 weight ratio of P(LLA-CL) to collagen.  
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Table 3.3. Atomic ratios of carbon (C), nitrogen (N), and oxygen (O) on the surface 
of P(LLA-CL) NFM, collagen-blended P(LLA-CL) NFM with various weight ratios 
of P(LLA-CL) to collagen, and collagen NFM as determined by XPS  
NFM C atomic ratio 
(%)  
N atomic ratio 
(%) 
O atomic ratio 
(%) 
P(LLA-CL) 65.9 0 34.1 
P(LLA-CL): collagen=4:1 67 Not Detectable 33 
P(LLA-CL): collagen=2:1 56.2 9.2 34.6 
P(LLA-CL): collagen=1:1 59 11.7 29.3 
P(LLA-CL): collagen=1:2 63.3 13.3 23.4 
Collagen 61.6 15.1 23.3 
 
3.2.1.3 Mechanical properties  
 
One of the main failure modes of synthetic vascular grafts is intimal 
hyperplasia (IH), which is partly due to shear stress disturbances caused by the 
compliance mismatch at the end-to-end anastomosis between arteries and rigid grafts 
(Salacinski et al., 2001a). Thus the mechanical property of NFM is critical for their 
successful application as tissue engineered vascular grafts. Compliance is a 
mechanical property of a tubular structure which depends on the tube dimensions and 
modulus. In this study we mainly studied the tensile modulus, tensile strength, and 
ultimate strain of NFM which all have impact on the compliance of tubelike 
structures.  
 
Mechanical evaluation of both P(LLA-CL) NFM and collagen-blended 
P(LLA-CL) NFM revealed the nonlinear stress-strain behavior (Figure 3.5). It shows 
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that incorporation of collagen at a P(LLA-CL)-to-collagen weight ratio of 1:1 led to a 
decrease in mechanical properties of the P(LLA-CL) NFM. It was also found that 
tensile strength of both NFM was in the range of that of a human coronary artery 
(Table 3.4). Moreover, both NFM had much less stiffness compared with Dacron® 
(PET; commonly used in large-diameter vascular grafts), which has a  tensile strength 
of 170-180 MPa in orientated form and a tensile modulus of about 14, 000MPa 
(Salacinski et al., 2001a). Ideally, less stiff (more compliant) and biodegradable 
scaffolds are a better choice for constructing tissue engineered vascular grafts.  

















Figure 3.5. Typical stress-strain curves of the P(LLA-PCL ) NFM and collagen-




                                                                                                                         Chapter 3                              
Table 3.4. Tensile properties of collagen-blended P(LLA-CL) NFM, with the weight 







Tensile Modulus (MPa) 26 ± 7 44 ± 4 - 
Tensile strength (MPa) 1.54 ± 0.32 6.27 ± 1.38 1.40-11.14 
Ultimate strain (%) 66 ±  22 176 ± 49 45-99 
aData is representative of three independent experiments and represented as means ± 
SD (n=3). 
bSee Ref (Xu et al., 2004b).  
 
 
3.2.2 Cellular behaviors characterization 
 
3.2.2.1 Cellular viability  
 
For cellular viability test, HCAECs were seeded onto the NFM at a density of 
1.5 × 104 cells/cm2 (30% confluence). On day 1, 3, 5, and 7 after cell seeding, 
unattached cells were washed out and the attached cells were quantified by MTS 
assay. Figure 3.6 shows viability of HCAECs cultured on (1) collagen-blended 
P(LLA-CL) NFM, (2) TCPS, (3) collagen NFM, (4) P(LLA-CL) NFM, and (5) 
P(LLA-CL)-collagen film (blended film) on days 1, 3, 5, and 7 after seeding. Results 
from day 3 and day 7 are particularly summarized into Figure 3.7 for clarity. The 
viability of HCAECs increased with collagen weight ratio in the collagen-blended 
NFM, which can be explained by the previous results showing that more collagen was 
present on the surface of the NFM with higher collagen weight ratios (Table 3.3). The 
collagen on the nanofiber surface can help to attach more HCAECs and therefore 
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leads to higher total cellular viability. The results also showed better HCAECs 
viability on the collagen-blended NFM than on the blended film, which may indicate 
the advantage of nanofiber structure in supporting ECs growth.  
 
It is crucial to adjust weight ratios of P(LLA-CL) to collagen for optimal cell 
growth. From Figure 3.7, it can be found that at a P(LLA-CL)-to-collagen weight 
ratio of 1:1, the collagen-blended NFM have good cell viability which is comparable 
to pure collagen NFM and TCPS. The following studies therefore focused on 
collagen-blended NFM at this ratio. Although pure collagen NFM showed the best 
cell viability among all the samples, it was not chosen because the collagen NFM 
swollen into hydrogels in cell culture medium and showed poor mechanical strength, 
leading to a poorly handlable material.  
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 BNF 1:1 
 BNF 2:1 
 BNF 4:1
 P(LLA-CL) NFM
  Blended Film
Figure 3.6. Total viability of HCAECs cultured on TCPS, collagen NFM, collagen-
blended P(LLA-CL) NFM (BNF) with various weight ratios of P(LLA-CL) to 
collagen( BNF 1:1, BNF 2:1, BNF 4:1), P(LLA-CL) NFM, and collagen-blended 
P(LLA-CL) film (Blended film).  
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Figure 3.7. Viability of HCAECs on day 3 and 7 shown in Figure 3.6 were 
summarized here for clarity. 
 
3.2.2.2 Cellular morphology 
 
HCAECs were seeded at a density of 3 × 104 cells/cm2 and observed on day 5 
under laser scanning confocal microscope (LSCM) and SEM (Figure 3.8). It was 
observed that HCAECs cultured on the P(LLA-CL) NFM were rounded in shape 
instead of spreading, whereas on the collagen-blended P(LLA-CL) NFM HCAECs 
adopted a spreading polygonal shape that is typical of normal cell morphology on 
TCPS. On day 5, HCAECs reached subconfluence on collagen-blended NFM, 
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TCPS                             P(LLA-CL) NFM               Collagen-blended NFM 
Figure 3.8. LSCM [original magnification: (a): × 400; (b and c): × 200] and SEM 
[original magnification: (d-f): × 500] images of HCAECs cultured on (a and d) TCPS, 
(b and e) P(LLA-CL) NFM, and (c and f) collagen-blended P(LLA-CL) NFM.  
 
Figure 3.9 shows interactions between HCAECs and the collagen-blended 
P(LLA-CL) NFM at higher magnification of SEM. Compared with HCAECs on the 
P(LLA-CL) NFM which adopted a round shape, HCAECs on the collagen-blended 
NFM showed better phenotypic spreading. It was also observed that HCAECs 
interconnected well with the collagen-blended NFM and pseudopods of the cells were 
oriented along the NFM. Also HCAECs maintained a typical shape of motility, i.e: 
broad, flat lamella extending in the direction of migration and terminating in a narrow 
ruffling lamellipodium (Wittmann and Waterman-Storer, 2001).  
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Figure 3.9. Higher magnification of SEM micrographs (original magnification, × 
3000), showing the detailed interactions between HCAECs and (a) the P(LLA-CL) 
NFM and (b) the collagen-blended P(LLA-CL) NFM at 5 days of culture. 
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3.2.2.3 Cellular attachment 
 
For cellular attachment study, HCAECs were seeded at the density of 3 × 104 
cell/cm2 (60% confluence). At 1, 2, 4, 6 and 8 h after cell seeding, unattached cells 
were washed out and the attached cells were quantified by MTS assay. Attachment of 
HCAECs to the TCPS, P(LLA-CL) NFM, and collagen-blended P(LLA-CL) NFM is 
shown in Figure 3.10. Significantly more HCAECs attached to collagen-blended 
P(LLA-CL) NFM than P(LLA-CL) NFM in the first 4 h (p < 0.05). HCAECs were 
shown to attach on collagen-blended NFM at a rate similar on TPCS.  
 






















 Collagen-blended P(LLA-CL) NFM
 
Figure 3.10.Attachment of HCAECs on the TCPS, P(LLA-CL) NFM, and collagen-
blended P(LLA-CL) NFM. 
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3.2.2.4 Cellular phenotype  
 
Tissue engineered vascular grafts should not only support ECs spreading 
morphology, viability, and attachment but also encourage ECs phenotype 
maintenance (VanKooten et al., 1997). This is more important because, for suitable 
vascular grafts, the material should not hamper the adhesion of ECs nor favor the 
inflammation phenomena (Cenni et al., 1995). Here, ECs phenotype was assessed 
mainly through RTT-PCR analysis of cell adhesion molecules (CAMs) and EC’s 
universal markers. The functions of CAMs are to mediate cell-cell or cell-matrix 
interactions. ICAM-1, VCAM-1, and E-selectin are important CAMs expressed by 
ECs for adhesion and migration of leukocytes or lymphocyte from blood side to 
tissues during immune responses. Upregulated expression of ICAM-1, VCAM-1, and 
E-selectin may indicate the onset of the inflammation response (Cenni et al., 1995). 
PECAM-1 is mainly involved in the homotypic ECs-ECs adhesion, which favors 
maintenance of endothelium integrity, and can be used to indicate reduced adhesions 
of ECs to materials (Cenni et al., 1995). Von Willebrand Factor (vWF) is an adhesive 
glycoprotein synthesized exclusively in ECs and megakaryocytes. It plays a central 
role in hemostasis by mediating the adhesion of an initial platelet plug to the 
subendothelium of injured blood vessels and serves as the carrier for factor VIII in 
plasma (Mohlke et al., 1996). PECAM-1 and vWF are universal EC markers, which 
can represent the differentiation status of ECs. 
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Figure 3.11 shows expression of above molecules from HCAECs cultured on 
the collagen-blended NFM for 10 days. It was found that gene expression levels of 
the CAMs and vWF from HCAECs cultured on the collagen-blended NFM were 
comparable to those of cells cultured on TCPS, demonstrating that normal cell 
phenotype was preserved during in vitro culture. Expression of PECAM-1 and vWF 
revealed that the HCAECs maintained their differentiated status after culturing for 10 
days on the collagen-blended NFM. Further, similar expression levels of PECAM-1 
represented the normal attachment of HCAECs on the collagen-blended NFM and 
TCPS, which is especially important for ECs to function well under shear force in a 
natural environment. The expression of ICAM-1, VCAM-1, and E-selectin indicated 
that ECs kept the important function of mediating blood cells adhesion in an 
inflammation response, which further revealed the phenotype maintenance of 
HCAECs on collagen-blended NFM. Further it shows a higher expression level of 
VCAM-1 and ICAM-1 from cells grown on blended NFM than on TCPS.  
 
Figure 3.11. Expression of ECs-characteristic genes from HCAECs cultured on TCPS 
and collagen-blended P(LLA-CL) NFM (BNF) for 10 days. On day 10, total RNA 
was extracted and RT-PCR was performed with gene-specific primer pairs shown in 
Table 3.1, including E-Selectin (E-SEL, CD62E), VCAM-1 (CD106), ICAM-1 
(CD54), won Willebrand factor (vWF), PECAM-1 (CD31), and β-actin as a 
housekeeping gene.  
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 83
3.3 Conclusion  
 
Collagen-blended P(LLA-CL) nanofiber meshes (NFM) were constructed by 
electrospinning a mixture of collagen and P(LLA-CL) dissolved HFP. The collagen-
blended NFM had a well-controlled diameter distribution ranging from 100 to 200 nm 
and porosity around 70%. Existence of collagen on the surface of the collagen-
blended NFM was verified by ATR-FTIR and XPS. The collagen-blended NFM had 
a decreased tensile modulus, tensile strength, and ultimate strain compared with the 
P(LLA-CL) NFM. Cell culture showed that the collagen-blended NFM has improved 
viability and attachment of HCAECs compared with the P(LLA-CL) NFM. HCAECs 
adopted a spreading polygonal shape and interconnected well with the collagen-
blended NFM, whereas HCAECs had a round non-spreading shape on the P(LLA-CL) 
NFM. Moreover, HCAECs maintained phenotypic expression of cell adhesion 
molecules such as PECAM-1, ICAM-1, VCAM-1, E-Selectin, and vWF on the 
collagen-blended NFM.  
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Chapter 4 
 
Collagen-Coated P(LLA-CL) Nanofiber Meshes (NFM) 
 
 The results in chapter 3 showed that blending with collagen type I into 
electrospun P(LLA-CL) nanofiber meshes (NFM) is a simple method to improve 
endothelialization ability of the material. But the collagen must be dissolved in 
organic solvent (HFP) with the polymer prior to the electrospinning process, which 
may be a harsh environment for the collagen. Secondly, consuming quite a lot of 
expensive collagen (500 μg collagen per mg NFM) is also a concern. Further, 
blending with collagen resulted in decreased mechanical properties of the P(LLA-CL) 
NFM, as was observed in the chapter 3. Most importantly, due to the collagen type I 
was extracted from natural animal tissues (calf skin), the material’s molecular 
structure is far from as repeatable as synthetic polymers. It was found that the batch 
difference of the collagen type I even from the same manufacturer (Sigma-Aldrich) 
often leaded to variable solubility in the HFP, resulting in poor repeatability of the 
electrospinning conditions. To overcome above problems, in this chapter, collagen-
coated P(LLA-CL) NFM were fabricated. P(LLA-CL) NFM were first treated by 
inductive coupled radiofrequency glow discharge plasma to improve the wettability, 
followed by collagen coating. The morphology, porosity, mechanical properties, and 
surface chemistry of the collagen coated P(LLA-CL) NFM were studied. Behaviors 
of human coronary artery endothelial cells (HCAECs) on the collagen-coated P(LLA-
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CL) NFM were evaluated in terms of morphology, viability, attachment,  phenotype, 
and functional maintenance.  
 




Dichloromethane (DCM), N,N-dimethylformamide (DMF), and hydrochloric 
acid (HCl) were from Merk & Co.(Whitehouse Station, NJ, USA). The mouse 
monoclonal antibody to human platelet endothelial cell adhesion molecule-1 
(PECAM-1, CD 31) was from Cymbus Biotechnology (Hants, UK). The mouse 
monoclonal antibodies to human fibronectin and collagen type IV were from Acris 
(Hiddenhausen, Germany). Other chemical and biological reagents and materials 
were all the same as used in chapter 3 (see section 3.1.1) 
 
4.1.2 Fabrication of P(LLA-CL) NFM 
 
For electrospinning of the P(LLA-CL) NFM, P(LLA-CL) (10 wt%) solution 
in DCM and DMF (70:30 wt:wt) was added into a plastic syringe with a needle (inner 
diameter, 0.21 mm). With the aid of a syringe pump, the solution was injected out at a 
feed rate of 0.5 mL/h. Electrospinning voltage was applied to the needle at 10 kV 
using a high-voltage power supply (Gamma High Voltage Research, Ormond Beach, 
FL, USA). The nanofibers were collected on an aluminum collector which was 10 cm 
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below the needle. For colleting the random NFM, a static flat alumina plate was used; 
while for colleting the aligned NFM, a rotating disk (1000 rpm) was used. The 
rotating plate had a sharpen edge that can strengthen the electric field near the 
collector. The experiment setups are showed in Figure 4.1.  
 
Figure 4.1. Experimental setups for fabricating the random and aligned P(LLA-CL) 
NFM, which were collected with a static plate (a) and rotating disk (b), respectively.  
 
4.1.3 P(LLA-CL) NFM modification by collagen coating  
 
Air plasma treatment of P(LLA-CL) NFM was performed in an inductive 
coupled radiofrequency glow discharge plasma cleaner (PDC-001, Harrick Plasma, 
Ithaca, NY, USA) with the radiofrequency power of 30 W. The plasma treatment  
increased the surface hydrophilicity of the nanofiber significantly (Chan et al., 
1996;Wang et al., 2004), making the P(LLA-CL) NFM easily wettable by collagen 
solution. The plasma-treated P(LLA-CL) NFM were then immersed in a collagen 
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solution in 0.01 M hydrochloride (HCl) with a concentration of 290 µg/mL at 4oC 
overnight. They were then dried at room temperature. The complete surface 
modification scheme for P(LLA-CL) NFM is shown in Figure 4.2. 
 
 
Figure 4.2. Schematic representation of the plasma treatment and collagen coating of 
the electrospun P(LLA-CL) nanofiber mesh.  
 
4.1.4 Material characterization  
 
4.1.4.1 Physical properties 
 
  SEM micrographs of the collagen-coated P(LLA-CL) NFM were obtained on 
a JSM-5800LV SEM (JEOL, Tokyo, Japan). Diameter range and pore size (the length 
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of the diagonals of the pore square) of the NFM were measured from the SEM images 
by random counting of 60 nanofibers using image analysis software (ImageJ, 
Bethesda, USA). Thickness of the NFM was measured using a micrometer (Mitutoyo, 
Kawasaki, Japan). Tensile tests were carried out in the same way as described in 
chapter 3 (see section 3.1.3.3).  
 
4.1.4.2 Surface chemistry 
 
  Wettability of the P(LLA-CL) NFM and films before and after air plasma 
treatment were measured by sessile drop contact angle measurement using a VCA 
Optima Surface Analysis System (AST products, Billerica, MA). Briefly, 7.5 μL 
water was dropped onto the material surface and the water drop shape was recorded 
in 30 seconds. Six independent determinations at different sites of one sample were 
averaged. To get water contact angle on plane P(LLA-CL) surface, P(LLA-CL) films 
were prepared by a solvent casting method described in chapter 3 (see section 3.1.2) 
in detail. XPS spectra of the NFM were obtained in a same way as described in 
chapter 3 (see section 3.1.3.2). 
 
4.1.4.3 Collagen distribution and quantification 
 
To visualize the collagen distribution on the P(LLA-CL) NFM, P(LLA-CL) 
NFM coated with rhodamine B isothiocyanate (RBITC, Sigma, USA)-labeled 
collagen were observed under a laser scanning confocal microscope (LSCM, Leica 
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Microsystems, Wetzlar, Germany). Depth projection images for three-dimensional (3-
D) micrographs were constructed from 20 horizontal slices of step size 1 μm. The 
RBITC-labeled collagen was prepared as follows: collagen (Mw=285 k) solution (1 
mg/mL) in 0.01M HCl was mixed with the RBITC (Mw=536.1) with the molar ratio 
of RBITC to collagen 50:1. The mixed solution was incubated in darkness at room 
temperature for 3 h and then added into a dialysis tubing cellulose membrane 
(molecular weight cutoff = 12,400) and dialyzed in 0.01 M HCl solution for 30 days 
until no more RBITC could be released into the HCl solution.  
 
The amount of collagen coated onto the P(LLA-CL) NFM was quantified by 
bicinchoninic acid (BCA) Protein Assay Kit (Pierce, USA) with the protocol provided 
by the manufacture. Briefly, the collagen-coated NFM were immersed in 0.1 mL PBS 
together with 2 mL working reagent at room temperature for 2 hours under gentle 
shaking, and then the absorbance at 562 nm of the supernatant was measured. The 
collagen concentration was calculated from the collagen standard curve. 
 
4.1.5 Characterization of cellular behaviors 
 
4.1.5.1 In vitro cell culture  
 
   HCAECs culture, HCAECs morphology studies by SEM and green 
fluorescent probe CMFDA (5-chloromethyl fluorescein diacetate) staining, and 
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HCAECs viability and attachment studies by MTS assay were all the same as 
described in chapter 3 (see section 3.1.4.1, 3.1.4.2, and 3.1.4.3). 
 
4.1.5.2 Immunostaining  
 
After 5 days of culture with seeding density of 1.5 × 104 cells/cm2, the 
HCAECs cultured on NFM were washed with 1 × PBS, fixed with 2.5% 
paraformaldehyde, and blocked by 2% bovine serum albumin (BSA). The HCAECs-
NFM constructs were then incubated for 2 h at 37oC with primary antibody. After 
washing with 0.02% BSA, fluorescein isothiocyanate (FITC) labeled rabbit anti-
mouse IgG (Chemicon, Temecula, CA, USA) was added and incubated for 2 h at 
37oC in dark, followed by washing with 0.02% BSA and counterstaining with 
propidium iodide (PI, 2.5 µg/mL) for 1 min at 37oC. The immunostained construct 
samples were then mounted on glass slides. 7 µL FluorSave reagent (Calibiochem, 
Germany) was dropped onto the samples to prevent photo-bleaching. The samples 
were viewed under laser scanning confocal microscope (LSCM).  
 
4.1.5.3 RT-PCR analysis 
 
PECAM-1, fibronectin, and collagen type IV were studied by reverse 
transcriptase polymerase chain reaction (RT-PCR) for gene expression analysis in 
mRNA level. Forward and reverse primers of each gene are listed in Table 4.1. Total 
RNA was extracted from subconfluent 2.5 × 106 HCAECs using RNeasy Mini Kit 
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(Qiagen, Hilden, Germany).  For RT-PCR, complementary DNA (cDNA) was reverse 
transcribed from 1 µg of total RNA. Further information was described in chapter 3 
(see section 3.1.4.3) in details. The PCR products were analyzed by electrophoresis of 
10 μL of each sample in a 1% agarose gel, and the bands were visualized under 
ultraviolet light by ethidium bromide staining with a gel documentation system (Gel 
Doc 2000, BioRad, Hercules, CA, USA). 
 
Table 4.1. PCR primers for RT-PCR analysis 
Gene                          Genebank No.      size (bp)          Primer pair sequences 
β-actin                               BC002409             318                  5’ GAG TCC TGT GGC ATC CAC G 3’    
                                                                                                5’ GAA GCA TTT GCG GTG GAC G 3’ 
PECAM-1 (CD31)            BC051822             367                 5’ TCA TCG GAG TGA TCA TTG CTC 3’ 
                                                                                       5’ CTA GAG TAT CTG CTT TCC ACG 3’ 
Fibronectin                         M10905                276                 5’ TGA CCC TCA TGA GGC AAC G 3’ 
                                                                                       5’ TCA GCC TGT ACA TCT AAA GGC 3’ 
Collagen Type IV               NM_001845        257                5’ CTT TTG TGA TGC ACA CCA GC 3’ 
                                                                                       5’ TCT CAT ACA GAC TTG GCA GC 3’ 
 
4.1.5.4 cDNA microarray analysis 
 
  Total RNA was extracted from the HCAECs cultured for 5 days on tissue 
culture polystyrene (TCPS), the random and aligned collagen-coated P(LLA-CL) 
NFM using RNeasy Mini Kit. A biotin-2’-deoxyuridine (dUTP) (Roche, Pleasonton, 
CA, USA) labeled cDNA probe was synthesized according to GEArray™ probe 
synthesis kits (GEArray Ampolabeling-LPR kit, SuperArray®, Frederick, MD, USA) 
 91
                                                                                                                         Chapter4                              
and stored at -20oC. Hybridization with a 2.5 μg biotinylated cDNA probe was done 
on a nylon membrane printed with the GEArray™ S series (human endothelial cell 
biology gene array, SuperArray®), which contained 112 genes associated with major 
functions of ECs. Prehybridization and hybridization were carried out in a 
hybridization oven (Biometra, Goettingen, Germany) for 2 h and overnight 
respectively. Finally, the chemiluminescent membranes were scanned by 
ScannArray® (GSI Lumonics, Billerica, MA, USA).  
 
4.1.6 Statistical analysis 
 
  Data were made at least in triplicate and expressed as mean ± standard 
deviation (SD). Each experiment was repeated three times. Statistical analysis was 
carried out for HCAECs viability and attachment studies using One-Way ANOVA 
testing by SPSS for Windows (SPSS Inc., Copyright 1989-2002) version 11.5.0. 
Significant difference between data groups was determined by the Student-Newman-
Keuls (SNK) post hoc test (p < 0.05). 
 
4.2 Results and discussions  
 
4.2.1 Material characterization 
 
4.2.1.1 Physical properties 
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 Morphology of the random and aligned collagen-coated P(LLA-CL) NFM is 
shown in Figure 4.3. Diameter and distribution of the random and aligned collagen-
coated P(LLA-CL) NFM are shown in Figure 4.4 and Table 4.2. More uniform 
diameter distribution was found for the random NFM than the aligned NFM (Figure 
4.4 a). The diameter of the aligned NFM (406 ± 126 nm) was smaller than that of the 
random NFM (470 ± 80 nm). Similar results were also reported for aligned PCL (Ma 
et al., 2005a) and PLLA NFM (Yang et al., 2005). This might be due to stretching 
tangential force exerted by the high-speed rotating disk on the nanofiber produced 
(Ma et al., 2005a).  
 
The pore size for the random NFM was defined as length of diagonal of the 
pore polygon, which is not applicable for the aligned NFM. Figure 4.4 b and table 4.2 
shows pore size of the random NFM to be mainly between 5 and 10 μm. The 
thickness, apparent density, and porosity of the random and aligned collagen-coated 
P(LLA-CL) NFM are summarized in Table 4.2. With the known bulk density of 
P(LLA-CL) (1.2-1.3 g/cm3) and collagen (1.3-1.4 g/cm3), the porosity of the 
collagen-coated P(LLA-CL) NFM can be estimated by measuring their apparent 
density. Porosity for both NFM was found to be approximately 70%. Porosity is an 
important measure for tissue engineering scaffolds. Vascular grafts should be porous, 
and the porosity should allow cells infiltration from the adventitial side and maintain 
hemostasis, as well as allow sufficient mass transfer of gases and nutrients (Sullivan 
and Brockbank, 2002). It is generally accepted that a high porosity vascular graft 
exhibits high patency (Niklason and Seruya, 2002). 
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Figure 4.3. SEM pictures of the cross section (a and d), 3-dimensional structure (b 
and e), and top view (c and f) of the random (a-c) and aligned (d-f) collagen-coated 
P(LLA-CL) NFM.  
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Figure 4.4. (a) Diameter distribution of the random and aligned collagen-coated 
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Table 4.2. Diameter, thickness, apparent density, porosity, and pore size of the 
















Random 470 ± 80 26 ± 5 0.43 ± 0.08 64-69 6 ± 2 
Aligned 406 ± 126 24 ± 2 0.37 ± 0.02 69-74 N.A. 
a Data are representative of three independent experiments and are presented as mean 
± SD (n=5) 
 
4.2.1.2 Collagen coating 
 
As an adhesion protein that facilitates cell attachment and proliferation 
(Ruoslahti and Pierschbacher, 1987a), collagen is commonly used to modify the 
surface of vascular grafts. The first complete tissue engineered vascular graft was 
fabricated with collagen gel (Weinberg and Bell, 1986). However, pure collagen 
scaffolds always encountered mechanical limitation (L'Heureux et al., 1993). 
Electrospinning of collagen nanofibers and modification of nanofibers with collagen 
are new approaches that may improve scaffold strength (Matthews et al., 2002a) 
 
Due to the hydrophobic nature of the P(LLA-CL), collagen solution stayed on 
the top surface of the P(LLA-CL) NFM and could not be absorbed into the NFM, 
which made collagen coating of the NFM not efficient or even. To help the collagen 
solution easily go into the porous P(LLA-CL) NFM, the hydrophobic P(LLA-CL) 
NFM was treated with air plasma to make it highly wettable. The effectiveness of the 
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plasma treatment to increase P(LLA-CL) NFM’ wettability was verified by water 
contact angle measurement. Water contact angles of the random P(LLA-CL) NFM 
and films before and after plasma treatment are summarized in Table 4.3. The 
P(LLA-CL) NFM exhibited different water contact angles from the films due to 
different surface structure. The P(LLA-CL) NFM and films were both hydrophobic in 
nature before plasma treatment and the NFM showed higher contact angle than the 
films. Although the original P(LLA-CL) NFM showed high water contact angle, after 
plasma treatment, they became highly wettable. The water drop, upon contact with 
the plasma treated P(LLA-CL) NFM, was immediately absorbed into the NFM, 
giving a zero apparent water contact angle. Although the films also tended to be more 
hydrophilic after plasma treatment, the contact angle change after the air plasma 
treatment was not as big as that for the P(LLA-CL) NFM. It’s also shown in Table 4.3 
that plasma treatment of 5 min was enough to increase the P(LLA-CL) NFM’ 
wettability.  
 
Table 4.3. Water contact angles of the P(LLA-CL ) NFM and films before and after 
plasma treatment for various timea 






0 129 ±  1 96 ± 6 
5 0 ± 0 60 ± 1 
15 0 ± 0 57 ± 3 
30 0 ± 0 55 ± 3 
a Data are representative of three independent experiments and represented as mean ± 
SD (n=6). 
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The big difference of the P(LLA-CL) NFM’ wettability before and after 
plasma treatment can be explained as the following. The water contact angle of a 
solid surface is affected by surface roughness in such a manner: if the material is 
intrinsically hydrophobic, the water will not be able to penetrate into the hollows and 
pores on the rough surface and can be regarded as resting on a semi-solid and semi-
air plane surface, which will increase the contact angle significantly. In contrast, the 
water will penetrate and fill up most of the hollows and pores formed by an 
intrinsically hydrophilic material, forming a surface which is partly solid and partly 
liquid and therefore leading to a low water contact angle. Having a highly rough 
surface, the P(LLA-CL) NFM experienced a big improvement in wettability after 
they were plasma treated from hydrophobic to hydrophilic (Ma et al., 2005b). 
 
After the plasma treatment, the P(LLA-CL) NFM were then immersed in a 
collagen solution in 0.01 M hydrochloride (HCl) with a concentration of 290 µg/mL 
at 4 oC overnight. They were then dried at room temperature. 
 
4.2.1.3 Surface chemistry  
 
The presence of the collagen on the P(LLA-CL) NFM’s surface was 
confirmed by the appearance of the N1S peak (indicated in nitrogen [N] atomic ratio) 
in the XPS spectrum of the collagen-coated P(LLA-CL) NFM (Table 4.4), while no 
N1S peak was found in the spectrum of the pure P(LLA-CL) NFM. Compared with 
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the pure electrospun collagen NFM (15.1%), less nitrogen was found on the collagen-
coated NFM (5.2%).  
 
Table 4.4. Atomic ratio of C, N, and O on the surface of the P(LLA-CL) NFM, the 
collagen-coated P(LLA-CL) NFM, and the pure collagen NFM determined by XPS  






P(LLA-CL) 65.9 0 34.1 
Collagen-coated P(LLA-CL) 61.5 5.2 33.3 
Collagen 61.6 15.1 23.3 
 
  To visualize spatial distribution of the collagen coated onto the P(LLA-CL) 
NFM, rhodamine-labeled collagen was coated onto the P(LLA-CL) NFM and 
observed under laser scanning confocal microscope (LSCM). It shows in 3-
dimensional (3-D) images of the NFM that collagen was uniformly distributed on the 
surface of every nanofiber in both random (Figure 4.5 a) and aligned (Figure 4.5 b) 
NFM. There was no auto-fluorescence observed on the P(LLA-CL) NFM without 
collagen-coating under LSCM (data not shown).  
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Figure 4.5. 3-D laser scanning confocal microscopy (LSCM) (original magnification, 
× 600) of the collagen-coated random (a) and aligned (b) P(LLA-CL) NFM. 
Existence of rhodamine-labeled collagen was identified by its red fluorescence.  
 
By BCA protein assay analysis, the amount of collagen coated onto the 
P(LLA-CL) NFM was measured and normalized by NFM’ weight. It was found that 
15 ± 5 µg collagen was coated per 1 mg NFM. Compare with the collagen amount 
used in the collagen-blended P(LLA-CL) NFM at P(LLA-CL)-to-collagen weight 
ratio of 1:1 (500 μg collagen per 1 mg NFM), collagen coating used much less 
amount of collagen.  
 
4.2.1.4 Mechanical properties  
 
Figure 4.6 shows the stress-strain curves for the random and aligned P(LLA-
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CL) NFM under tensile loading. The stretching direction for the aligned NFM is in 
the fiber alignment direction. Mechanical strength of the aligned P(LLA-CL) NFM 
were higher compared with the random NFM. Tensile properties of the NFMs are 
further summarized in Table 4.5, which also shows that aligned NFM has larger 
tensile modulus and tensile strength but smaller ultimate strain than the random NFM. 
This finding correlates to the report that orientation of the fibers directly enhanced the 
mechanical properties of the nanofibers along the fiber alignment direction (Matthews 
et al., 2002b).  
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Table 4.5. Tensile properties of the random and aligned P(LLA-CL) NFMa  
 Random Aligned 
Tensile Modulus (MPa) 44 ± 4 103 ± 6 
Tensile strength (MPa) 6.3 ± 1.4 10.6 ± 1.3 
Ultimate strain (%) 176 ± 49 99 ± 5 
a Data are representative of three independent experiments and represented as mean ± 
SD (n=3) 
 
4.2.2 Characterization of cellular behaviors 
 
4.2.2.1 Cellular morphology  
 
HCAECs were seeded at a seeding density of 3 × 104 cells/cm2 and observed 3 
days later by CMFDA staining for fluorescent microscopy or fixed by glutaraldehyde 
for SEM study (Figure 4.7). HCAECs cultured on the P(LLA-CL) NFM were 
rounded in shape instead of a spreading morphology, whereas on the collagen-coated 
P(LLA-CL) NFM HCAECs adopted a spreading polygonal shape which is typical of 
the normal ECs morphology as on TCPS. Further, immunostaining of PECAM-1 
from HCAECs cultured on TCPS and collagen-coated P(LLA-CL) NFM showed 
similar pattern of PECAM-1 expression which occurred mainly at cell-cell interfaces. 
The P(LLACL) NFM was red in color due to the presence of  rhodamine-labeled 
collagen being coated on NFM’s surface (Figure 4.8). 
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Figure 4.7. LSCM (original magnification, × 400) and SEM (original magnification, × 
1000) images of HCAECs cultured on (a, d) TCPS, (b, e) P(LLA-CL) NFM, and (c, f) 
collagen-coated P(LLA-CL) NFM.  
 
Figure 4.8. Immunofluorescent staining of PECAM-1 from HCAECs cultured on 
TCPS (a) and the collagen-coated P(LLA-CL) NFM (b). Existence of rhodamine-
labeled collagen was identified by its red fluorescence in (b). White arrows indicate 
strong PECAM-1 expression at cell-cell interfaces. 
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4.2.2.2 Cellular viability and attachment  
 
Total viability of HCAECs at day 1, 3, 5, and 7 cultured on the TCPS, 
collagen-coated P(LLA-CL) NFM, and pure P(LLA-CL) NFM is shown in Figure 4.9. 
Viability of HCAECs on the collagen-coated P(LLA-CL) NFM was obviously 
increased compared with that on the pure P(LLA-CL) NFM from day 3 onwards (p < 
0.05).  
 
Figure 4.9. Viability of HCAECs on the TCPS, P(LLA-CL) NFM, and collagen-
coated P(LLA-CL) NFM. (* p < 0.05 compared with the P(LLA-CL) NFM).  
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The attachment of HCAECs to the TCPS, collagen-coated P(LLA-CL) NFM, 
and pure P(LLA-CL) NFM is shown in Figure 4.10. Significantly higher cellular 
viability on the collagen-coated P(LLA-CL) NFM than the pure P(LLA-CL) NFM, 
which may indicate more attached cells, was found 2 h after cells seeding (p < 0.05). 
HCAECs were found to attach on the collagen-coated P(LLA-CL) NFM at a very 
similar rate as that they attached on the TPCS. This is because collagen is the most 
abundant ECM protein with both structural and adhesive functions, facilitating cell 
adhesion through the integrin receptors (Ruoslahti and Pierschbacher, 1987b).  
 
 
Figure 4.10. Attachment of HCAECs on the TCPS, P(LLA-CL) NFM, and collagen-
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4.2.2.3 Cellular Phenotype 
 
In order to study phenotypic and functional maintenance of HCAECs on the 
collage-coated P(LLA-CL) NFM, we performed a series of studies ranging from ECs 
morphology, and ECs phenotype studies through immunostaining and RT-PCR, to a 
deeper analysis of gene expression by cDNA microarray.  
 
Morphology of HCAECs was studied first. Figure 4.11A shows HCAECs 
adopted a spindle shape on the aligned NFM in the direction of fiber alignment. This 
finding was distinct from the polygonal shape of HCAECs on the TCPS and random 
NFM. Ability of the aligned NFM to control cell orientation is meaningful for tissue 
engineered vascular grafts (Nerem and Seliktar, 2001). Shear stress caused by blood 
flow in vivo orientates ECs growth along the direction of blood flow (Dewey et al., 
1981), which may increase the ability of ECs to resist shear stress and decrease 
desquamation of these cells from vascular grafts. One way to orientate cells in vitro is 
through dynamic cell culture in a bioreactor. It was reported that smooth muscle cells 
(SMCs) cultured in a perfusion bioreactor showed contractile phenotype, significant 
cell alignment, and increased collagen production (Jeong et al., 2005). Similarly, Lee 
et al found human ligament fibroblast cultured on the aligned polyurethane 
nanofibers were orientated along the fiber direction and secreted more collagen than 
on the randomly orientated nanofibers (Lee et al., 2005). Thus, aligned NFM might 
be used as substitute for a bioreactor which necessitates a complicated fluid system in 
a specific application where cell alignment is important. 
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 Phenotype studies of HCAECs were then carried out by immunostaining and 
RT-PCR analysis. First, immunostaining of PECAM-1, a universal EC marker, 
showed the differentiation status and phenotypic maintenance of HCAECs on both 
TCPS and random and aligned NFM (Figure 4.11 A, top). Second, Figure 4.11 B 
showed immunostaining of fibronectin and collagen IV for HCAECs on the TCPS, 
random and aligned NFM. HCAECs cultured on the collagen-coated P(LLA-CL) 
NFM expressed the ECs-characteristic ECM proteins, indicating  the potential 
capability of HCAECs to build ECM in vitro. Finally, Figure 4.11 C further revealed 
the expression of these three molecules (PECAM-1, fibronectin, and collagen IV) at 
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Figure 4.11. (A) Fluorescent microscopy (original magnification, × 600) and SEM 
(original magnification, × 1000) images from HCAECs on TCPS, random NFM 
(RNF) and aligned (ANF) collagen-coate P(LLA-CL) NFM. (B) LSCM images of 
fibronectin and collagen type IV expressions from HCAECs on the TCPS, RNF, and 
ANF. (C) RT-PCR analysis of expressions of PECAM-1, fibronectin, and collagen 
type IV from HCAECs on the TCPS, RNF, and ANF.  
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4.2.2.4 Gene expression  
 
In order to study functional maintenance of HCAECs, cDNA microarray was 
applied to study gene expression profiles of HCAECs cultured on the TCPS, 
collagen-coated random and aligned P(LLA-CL) NFM. Figure 4.12 A shows the 
expression profile of 112 genes, printed onto a nylon membrane in the form of 8×14 
grid, which are associated with four major functions of ECs, i.e., permissibility and 
tone, angiogenesis, ECs activation, and ECs injury. Figure 4.12 B shows three groups 
of comparison by scatter plots: random NFM (RNF) versus TCPS; aligned NFM 
(ANF) versus TCPS, and ANF versus RNF. Quantitative analysis of the scatter plot 
revealed similarities of 87.5%, 89.3%, and 94.6%, respectively. This means, for 
example, that 87.5% of the genes from HCAECs cultured on random NFM have an 
expression level similar to that on TCPS. So is for the other two. The results are 
further summarized in Table 4.6. It shows the functional maintenance of HCAECs on 
TCPS, and random and aligned NFM. RT-PCR analysis (Figure 4.12 C) was further 
performed to verify gene expression profile from the cDNA microarray. Three 
continuous spotted genes from the integrin family (integrin α5, integrin αV, and 
integrin β1) were chosen, highlighted by a red quadrangle in Figure 4.12A. The 
cDNA microarray results showed a clear pattern of higher expression levels of 
integrin α5 and integrin β1 compared with integrin αV. Accordingly, RT-PCR results 
(Figure 4.12 C) also displayed the highest expression level of integrin α5 amongst the 
3 integrins. However integrin β1 and integrin αV seemed to have the same expression 
level.  
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Figure 4.12. (A) Gene expression profiles of HCAECs on TCPS, random (RNF), and 
aligned (ANF) collagen-coated P(LLA-CL) NFM by cDNA microarray analysis. 
Expression of each gene is represented by the fluorescence of a tetra-spot. (B) Scatter 
plots showing the relative gene expression of (B1) RNT versus TCPS, (B2) ANF 
versus TCPS, and (B3) ANF versus RNF. (C). RT-PCR analysis of integrin α5 
(ITGA5), αV (ITGAV), and β1 (ITGB1) expression from HCAECs cultured on TCPS, 
RNF, and ANF, which correlate to the genes in a red frame in (A). 
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Table 4.6. Percentage (%) of genes with over-expressed, similar-expressed, and less-
expressed levels between HCAECs grown on TCPS, random (RNF) and aligned 









RNF/TCPS 8.9 87.5 3.6 
ANF/TCPS 7.1 89.3 3.6 
ANF/RNF 3.6 94.6 1.8 
 
4.3 Comparison between collagen-blended and collagen-coated NFM 
 
The comparison between the two collagen-modified NFMs is summarized in 
Table 4.7. Both the collagen-coated and the collagen-blended NFM showed similarly 
improved ECs growth compared with the pure polymer NFM. However, the collagen-
coated NFM has several advantages over the collagen blended NFM. First, the 
collagen coating process consumes less amount of collagen than the collagen 
blending process. It was found 25-50 times more collagen was used in the blending 
process than that was used in the coating process, which is a disadvantage for mass 
production of collagen-blended NFM. Second, collagen-coated NFM had higher 
mechanical properties compared with the collagen-blended NFM as is shown in Table 
4.7. Third, as to collagen-blended NFM, the collagen must be dissolved in organic 
solvent (HFP) with the polymer prior to the electrospinning process (Matthews et al., 
2002b), which may be a harsh environment for the collagen. In parallel, the collagen 
can be dissolved in aqueous solvent (HCl) in the coating process, which is a mild 
condition for collagen. Further, the batch difference of collagen will affect the 
viscosity and solubility of collagen solution which would affect the 
electrospinnability because electrospinning process is highly dependent on the 
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character of spin solution (Huang et al., 2003). However characteristics of collagen 
solution would not affect the coating process. For this reason, the repeatability of 
fabrication of collagen-coated NFM was much better than that of the collagen-
blended NFM. Based on above reasons, collagen coating was used in the following 
study to modify the 3-D tubular nanofiber scaffolds. 
 
Table 4.7. Comparison between the collagen-blended NFM and collagen-coated NFM 
 Collagen blended NFM Collagen coated NFM 
Amount of collagen used 
 
500 μg collagen in 1 mg 
NFM 
 




Tensile modulus, 26 MPa; 
tensile strength, 1.5 Mpa 
 
Tensile Modulus, 44 MPa; 
tensile strength, 6.3 MPa 
Organic solvent used 
 
HFP No 
Cell behaviors Spreading morphology, 
good viability and 




good viability and 
attachment, and preserved 
phenotype 
Others Batch difference will 
affect collagen solubility 
in HFP  
Batch difference won’t 
affect collagen solubility 
in HCl  
 
4.4 Conclusion  
 
P(LLA-CL) NFM were treated by inductive coupled radiofrequency glow 
discharge plasma, followed by collagen coating. The collagen-coated P(LLA-CL) 
NFM displayed the features of ECM-like non-woven architecture, high porosity, 
proper mechanical properties, bioactive surface, and controllable fiber alignment. 
Collagen was found to be evenly coated throughout the surface of nanofibers. 
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Collagen coating improved the viability and attachment of HCAECs on P(LLA-CL) 
NFM. Immunostaining and RT-PCR analysis showed that HCAECs maintained the 
phenotypic expression of PECAM-1, fibronectin, and collagen IV. cDNA microarray 
analysis further indicated that HCAECs kept the expressions of 112 function-related 
genes. Particularly, aligned collagen-coated P(LLA-CL) NFM were constructed. The 
aligned NFM have higher mechanical strength and modulus than the random NFM. 
HCAECs grew along the direction of nanofiber alignment and showed elongated 
morphology. 
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Chapter 5 
 
3-D Tubular Nanofiber Scaffolds 
 
The works in chapter 3 and 4 achieved the flat P(LLA-CL) nanofiber meshes 
(NFM) with effective endothelialization. In order to approach the long-term goal of 
constructing blood vessel-like scaffolds, 3-D tubular nanofiber scaffolds should be 
fabricated. An attractive feature of electrospinning process is its ability to deposit 
nanofibers onto a rotational mandrel to get a tubular scaffold. In this chapter we 
studied fabrication of electrospun tubular nanofiber scaffolds and HCAECs seeding 
onto their lumens. Collagen coating technique developed in chapter 4 was used to 
surface modify the tubular nanofiber scaffolds. One big difference between ECs 
culturing on the flat NFM and the tubular nanofiber scaffolds is the cell seeding 
method. In this chapter, a special cell seeding technique was developed to seed cells 
evenly distributed onto the lumen of the scaffolds. Mechanical properties of the 
tubular nanofiber scaffolds and HCAECs’ morphology and phenotypic maintenance 
were studied with commercialized ePTFE 3 mm vascular grafts as a control.  
 
5.1 Materials and Methods  
 
5.1.1 Materials  
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P(LLA-CL), collagen Type I (calf skin), and HCAECs were as same as those 
used in chapter 3 (see section 3.1.1). ePTFE (Gore-Tex®)3 mm vascular grafts were 
obtained from Professor Peter Ashley Robless, a vascular surgeon of National 
University of Hospital in Singapore.  
 
5.1.2 Fabrication of P(LLA-CL) tubular nanofiber scaffolds  
 
For electrospinning of the P(LLA-CL 70:30) tubular nanofiber scaffolds, 
P(LLA-CL) (10 wt%) solution in DCM and DMF (70:30 wt:wt) was added into a 
plastic syringe with a needle (inner diameter, 0.21 mm). With the aid of a syringe 
pump, the solution was injected out at the feed-rate of 1 mL/h. Electrospinning 
voltage was applied to the needle at 10 kV using a high voltage power supply 
(Gamma High Voltage Research, USA). The nanofibers were collected onto a 
rotating metallic mandrel (3 mm in outer diameter, 12 cm in length) at the speed of 
150 rpm. The electrospinning setup is shown in Figure 5.1. SEM micrographs of the 
tubular scaffold were obtained on a FEI Quanta 200F SEM (Japan). Collagen was 
coated onto surface of nanofibers in a method reported in chapter 4 (see section 4.1.3). 
Briefly, P(LLA-CL) tubular nanofiber scaffolds were treated by air plasma to increase 
the hydrophilicity. The 3-D tubular nanofiber scaffolds were treated for a longer time 
(15 min) than the nanofiber meshes (5 min). The plasma-treated scaffolds were then 
immersed in a collagen solution with a concentration of 290 µg/mL at 4oC overnight, 
and then were dried at room temperature.  
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Figure 5.1. (A) Setup and operation parameters for fabrication of the P(LLA-CL) 
tubular nanofiber scaffolds. (B) The electrospun tubular nanofiber scaffold collected 
on the mandrel.  
 
5.1.3 Mechanical properties  
 
Tensile tests were carried using a 5848 microtester (Instrom, Canton, MA) at a 
stroke rate of 3 mm/min with a 5 mm gauge length. The collagen-coated P(LLA-CL) 
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tubular nanofiber scaffolds were unfolded and prepared in a rectangular (5 × 5 mm) 
shape for the tensile test in both circumferential and longitudinal directions.  
 
5.1.4 Cellular behaviors characterization 
 
5.1.4.1 Rotational cell seeding  
 
HCAECs suspension to be seeded into the lumen of the tubular scaffolds was 
prepared first. To determine the cell suspension concentration, the following method 
was used. The desired seeding density of HCAECs onto the lumen surface of the 
scaffolds is 4 × 104 cellls/cm2, which is about 80% of the confluence density (5 × 104 
cellls/cm2). So the cell suspension concentration can be calculated by the following 
equation.  
)/(104)()/()( 24233 cmcellscmAcmcellsConccmV ××=×  
Where V is the volume of the tubular nanofiber scaffold and A is the lumen 
area of the scaffold. For the tubular nanofiber scaffolds with length of 3 cm and inner 
diameter of 3 mm, A is π × 3 mm × 3 cm = 2.8 cm2 and V is π × (1.5 mm)2 ×3 cm = 
0.2 cm3. Thus seeding concentration (Conc) was calculated to be 6 × 105 cells/cm3 
based on the above equation. The suspension of HCAECs at this concentration was 
injected into the collagen-coated P(LLA-CL) tubular nanofiber scaffolds, the ends of 
which were connected to PTFE tubes. Because of the high hydrophobicity of PTFE 
tubes, the HCAECs suspension was limited in the lumen of the tubular nanofiber 
scaffolds. The cells-scaffold constructs were rotated at the speed of 6 rpm for 4 h, and 
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then taken out and cultured in a normal static environment. On day 1, 5, 7, and 10 
after culture, the HCAECs-scaffolds constructs were taken out for morphology and 
phenotype studies. The schematic representation of HCAECs seeding is shown in 
Figure 5.2. HCAECs culture and morphology studies by SEM were the same as 




Figure 5.2. Schematic illustration of HCAECs seeding onto the lumen of the 
collagen-coated P(LLA-CL) tubular nanofiber scaffold.  
 
5.1.4.2 Hematoxylin & Eosin (H&E) staining 
 
After 10% formalin fixation, ethanol dehydration, and toluene immersion, the 
HCAECs-scaffold constructs cultured for 10 days were embedded in the paraffin by 
the Leica EG 1160 tissue embedding center (Leica, Germany). The paraffin-
embedded constructs were cross-sectioned by the microtome (Leica RM2135, 
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Germany) into slices with 10 µm in thickness. After de-paraffinization in xylene and 
rehydrate in ethanol, the slices were stained with Hematoxyline (Sigma, USA) for 70 
seconds and Eosin (Sigma, USA) for another 10 seconds. The slices were mounted 
onto glassslides and observed under optical microscope.  
 
5.1.4.3 Immunostaining  
 
For immunostainning, the de-paraffinized slices were immersed into 1 × PBS 
for half an hour then blocked by 2% BSA. The slices were then incubated for 2 h at 
37oC with primary antibody (mouse anti-human Platelet Endothelial Cell Adhesion 
Molecule-1 (PECAM-1, CD 31)) (Cymbus Biotechnology, UK) diluted at 1:50. After 
washing, fluorescein isothiocyanate (FITC) labeled rabbit anti-mouse IgG (Chemicon, 
USA) diluted at 1:50 was added and incubated for 2 h at 37 oC. The immunostained 
slices were then mounted onto glassslides with FluorSave™ reagent (Calibiochem, 
Germany), and viewed under LSCM.  
 
5.2 Results and discussions 
 
5.2.1 Material characterization  
 
5.2.1.1 Morphology  
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Collagen-coated P(LLA-CL) tubular nanofiber scaffolds with inner diameter 
of 3 mm and wall thickness of about 100 µm were fabricated from 2 h electrospining 
at the condition shown in Figure 5.1. Length and inner diameter of the scaffolds can 
be readily adjusted by choosing mandrel with different sizes to collect nanofibers. In 
our lab, tubular nanofiber scaffolds with length up to 8 cm and inner diameter in the 
range of 1-6 mm have been successfully fabricated. Wall thickness of the tubular 
nanofiber scaffolds can be controlled by electrospinning time at the rough 
relationship of 50-60 µm/h.  
 
Morphology of the collagen-coated P(LLA-CL) tubular nanofiber scaffolds 
(Figure 5.3) were compared with that of the commercialized ePTFE 3 mm vascular 
grafts (Figure 5.4) for macroscopic and microscopic structure analysis. ePTFE 
vascular grafts are generally recognized as the gold standard for vascular surgeries in 
medium-diameter (inner diameter 6-12 mm) blood vessel replacements and have a 5 
year patency rate of 91-95% in aortic sites (Pourdeyhimi, 1986). However, synthetic 
vascular grafts, including ePTFE, have rarely been proved successful in small-
diameter blood vessel replacement (inner diameter < 6 mm) (Seal et al., 2001). 
 
For macroscopic structures, the tubular nanofiber scaffold showed the same 
length and inner diameter as the EPTFE® vascular graft (Figure 5.3 and 5.4 a and b). 
The ePTFE vascular graft was thicker in wall than the tubular nanofiber scaffold 
(Figure 5.3 and 5.4 d). For microscopic structures, there were some differences. First, 
the inner surface of the ePTFE vascular graft is composed of relatively large and 
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circumferentially orientated nodes from which extend fine longitudinal fibrils at the 
nanometer scale (Figure 5.4 e), whereas the inner surface of the tubular nanofiber 
scaffold was only composed of nanofiber network (Figure 5.3 e). This indicates that 
both grafts had nanoscale fibers at similar dimensional scale, which may increase the 
surface area for cell attachment. Second, the tubular nanofiber scaffold has 
interconnected pores in the whole structure (Figure 5.3 f), whereas the ePTFE 
vascular graft is not porous in the outer layer (Figure 5.4 f). To make it clearer, major 
properties such as inner diameter, wall thickness, pore size, and fabrication methods 
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Figure 5.3. Macroscopic and microscopic structures of the collagen-coated P(LLA-
CL) tubular nanofiber scaffolds . (a, b) optical images of macroscopic structures. (c, d, 
e, f) SEM photographs: (c) whole structure; (d) enlarged cross-section of wall; (e) 
inner layer; (f) out layer. Original magnification: × 50, × 2500, × 5000, × 5000 for c, 
d, e, f, respectively.  
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Figure 5.4. Macroscopic and microscopic structures of the ePTFE vascular grafts. (a, 
b) optical images of macroscopic structures. (c, d, e, f) SEM photographs: (c) cross 
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Table 5.1. Comparison between the ePTFE vascular grafts and the tubular nanofiber 
scaffolds in terms of inner diameter, wall thickness, pore size, and fabrication 
methods 
















3 mm Controllable Around 
5 µm 
Polymer is 
dissolved in organic 






















One distinct character of the collagen-coated P(LLA-CL) tubular nanofiber 
scaffolds compared with the ePTFE vascular grafts is biodegradability. ePTFE 
vascular grafts are non-biodegradable. Nowadays it is generally believed that a 
biodegradable graft is superior to a non-biodegradable graft because scaffold that 
degrades over time will allow natural tissue in-growth and healing in time. Also a 
biodegradable graft can reduce the possibility of infection from a non-biodegradable 
graft due to shorter existence in human body. Thus it could be the trend for the 
replacement of biodegradable grafts for the current commercially available non-
biodegradable grafts.  
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5.2.1.2 Surface chemistry  
 
To visualize spatial distribution of the collagen coated on the P(LLA-CL) 
tubular nanofiber scaffolds, rhodamine-labeled collagen was coated onto the tubular 
scaffolds and observed under laser scanning confocal microscope (LSCM). Figure 5.5 
(left) is the picture of 3-D reconstruction of surface part of the tubular nanofiber 
scaffold. It shows clearly that collagen was uniformly coated on the surface of 
nanofibers in a larger magnification image (Figure 5.5 right), which correlated with 
the results in chapter 4 (Figure 4.5). This implies that plasma treatment was not only 
effective for modifying the flat nanofiber meshes but also the 3-D tubular nanofiber 
scaffolds. There was no auto-fluorescence observed on the P(LLA-CL) tubular 
nanofiber scaffolds without collagen-coating under LSCM (data not shown).  
 
Figure 5.5. (Left) 3-D LSCM (original magnification, × 600) image of the collagen-
coated P(LLA-CL) tubular nanofiber scaffolds. (Right) Enlarged LSCM image of the 
frame in (A).  Rhodamine-labeled collagen was identified by its red fluorescence. 
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5.2.1.3 Mechanical properties 
 
Vascular grafts should have enough strength to resist rupture or excessive 
dilation when subjected to pulsatile pressure in vivo. They should also have stable 
mechanical properties during their expected life time. Although it is generally 
accepted that mechanical properties of vascular grafts should match those of natural 
blood vessels, current commonly used commercialized vascular grafts made from 
PET and PTFE have much stronger mechanical properties than that of aortic tissues 
(How, 1992). Figure 5.6 shows the typical stress-strain curves of the collagen-coated 
P(LLA-CL) tubular nanofiber scaffolds in both circumferential and longitudinal 
directions. The results suggested that tensile strength at the longitudinal direction was 
larger than that at the circumferential direction. The ultimate strain in both directions 
was similar to each other. Tensile properties of the tubular nanofiber scaffolds are 
further summarized in Table 5.2. Particularly, the longitudinal and circumferential 
tensile strength of the tubular nanofiber scaffolds were compared with that of the 
Teflon® (TF-208), another kind of commercialized vascular graft, and natural 
abdominal aorta, results of which are shown in Table 5.3. We could not find the 
detailed mechanical properties of the ePTFE (Gore-Tex®)3 mm vascular graft, thus 
Teflon® (TF-208), which is also made from ePTFE, was used for comparison. It can 
be found that tensile properties of the tubular nanofiber scaffolds were closer to that 
of the natural human artery than the Teflon® (TF-208).  
 
It was reported that larger anisotropic property (defined as the ratio of 
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circumferential tensile strength to the longitudinal tensile strength) of the tubular 
nanofiber grafts was noticed at mandrel rotation speed of 150 rpm compared with that 
at the speed of 3400 rpm (Matsuda et al., 2005). This may indicate that fiber 
orientation induced by the mandrel rotation of a fiber might affect the anisotropic 
mechanical properties of a graft wall. Our results were consistent with the above 
studies regarding to the point of larger tensile stress in the longitudinal direction than 
the circumferential direction at the mandrel rotational speed of 150 rpm.  
 



















Figure 5.6. Typical uniaxial stress-strain curves for the collagen-coated P(LLA-CL ) 




                                                                                                                         Chapter 5                             
Table 5.2. Tensile properties of the collagen-coated P(LLA-CL) tubular nanofiber 
scaffolds in both longitudinal and circumferential directionsa 




Tensile modulus (MPa) 16 ± 7 17 ± 4.4 
Tensile strength (MPa) 7.0 ± 0.4 3.9 ± 0.3 
Ultimate strain (%) 289 ± 55 292 ± 87 
aData is representative of 3 independent experiments and represented as mean ± SD 
(n=3) 
 
Table 5.3. Longitudinal and circumferential tensile strength of the tubular nanofiber 
scaffolds, Teflon® (TF-208), and natural abdominal aorta 





Tubular nanofiber scaffolds 7.0 3.9 
Teflon® (TF-208) (How, 1992) 85.2 66.7 
Abdominal aorta (How, 1992) 1.47 5.29 
 
5.2.2 Characterization of cellular behaviors 
 
5.2.2.1 Morphology and phenotype 
 
HCAECs were seeded into the lumen of the collagen-coated P(LLA-CL) 
tubular nanofiber scaffolds connected in a customized seeding device at a speed of 6 
rpm for 4 h. By optical microscope observation, there was neglected number of cells 
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remained in the cell suspension after seeding. So the cell seeding efficiency, which is 
defined as the percentage of attached cells of the total seeded cells, can be assumed to 
be 100% after the 4 h rotational seeding. Then the cells-scaffolds constructs were put 
into an incubator for further static culture after the rotational seeding. On day 1, 5, 
and 7 the HCAECs-scaffolds constructs were taken out for morphology studies 
(Figure 5.7), and for phenotype studies on day 10 (Figure 5.8). For SEM studies of 
HCAECs morphology on the lumen of the tubular nanofiber scaffolds, the HCAECs-
scaffold constructs were cut open into flat meshes to expose the lumen side for direct 
SEM observations (Figure 5.7). It was found that seeded at 80% of confluence 
density, HCAECs grew into sub-confluence immediately in 1 day’s time (Figure 5.7a 
and b). Further, HCAECs spread well and evenly on the lumen of the tubular 
nanofiber scaffolds from day 1 onwards to day 7 after culture. These results indicated 
that the tubular nanofiber scaffolds facilitated quick and stable in vitro 
endothelialization. There are still gaps between cells indicating cells have yet reached 
confluence which could be readily improved by using a higher concentration of cell 
suspension for seeding.  
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Figure 5.7. HCAECs grew on the lumen of the tubular nanofiber scaffolds for 1 day 
(a and b), 5 days (c and d), and 7 days (e and f) after seeding at the density of 6 × 105 
cells/cm3. (b, d, and f): higher magnification images of (a, c, and e) respectively. 
Original magnification: a, × 200, c, × 42, e, × 80, b, d and f, × 1000.  
 
Figure 5.8 further revealed that HCAECs existed as a thin layer covering the 
lumen of the tubular nanofiber scaffolds (Figure 5.8 b) and there was no cells 
infiltration in the scaffolds (Figure 5.8 c) after 10 days’ culture. Further, HCAECs 
possessed the phenotypic expression of PECAM-1(Figure 5.8 d), indicating no de-
differentiation of ECs occurred. On the control group, the ePTFE vascular grafts, 
there were no HCAECs found from day 1 onwards after the rotational seeding of 
HCAECs (data not shown). Although successfully used as large and medium size 
vascular grafts, ePTFE vascular grafts did not favor ECs growth because of negative 
surface charge, which is an important property against platelet deposition but also 
obstruct the negatively charged ECs from accessing graft surface (Xue.L, 2000). 
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It needs to be noticed that SMCs and fibroblasts, another two types of vascular 
cells, grow as multi-layers on the media and adventitia of blood vessels, which is 
different from mono-layer growth of ECs in the intima. To encourage the infiltration 
of SMCs and fibroblasts, an approach is to electrospray the cells during 
electrospinning process. It has been reported that after electrospraying, vascular 
smooth muscle cells remained their viability and proliferation compared with the 
unprocessed cells (Stankus et al., 2006).  
Figure 5.8. HCAECs grew on the lumen of the tubular nanofiber scaffolds for 10 days 
after seeding. (a, b) SEM images showing the overall structure of the HCAECs-
scaffold constructs: (a) cross-section of wall of the constructs; (b) enlarged 
quadrangle in (a). (c) H&E staining of the cross-section of the constructs. (d) 
Immunostaining of PECAM-1 from HCAECs on the lumen of the tubular nanofiber 
scaffolds. Original magnification: a, × 80, b, × 2000, c, × 200, d, × 630.  
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The good HCAECs attachment on lumen of the tubular nanofiber scaffolds 
may be due to two important cues presented by the scaffolds: 1). physical cues of 
high porosity, high spatial interconnectivity, and high surface area to volume ratio for 
cells attachment; 2). chemical cues of collagen, which is the main type of collagen in 
connective tissue and is present throughout the arterial wall. Study in chapter 4 have 
already shown that collagen-coating improved spreading, viability, and attachment of 
HCAECs on the pure P(LLA-CL) NFM. Because of co-existence of the two cues, 
tubular nanofiber scaffolds provide ECs an environment similar as the basement 




3-D P(LLA-CL) tubular nanofiber scaffolds (inner diameter 3 mm) were 
fabricated by electrospinning onto a rotating metallic mandrel. Collagen was coated 
onto the scaffolds after air plasma treatment. Tensile properties of the tubular 
nanofiber scaffold were closer to that of the natural human arteries compared with the 
ePTFE vascular grafts. HCAECs were seeded onto the lumen of the scaffolds and 
rotated at the speed of 6 rpm for 4 h, followed by normal static culture. It was found 
that HCAECs spread evenly on the lumen of the P(LLA-CL) tubular nanofiber 
scaffolds and reached sub-confluence immediately after seeding. After 10 day’s 
culture, HCAECs possessed the phenotypic expression of PECAM-1 and existed as a 
thin layer covering the lumen of the scaffolds. On the ePTFE vascular grafts, there 
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were no HCAECs present after rotational seeding of HCAECs onto lumen of the 
grafts. 
                                                                                                                         Chapter 6                              
Chapter 6 
 
In Vivo Rabbit Model  
 
 The works in chapter 5 achieved tubular nanofiber scaffolds with good 
attachment and phenotypic maintenance of ECs in vitro. However, there are several 
concerns from vascular surgeons’ point of views regarding the feasibility of the 
tubular nanofiber scaffolds to be used as tissue engineered vascular grafts in vivo. For 
example, are the tubular nanofiber scaffolds easy to be connected with natural blood 
vessels by suturing? Will blood leak from the porous nanofiber scaffolds after 
implantation? In order to answer these basic questions, in this chapter, an animal 
model which can test the feasibility and in vivo patency of the tubular nanofiber 
scaffolds was established, and short-term (7 weeks) implantation of the tubular 
nanofiber scaffolds into the animal model was evaluated. We chose a well-established 
and reliable flap, the rabbit epigastric flap, as the animal model because 
thrombogenically, the rabbit resembles the human more closely than does the rat. The 
viability of a rabbit epigastric free flap has been described as a good indicator of 
vascular graft patency (Terada et al., 1999). As an initial study, ECs-seeded tubular 
nanofiber scaffolds were not used for the implantation. It is hoped that with the 
advanced development in autologous ECs extraction technique, results from the non 
ECs-seeded tubular nanofiber scaffolds could demonstrate the basic possibility for 
further study using ECs-seeded scaffolds. 
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6.1 Materials and methods  
 
The rabbit epigastric free flap model has been approved from the Institutional 
Animal Care and Use Committee (IACUC) of National University of Singapore. All 
animals received humane care in compliance with the “Guide for the Care and Use of 
Laboratory Animals” published by the National Institutes of Health (NIHpublication 
no. 85-23, revised 1985). 
 
Male New Zealand white rabbits (n=3) were operated on under sterile 
conditions and general anaesthesia with a halothane/oxygen mixture (2.5%) at 2 
L/min using a standard anaesthetic machine after induction with intramuscular 
ketamine/xylazine at 35/5 mg/kg. After shaving and prepping, an epigastric flap 
measuring 2 × 2 cm was outlined on the rabbit’s lower abdomen. Using an operating 
microscope, the flap was raised and the pedicle consisting of the inferior superficial 
epigastric vein, which is shown in Figure 6.1, was exposed and dissected to its origin 
from the superficial femoral vessels. The flap was completely detached and a segment 
of the venous pedicle of 1 cm in lengths was completely excised and replaced with 
the tubular nanofiber scaffold, which is shown in Figure 6.2. The inner diameter of 
the tubular scaffolds was 1 mm to match the size of the veins. End-to-end 
anastomosis was performed with 9-0 nylon using interrupted sutures. Once the 
anastomosis was completed, the microvascular clamp was released and flap perfusion 
was observed. The skin portion was closed with 4-0 Prolene running suture. The flap 
was then covered with Opsite spray to help prevent self-mutilation. Antibiotics 
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(cephalexin 500 mg/day) was administered in the drinking water postoperatively for 7 
days. Flap was also checked daily for signs of ischaemia and/or venous congestion or 
infection. The rabbits were housed singly after surgery and received human care in 
compliance with the guidelines from National University of Singapore for the care 
and use of laboratory animals. At 7 weeks post procedure, the rabbits were 
anaesthetized using the same procedure and the tubular nanofiber scaffolds were 
explanted for histological analysis.  
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Figure 6.2. Image of the P(LLA-CL) tubular nanofiber scaffold (length: 1 cm, inner 
diameter: 1 mm) before implantation. 
 
6.2 Results and discussion  
 
 Without ECs covering, collagen might be a thrombogenic surface, being 
adhesive to other types of cells like platelets. Thus, pure P(LLA-CL) tubular 
nanofiber scaffolds without collagen coating and without ECs seeding were implanted 
into the rabbit model to replace the 1 cm segments of the excised inferior superficial 
epigastric veins (Figure 6.3). The implantation showed that the tubular nanofiber 
scaffolds are suturable, and did not show dehiscence at the anastomosis or blood 
leaking from the inside of the scaffolds. As a porous material with a possibility of 
blood leaking, nanofiber meshes were reported to be able to stop the filtration of 
micro-particles with 1 μm in diameter (Gopal et al., 2006). Therefore being larger 
than 1 μm, blood cells which include red blood cells, white blood cells, and platelets 
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would not leak from the scaffolds. Plus, adhesions of plasma (cell free serum in blood) 
proteins to the lumen surfaces of the tubular scaffolds may further prevent the 
infiltration of blood cells.  
 
Figure 6.3. Image of the replacement of the inferior superficial epigastric vein with 
the P(LLA-CL) tubular nanofiber scaffold. 
 
After 7 weeks’ implantation into the rabbit model, the tubular nanofiber 
scaffolds were explanted for macroscopic structure and histochemical analysis. First, 
macroscopically, the explanted scaffolds kept the structure integrity and no 
deformation was found, which correlated with our observation from in vitro 
biodegradation study of the electrospun P(LLA-CL) NFM: no weight loss or 
morphology change for the NFM immersed in 1 × PBS for 3 month at 37 oC (Figure 
6.4 c and d). The P(LLA-CL) NFM did not lost the total weight and structure 
integrity until 8 months later. It was found that most of nanofibers broke into small 
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segments of fibers (Figure 6.4 e and f) probably because the materials became more 
brittle, resulting in very poor handability of the P(LLA-CL) NFM.  
 
 
Figure 6.4. SEM images showing morphology of the P(LLA-CL) NFM biodegraded 
in 1 × PBS at 37 oC for (a and b) 0 month, (c and d) 3 month, and (e and f) 8 month. 
(b, d, and f) are magnified images of (a, c, and e) respectively.  
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Second, H&E staining from the oblique-section of the paraffin-embedded 
tubular nanofiber scaffolds revealed a thick fibrous tissue, indicating a natural host-
tissue foreign body response towards the scaffolds, around the scaffolds but no cell 
infiltration was found (Figure 6.5). This was similar as the previous results in Figure 
5.7c, showing there was no ECs infiltration into the tubular scaffolds after 10 days’ in 
vitro culture.  
 
 
Figure 6.5. H&E staining image of the oblique-section of the explanted tubular 
nanofiber scaffold after 7 weeks’ implantation in the rabbit model. 
 
Third, it was found that no ECs-like cells were present on the lumen of the 
tubular nanofiber scaffolds, indicating the challenge of immediate in vivo 
endothelialization and the necessity of in vitro ECs-seeding of vascular grafts. 
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Although no blood coagulation occurred in the lumen of the scaffolds for 7 weeks’ 
implantation, it is highly possible that blood coagulation (thrombosis) would occur in 
a later phase due to the lack of anti-thrombogenic ECs layer. Thus EC-seeded 
vascular grafts should be implanted into the rabbit to test the patency in the future. 
There are several approaches regarding where and how to extract ECs. Autologous 
ECs could be harvested from veins, arteries, capillaries, and fatty tissues etc. Recent 
advances in stem cell technology also provide alternative ECs sources. It was 
reported that endothelial progenitor cells (EPCs), circulating in the peripheral blood, 
could be differentiated into ECs with comparable antithrombogenic potential (Lin et 
al., 2000). Further, human embryonic stem cells were shown to be differentiated into 
ECs forming vascular-like structures successfully (Levenberg et al., 2002).  
 
6.3 Conclusion   
 
To prove the basic concept of using the tubular nanofiber scaffolds as vascular 
grafts, the tubular P(LLA-CL) nanofiber scaffolds (inner diameter 1 mm) without 
collagen coating and without ECs seeding were implanted in vivo into a rabbit model 
to replace the inferior superficial epigastric veins. Results showed the scaffolds could 
sustain the suturing during the implantation process and there was no blood leaking 
from the scaffolds. After 7 weeks, the explanted scaffolds kept the structure integrity. 
There was a thick fibrous tissue around the scaffolds. No ECs layer or blood 
coagulation occurred in the lumen of the scaffolds. The lack of ECs layer in the 
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lumen indicated the necessity of ECs seeding in vitro onto the scaffolds before 
implantation.  
                                                                                                                         Chapter 7                              
Chapter 7 
 
Conclusion and Recommendations 
 
The scope of this research encompasses modification of electrospun P(LLA-CL) 
nanofiber scaffolds with natural collagen type I and construction of tissue engineered 
small-diameter vascular grafts by hybridizing the scaffold and endothelial cells (ECs).  
 
7.1 Main conclusions 
 
1. Flat collagen-modified P(LLA-CL) nanofiber meshes (NFM) were successfully 
fabricated by two ways: (1) electrospinning a mixture of collagen and P(LLA-CL) 
dissolved in a polar organic solvent, HFP; (2) collagen coating on the electrospun 
P(LLA-CL) NFM after air plasma treatment. The modified NFM had diameter range 
between 100 to 800 nm and displayed features of ECM-like non-woven architecture, high 
porosity (around 70%), bioactive surface, proper mechanical properties (tensile strength, 
1-10 MPa), and controllable fiber alignment. Collagen coated aligned NFM have higher 
mechanical strength and modulus in the fiber alignment direction than the random NFM.  
 
 
2. The collagen-blended P(LLA-CL) NFM has improved viability and attachment 
of HCAECs compared with the unmodified P(LLA-CL) NFM. HCAECs adopted a 
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spreading polygonal shape and interconnected well with the collagen-blended NFM, 
whereas HCAECs had a round non-spreading shape on the P(LLA-CL) NFM. Further, 
HCAECs maintained phenotypic expressions of cell adhesion molecules such as 
PECAM-1, ICAM-1, VCAM-1, E-Selectin, and von Willebrand factor on the collagen-
blended NFM.  
 
3. The collagen coating treatment improved the viability and attachment of 
HCAECs on the P(LLA-CL) NFM. HCAECs maintained the phenotypic expression of 
PECAM-1, fibronectin, and collagen IV. Furthermore, HCAECs kept the expressions of 
112 function-related genes. On the collagen coated aligned NFM, HCAECs grew along 
the direction of nanofiber alignment and showed elongated morphology. 
 
4. 3-D P(LLA-CL) tubular nanofiber scaffolds were fabricated by electrospinning 
onto a rotating metallic mandrel. The tubular scaffolds were then modified with collagen 
by coating method. A rotational seeding technique can be used to seed HCAECs on the 
lumen of the scaffolds with even cell distribution. The collagen coated scaffolds 
possessed quick and stable endothelialization and reached sub-confluence of HCAECs 
immediately after seeding. After 10 day’s culture, HCAECs existed as a thin layer 
covering the lumen of the scaffolds. Further, the cells showed the phenotypic expression 
of PECAM-1. On the control (Gore-Tex® vascular grafts) there were no HCAECs 
present after rotational seeding. 
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5. The pure P(LLA-CL) tubular nanofiber scaffolds without collagen modification 
showed an in vivo patency for 7 weeks when implanted into a rabbit model. The scaffolds 
sustained the suturing and no blood leaked from the scaffolds. After 7 weeks, the 
scaffolds kept the structure integrity and no blood coagulation occurred in the lumen. A 




What’s left in this study is that some experiment designs are not optimized to a 
satisfied level. First of all, only one cell type, i.e. human coronary artery endothelial cells 
(HCAEC), has been studied. Other cell candidates such as human umbilical vein 
endothelial cells (HUVEC) and stem cells should been explored as they’re extensively 
used in literature. Secondly, the ePTFE graft should not act as a control for a viable 
TEVG because it’s made of synthetic and non-biodegradable materials. Ideally a natural 
vein/artery from humans could better show the existing “gap” between a TEVG and a 
conduit routinely used in clinical practice. Lastly, the very basic question which is why 
and how nanostructure topography affects cellular behavior remains unknown. We used 
cell grown on TCPS as a control to study cellular behavior on nanofiber scaffolds. 
However, as a hard surface with different chemical composition, TCPS could not 
theoretically act as a good control for nanofiber surface.   
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7.3 Recommendations 
 
7.3.1 Advanced mechanical properties studies 
 
 In this study, the mechanical properties of the flat nanofiber meshes were studied 
but they could not reflect other important mechanical properties of the 3-D tubular 
nanofiber scaffolds such as burst pressure and compliance, which need be studied using 
professionally customized apparatus. Burst pressure is a pressure under which vascular 
grafts rupture. It can be measured by affixing the tubular scaffold to a nozzle connected 
to a pressure gauge, pressure regulator, and filled with liquid. The pressure will be then 
increased slowly until the scaffold bursts. The burst pressure will be recorded and 
expressed in mmHg. Compliance is defined as the volume change of vascular grafts, 
usually expressed as percentage of radius change versus pressure change. For compliance 
test, the tubular scaffold will be immersed in a water bath and cannulated at either end. 
One cannula will be connected to a column of water and the other to a drainage tube. The 
column of water should create a pressure within the scaffold as high as 120 mmHg. 
Water can be then drained from the scaffold to lower the pressure in decrements of 10 
mmHg. At each decrement, the diameter of the scaffold will be recorded using a digital 
camera. This process will be repeated until the pressure reaches 0 mmHg.  
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7.3.2. Introducing growth factors into the nanofiber scaffolds 
 
A recently developed core-shell nanofibers in our lab have the potential of 
carrying proteins and growth factors into nanofibers (Figure 7.1) (Zhang et al., 2004). 
Initial study of release kinetic of core-shell nanofibers with fluorescein-isothiocyanate-
conjugated bovine albumin (FITC-BSA) encapsulated in the core showed a control 
release pattern (Ramakrishna et al., 2006). The drug release rate could be adjusted by the 
ratio of thickness of the shell to core. In the future, ECs chemokine such as vascular 
endothelial growth factor (VEGF) can be loaded into the core of the nanofibers. The 
gradually released VEGF may recruit host ECs onto lumen of the tubular scaffolds. 
 
 
Figure 7.1. Experimental setup for electrospinning core-shell nanofibers (Zhang et al., 
2004).  
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7.3.3 Constructing tubular nanofiber scaffolds with hierarchical structure 
 
 
It is important to design tubular nanofiber scaffolds with a controllable 
hierarchical organization which would better simulate the tri-layer structure of natural 
blood vessels. In natural blood vessels, the intima layer is for ECs growth and can be 
fabricated using collagen-modified NFM. The media layer is for SMCs growth and can 
be constructed by aligned collagen-modified NFM, having the ability to control the 
alignment of SMCs. The outer layer consists of fibroblasts. Random polymer NFM can 
be used to construct the outer layer because fibroblasts can easily grow well in a random 
pattern on surface of polymers. To conclude, ECs-seeded NFM, SMCs-seeded aligned 
NFM, and fibroblast-seeded NFM can be constructed one by one to obtain vascular grafts 
with unique mechanical strength (Figure 7.2). It needs to be noticed that SMCs and 
fibroblasts need to grow into multi-layers on the media and adventitia for functional 
blood vessels regeneration, which is different from ECs growing as a mono-layer in the 
intima. To encourage the multilayer growth of SMCs and fibroblasts, pore size of the 
NFM should be controlled to enable infiltration of the cells into the NFM. Another 
approach is to electrospray the cells during electrospinning process. It has been reported 
that after electrospraying, vascular smooth muscle cells remained their viability and 
proliferation compared with the unprocessed cells (Stankus et al., 2006).  
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Figure 7.2. Constructing tubular nanofiber scaffolds with hierarchical structure: ECs-
seeded NFM, SMC-contained aligned NFM, and fibroblasts-contained NFM can be used 
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ABSTRACT
Maintaining functions of endothelial cells in vitro is a prerequisite for effective endothelialization of
biomaterials as an approach to prevent intimal hyperplasia of small-diameter vascular grafts. The aim of
this study was to design suitable nanofiber meshes (NFMs) that further maintain the phenotype and
functions of human coronary artery endothelial cells (HCAECs). Collagen-coated random and aligned
poly(L-lactic acid)-co-poly(e-caprolactone) (P(LLA-CL)) NFMs were fabricated using electrospinning.
Mechanical testing showed that tensile modulus and strength were greater for the aligned P(LLA-CL)
NFM than for the random NFM. Spatial distribution of the collagen in the NFMs was visualized by
labeling with fluorescent dye. HCAECs grew along the direction of nanofiber alignment and showed
elongated morphology that simulated endothelial cells in vivo under blood flow. Both random and aligned
P(LLA-CL) NFMs preserved phenotype (expression of platelet endothelial cell adhesion molecule-1,
fibronectin, and collagen type IV in protein level) and functions (complementary DNA microarray
analysis of 112 genes relevant to endothelial cell functions) of HCAECs. The P(LLA-CL) NFMs are po-
tential materials for tissue-engineered vascular grafts that may enable effective endothelialization.
INTRODUCTION
SMALL-DIAMETER (<6MM) PROSTHETIC VASCULAR GRAFTSremain patent only 15–30% of the time after 5 years1
and are associated with thrombosis rates greater than 40%
after 6 months;2 these outcomes are due to thrombosis and
intimal hyperplasia (excessive tissue ingrowth). Seeding
endothelial cells onto the inner surface of a vascular graft is a
promising method to improve the antithrombogenicity
property of vascular grafts, which is considered the begin-
ning of tissue engineering for the cardiovascular system.3
However, endothelialization has always been limited be-
cause attached endothelial cells often detach from the sur-
face upon exposure to blood circulation.4 Thus, natural
extracellular matrix (ECM) proteins have been used to
modify the surface of vascular grafts to introduce cell rec-
ognition sites in order to induce cell-material interactions.5
Since endothelial cells are locally regulated by ECM,
biomimetic and bioactive materials may physically mimic
ECM and chemically could be preferred candidates to support
normal attachment, proliferation, and phenotypic and func-
tional maintenance of endothelial cells.6 Polymer nanofiber
scaffold is among the most promising biomaterials for native
ECM analogues. Biodegradable polymer nanofibers with di-
ameters ranging from 100 to 800 nm have been extensively
used as tissue engineering scaffolds7–11 because they pos-
sess many desirable properties: biocompatibility, ECM-like
architecture, high porosity, adjustable mechanical and bio-
degradable properties,12 capability of surface modifica-
tion,10,11 and flexibility of loading drugs or genes.13,14 We
have reported that the random electrospun poly(L-lactic acid)-
co-poly(e-caprolactone) P(LLA-CL) nanofiber can better sup-
port proliferation, adhesion, and differentiation of vascular
smoothmuscle cells7–9 than can the solvent cast polymer film.
1Division of Bioengineering, National University of Singapore, Singapore.
2Nanoscience and Nanotechnology Initiative, National University of Singapore, Singapore.
3Department of Mechanical Engineering, National University of Singapore, Singapore.
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The objective of the study was to design nanofiber
meshes (NFMs) that had properties suitable for tissue-
engineered vascular grafts and could support phenotypic
and functional maintenance of endothelial cells. We fabri-
cated collagen-coated random and aligned P(LLA-CL)
NFMs with nanoscale dimension, immobilized ECM pro-
tein, and adjustable fiber alignment. We chose the copolymer
from the biodegradable and bioresorbable aliphatic polyester
family, random P(LLA-CL) because the degradation rate of
the copolymer can be controlled readily by adjusting the ratio
of 2 components. In addition, poly(L-lactic acid) (PLLA) is a
semi-crystallized hard and brittle material, while poly(e-
caprolactone) (PCL) is a semi-crystalline material with rub-
bery properties.15 Copolymers of PLA and PCL could achieve
a balanced mechanical property through the adjustment of the
ratio of the 2 components. Collagen type I was chosen as the
immobilized ECM protein because it is the main type of col-
lagen in connective tissue and is present throughout the arterial
wall. The collagen-coated P(LLA-CL) NFMs were fabricated
through plasma treatment, followed by collagen coating.
Morphology, porosity, mechanical properties, and surface
chemistry of the NFMs were studied with respect to the re-
quirements of vascular grafts. Behaviors of human coronary
artery endothelial cells (HCAECs) on the collagen-coated
P(LLA-CL) NFMs were analyzed in terms of morphology,
phenotypic maintenance, and functional maintenance.
MATERIALS AND METHODS
Materials
The random P(LLA-CL) was bought from Boehringer
Ingelheim (Ingelheim, Germany); the molecular weight
was 150 kDa. Dichloromethane, N, N-dimethylformamide,
and hydrochloric acid were bought from Merck & Co.
(Whitehouse Station, NJ). Collagen type I (calf skin) and 1,
1, 1, 3, 3, 3-hexafluoro-2-propanol were purchased from
Sigma-Aldrich (St. Louis, MO). Human HCAECs were
obtained from Cambrex Bio Science (Walkersville, NJ).
The endothelial cell basal medium (Clonetics EBM-2) and
the growth factors were purchased from Cambrex Bio
Science. The mouse monoclonal antibody to human platelet
endothelial cell adhesion molecule-1 (PECAM-1, CD 31)
was bought from Cymbus Biotechnology (Hants, United
Kingdom). The mouse monoclonal antibody to human fibro-
nectin and collagen type IV were purchased from Acris
(Hiddenhausen, Germany).
Fabrication of the random and aligned
P(LLA-CL) NFMs
For electrospinning of the P(LLA-CL) NFMs, random
P(LLA-CL) (10 wt%) solution in dichloromethane and N,
N-dimethylformamide (70:30 wt:wt) was added to a plastic
syringe with a needle (inner diameter, 0.21mm). With the
aid of a syringe pump, the solution was injected at a feed
rate of 0.5mL/h. Electrospinning voltage was applied to the
needle at 10 kV using a high-voltage power supply (Gamma
High Voltage Research, Ormond Beach, FL). The resultant
nanofibers were collected on an aluminum collector. For
collecting the random NFM, a static flat alumina plate was
used; for the aligned NFM, a rotating disk (1000 rpm) was
used. The rotating plate has a sharpened edge that can
strengthen the electric field near the collector. Experiment
setups are shown in Fig. 1. Detailed information on the
equipment used to fabricate aligned nanofiber is provided
in a report by Xu et al.7
Collagen coating on the P(LLA-CL) NFMs
Air plasma treatment of the P(LLA-CL) NFMs was
performed in an inductive coupled radiofrequency glow dis-
charge plasma cleaner (PDC-001, Harrick Plasma, Ithaca,
FIG. 1. Experiment setups for electrospinning the random and aligned poly(L-lactic acid)-co-poly(e-caprolactone) nanofiber meshes,
which were collected with a static plate (A) or rotating disk (B), respectively. Color images available online at www.liebertpub.com/ten.
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NY) for 5min with the radiofrequency power set at 30W.
Plasma treatment can increase the surface hydrophilicity of
materials,16,17 which makes the NFMs wettable by collagen
solution. The plasma-treated NFMs were immersed in the
collagen solution in 0.01M hydrochloride with a concen-
tration of 290 mg/mL at 4oC overnight. They were then
dried at room temperature.
Characterization of the P(LLA-CL) NFMs
Scanning electron micrographs of the NFMs were ob-
tained on a JSM-5800LV scanning electron microscope
( JEOL, Tokyo, Japan). Diameter range and pore size
(length of the diagonals of the pore square) of the NFMs
were measured from the scanning electron microscope
images by random counting of 60 nanofibers using ImageJ
image analysis software (ImageJ, Bethesda, MD).
Thickness of the P(LLA-CL) NFM was measured by a
micrometer (Mitutoyo, Kanagawa, Japan) and its apparent
density and porosity were calculated using the following
equations:
NFM apparent density (g=cm3)
¼ NFM mass (g)
NFM thinckness (cm) ·NFM area (cm2)
NFM porosity
¼ 1 NFM apparent desnity (g=cm
3)




To visualize the collagen distribution, P(LLA-CL) NFMs
coated with rhodamine B isothiocyanate (Sigma)–labeled
collagen were observed under a laser scanning confocal
microscope (Leica Microsystems, Wetzlar, Germany).
Tensile tests were carried using a 5848 microtester (In-
strom, Canton, MA) at a stroke rate of 10mm /min with a
40-mm gauge length. For the test, the NFMs were prepared
in rectangular (1060mm) shapes with a thickness of ap-
proximately 20 mm.
In vitro culture of HCAECs
HCAECs were bought at passage 3. The cells were
cultured in Clonetics EBM-2 complete medium supple-
mented with 5% fetal bovine serum, penicillin (100 units/
mL), and streptomycin (100 mg/mL). The medium was re-
placed every 4 days and cultures were maintained in a
humidified incubator at 378C with 5% carbon dioxide.
When the cells reached 80–90% confluence, they were
trypsinized and subcultured at 1:3 ratios.
Immunofluorescent staining
After 5 days of culture at seeding density of 1.5104
cells/cm2, HCAECs were washed with phosphate-buffered
saline, fixed with 2.5% paraformaldehyde, and blocked by
2% bovine serum albumin. HCAECswere then incubated for
2 h at 37oCwith primary antibody.Afterwashing, fluorescein
isothiocyanate–labeled rabbit anti-mouse IgG (Chemicon,
Temecula, CA) was added and incubated for 2 h at 37oC,
followed by washing and counterstaining with propidium
iodide (2.5 mg/mL) for 1min at 37oC. The immunostained
cellular construct samples were then mounted on glass slides
with 7 mL FluorSave reagent (Calbiochem, Darmstadt, Ger-
many), and viewed under laser scanning confocal micro-
scope.
Reverse transcriptase polymerase chain
reaction analysis
PECAM-1, fibronectin, and collagen type IV were
studied by reverse transcriptase polymerase chain reac-
tion (RT-PCR) for gene expression analysis in messenger
RNA. Total RNA was extracted from subconfluent 2.5106
HCAECs using RNeasy Mini Kit (Qiagen, Hilden, Ger-
many). For RT-PCR, complementary DNA (cDNA) was
reverse transcribed from 1 mg of total RNA. Further infor-
mation is available in the report by He et al.18
The PCR products were analyzed by electrophoresis of
10 mL of each sample in 1% agarose gel, and the bands
were visualized under ultraviolet light by ethidium bromide
staining with a gel documentation system (Gel Doc 2000,
BioRad, Hercules, CA).
cDNA microarray analysis
Total RNA was extracted from the HCAECs cultured for
5 days on tissue culture polystyrene, the random and
aligned P(LLA-CL) NFMs using RNeasy Mini Kit. A
biotin–20-deoxyuridine 50-triphosphate (Roche, Pleasonton,
CA)–labeled cDNA probe was synthesized according to
GEArray probe synthesis kits (GEArray Ampolabeling-
LPR kit, Superarray, Frederick, MD) and stored at 20oC.
Hybridization with a 2.5-mg biotinylated cDNA probe was
done on a nylon membrane printed with the GEArray S
series (human endothelial cell biology gene array, Superar-
ray), which contained 112 genes associated with major
functions of endothelial cells. Prehybridization and hybrid-
ization were carried out in a hybridization oven (Biometra,
Goettingen, Germany) for 2 h and overnight, respectively.
Finally, the chemiluminescent detection results were scan-
ned using ScannArray (GSI Lumonics, Billerica, MA).
RESULTS
Characterizations of the P(LLA-CL) NFMs
Morphology of the random and aligned P(LLA-CL)
NFMs is shown in Fig. 2, which represents the cross-
section (parts A and D), 3-dimensional structure (parts B
and E), and top view (parts C and F) of the NFMs.
Diameter and pore size distribution of the random and
aligned P(LLA-CL) NFMs are shown in Fig. 3. This figure
BIODEGRADABLE POLYMER NANOFIBER MESH AND ENDOTHELIAL CELLS 2459
reveals a diameter range of 200–800 nm for both NFMs and
more uniform diameter distribution for the random NFM
than the aligned NFM (Fig. 3A). The pore size for the
random NFM was defined as length of diagonal of the pore
polygon, which is not applicable for the aligned NFM. Fig.
3B shows pore size distribution of the random NFM to be
mainly between 5 and 10 mm.
Diameter, thickness, apparent density, porosity, and pore
size of the random and aligned P(LLA-CL) NFMs are
further summarized in Table 1. This table shows that the
diameter of the aligned NFM (mean SD, 406 126 nm)
is smaller than that of the random NFM (mean SD,
470 80 nm). Similar results were reported for aligned
PCL11 and PLLA NFMs.19 This might be due to stretching
tangential force exerted by the high-speed rotating disk on
the nanofiber produced.11 With the known bulk density of
P(LLA-CL), the porosity of the NFMs can be calculated by
measuring their apparent density. Porosity for both NFMs
was found to be approximately 70%.
To visualize spatial distribution of the collagen coated
onto the P(LLA-CL) NFMs, rhodamine-labeled collagen
was coated onto the NFMs and observed under laser
scanning confocal microscope. Collagen was uniformly
coated on the surface of every nanofiber in both random























































FIG. 3. (A) Diameter distribution of the random and aligned
poly(L-lactic acid)-co-poly(e-caprolactone) (P(LLA-CL)) nanofi-
ber meshes. (B) Pore size distribution of the random P(LLA-CL)
nanofiber meshes.
TABLE 1. DIAMETER, THICKNESS, APPARENT DENSITY, POROSITY,
AND PORE SIZE OF THE RANDOM AND ALIGNED POLY(L-LACTIC
ACID)-CO-POLY(e-CAPROLACTONE) NANOFIBER MESH. DATA
ARE REPRESENTATIVE OF 2 INDEPENDENT EXPERIMENTS















ANF 406 126 24 2 0.37 0.02 69–72 N.A.
RNF 470 80 26 5 0.43 0.08 64–67 6 2
N.A.: not applicable; RNF: random NFM; ANF: aligned NFM.
FIG. 2. Scanning electron microscopy pictures of a cross-section (A and D), 3-dimensional structure (B and E), and top view (C and
F) of the random (A–C) and aligned (D–F) poly(L-lactic acid)-co-poly(e-caprolactone) nanofiber meshes. Color images available online
at www.liebertpub.com/ten.
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Mechanical properties of the P(LLA-CL) NFMs
Fig. 5 shows the typical stress-strain curves for the ran-
dom and aligned P(LLA-CL) NFMs under tensile loading.
Mechanical strength of the aligned P(LLA-CL) NFM in-
creased compared with the random NFM. This finding
correlates to the report that orientation of the fibers directly
modulates the mechanical properties of the nanofibers.20 It
also indicates a way to tailor mechanical properties of
NFM by changing the fiber alignment. Tensile properties of
the NFMs are further summarized in Table 2. This table
shows that aligned NFM has larger tensile modulus and
tensile strength but smaller ultimate strain than the random
NFM.
Morphology and phenotype studies of HCAECs
To study functional development of HCAECs on the
NFMs, we performed a series of studies ranging from basic
analyses of cell morphology and phenotype to a deeper
analysis of functional development by microarray gene
expression.
Fig. 6A shows that HCAECs adopted a spindle shape on
the aligned NFM, with the long axes parallel to each other
and with fibers aligned; this finding is distinct from the
polygonal shape on the tissue culture plates and random
NFMs.
FIG. 4. Three-dimensional laser scanning confocal microscopy (original magnification,600) of the collagen-coated random (A) and
aligned (B) poly(L-lactic acid)-co-poly(e-caprolactone) nanofiber meshes. Rhodamine-labeled collagen was identified by its red fluo-
rescence. Color images available online at www.liebertpub.com/ten.
FIG. 5. Typical stress-strain curves for the random and aligned
poly(L-lactic acid)-co-poly(e-caprolactone) P(LLA-PCL) nanofi-
ber meshes (NFMs) under tensile loading. Color images available
online at www.liebertpub.com/ten.
TABLE 2. TENSILE PROPERTIES OF THE RANDOM AND ALIGNED
POLY(L-LACTIC ACID)-CO-POLY(e-CAPROLACTONE) NANOFIBER
MESH. DATA ARE REPRESENTATIVE OF 2 iNDEPENDENT
EXPERIMENTS AND ARE PRESENTED AS MEANSD (n¼ 3)
ANF RNF
Tensile Modulus (MPa) 102.59 5.86 43.99 4.04
Tensile strength (MPa) 10.60 1.29 6.27 1.38
Ultimate strain (%) 99 5 175 49
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Phenotype studies of endothelial cells were carried out
from 2 main aspects: 1) phenotypic maintenance of endo-
thelial cells and 2) the ECM remolding potential of endo-
thelial cells. For the first step, immunostaining of PECAM-1,
CD31, a universal endothelial cell marker, shows the dif-
ferentiation status and phenotypic maintenance of endo-
thelial cells (Fig. 6A, top) on both tissue culture plates and
random and aligned P(LLA-CL) NFMs. For the second
step, Fig. 6B shows immunostaining of fibronectin and
collagen type IV from HCAECs on the tissue culture plates
FIG. 6. (A) Fluorescent microscopy (original magnification, 600) and scanning electron microscopy (SEM) (original magnifica-
tion, 1000) images of human coronary artery endothelial cells (HCAECs) cultured for 3 days at a density of 3104 cells/cm2 on tissue
culture plates (TCPS), random and aligned poly(L-lactic acid)-co-poly(e-caprolactone) (P(LLA-CL)) nanofiber meshes (NFMs).
HCAECs were stained with antibody directed against platelet endothelial cell adhesion molecule-1 (PECAM-1) (green) and nuclei
counterstained with propidium iodide (red) on fluorescent microscopy pictures. (B) Laser scanning confocal microscopy images of
fibronectin and collagen type IV expression from HCAECs on tissue culture plates, random NFM (RNF), and aligned NFM (ANF).
(C) Reverse transcriptase polymerase chain reaction analysis of expression of PECAM-1, fibronectin, and collagen type IV in HCAECs
cultured on tissue culture plates, random NFM, and aligned NFM. Color images available online at www.liebertpub.com/ten.
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and random and aligned P(LLA-CL) NFMs. HCAECs
cultured on the NFMs possessed the phenotypic expression
of endothelial cell–characteristic ECM protein, indicating
the potential capability of HCAECs to remold ECM when
cultured on NFMs in vitro. Fig. 6C further reveals the ex-
pression of these 3 molecules (PECAM-1, fibronectin, and
collagen type IV) at the gene level by RT-PCR analysis.
cDNA microarray analysis of HCAECs
To analyze functional maintenance of HCAECs cultured
on the synthetic NFMs, a cDNA microarray was applied to
study gene expression profiles of HCAECs cultured on the
tissue culture plates and random and aligned NFMs in a
high-throughput fashion. Fig. 7A shows the expression
profile of 112 genes, printed onto nylon membranes in the
form of an 814 grid, which are associated with 4 major
functions of endothelial cells: permissibility and tone, an-
giogenesis, endothelial cell activation, and endothelial cell
injury. Fig. 7B shows 3 comparison groups by scatter plots:
random NFM vs. tissue culture plates (Fig. 7B1); aligned
NFM vs. tissue culture plates (Fig. 7B2); aligned NFM vs.
random NFM (Fig. 7B3). Quantitative analysis of the
scatter plot reveals similarities of 87.5%, 89.3%, and
94.6%, respectively. This means, for example, that 87.5%
of the genes from HCAECs cultured on random NFM
have an expression level similar to that on tissue culture
plates. The results are further summarized in Table 3. This
table shows the functional maintenance of HCAECs on
tissue culture plates and random and aligned NFMs. RT-
PCR analysis (Fig. 7C) was performed to verify gene ex-
pression profile from the microarray. Three continuous
spotted genes from the integrin family—integrin a5, in-
tegrin aV, and integrin b1—were picked up, highlighted
by a red quadrangle in Fig. 7A. The microarray results
show a clear pattern of higher expression levels of integrin
a5 and integrin b1 than with integrin aV. RT-PCR re-
sults (Fig. 7C) displayed the highest level of expression of
integrin aV among the 3 integrins. However, integrin b1
and integrin aV seem to have the same expression level.
DISCUSSION
In this study, collagen-coated electrospun random and
aligned P(LLA-CL) NFMs were successfully fabricated.
The NFMs have several favorable characteristics, such as
ECM-like architecture, high porosity, adjustable mechani-
cal properties, suitable surface chemistry, and controllable
fiber alignment. The potential application of the NFMs as
tissue-engineered vascular grafts was primarily studied
with regard to phenotypic and functional maintenance of
endothelial cells.
The ECM-like architecture of the NFMs may provide
cells with a friendly environment. As the specific ECM
around endothelial cells, basement membrane was reported
to possess a nano to submicron-scale topography of ECM
macromolecules, includingfibermesh,pores, ridges,grooves,
and peak valleys,12 which are also features of the NFM.
Thus, it is reasonable to expect that ECM-mimicking NFMs
may play a role in promoting tissue regeneration in vitro
similar to that of the native ECM in vivo.6
Porosity is an important measure for tissue engineering
scaffolds. Vascular grafts should be porous, and the po-
rosity should both allow cell infiltration from the adventitial
side and maintain hemostasis, as well as allow sufficient
mass transfer of gases and nutrients.21 It is generally ac-
cepted that a higher-porosity vascular graft exhibits high
patency.22 Longer fibril expanded polytetrafluoroethylene
(60 and 90 mm) provided a much higher degree of en-
dothelialization and collagen production than the shorter
fibril groups (20 and 40 mm).23 Previous studies suggest that
effective pore diameters of vascular grafts for cell ingrowth
are 20–60 mm,24 which is larger than the diameter we ob-
tained with the P(LLA-CL) NFMs (Fig. 3B). The phe-
nomenaof dynamic interactions between cells and nanofibers
may explain possible cell ingrowth into pores of nanofibers,
which are smaller than the size of the cell. Researchers
have hypothesized that cells might push fibers aside to
force ingrowth since the loose and small fibers offer little
resistance to cell movement.25
Mechanical properties affect long-term patency of vas-
cular grafts.26,27 One of the main failure modes of synthetic
vascular grafts, intimal hyperplasia, is associated with shear
stress disturbances due to compliance mismatch of natural
arteries and vascular grafts.26 Compliance is a mechanical
property of a tube, and it depends on the tube dimension
and modulus.27 We studied the tensile modulus, tensile
strength, and ultimate strain of the NFMs (Fig. 5, Table 2)
and could use these findings to fabricate, evaluate, and
optimize compliant tube-like structure for tissue-engineered
vascular grafts.
Surface chemistry of materials mediates protein adsorp-
tion, which regulates cell adhesion, proliferation, and mi-
gration25 and affects the tissue regeneration rate. As an
adhesion protein that facilitates cell attachment and pro-
liferation,28 collagen is commonly used to modify the sur-
face of vascular grafts. The first complete tissue-engineered
vascular graft was fabricated with collagen gel.29 However,
pure collagen scaffolds always encountered mechanical
limitations.30 Electrospinning of collagen nanofibers and
modification of nanofibers with collagen are new approaches
that may improve scaffold strength.31 The collagen-coated
P(LLA-CL) NFMs showed improved attachment, spreading,
and proliferation of HCAECs compared with the unmodified
P(LLA-CL) NFMs (data not shown). However, collagen is
not cell-specific; thus, its use causes adhesion of any type of
cells, such as platelets, which may result in a thrombogenic
surface. Thus, it is critical to establish confluence and stable
endothelial cells on a collagen-modified vascular surface.21
Ability of the aligned NFMs to control cell orientation is
meaningful for tissue-engineered vascular grafts.32 Shear
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FIG. 7. (A) Gene expression profiles of human coronary artery endothelial cells (HCAECs) on tissue culture plates (TCPS), random
(RNF) and aligned (ANF) poly(L-lactic acid)-co-poly(e-caprolactone) nanofiber meshes (NFMs) by microarray analysis. Expression of
each gene is represented by the fluorescence of the tetraspot. (B) Scatter plot showing the relative gene expression of random NFM
versus tissue culture plates, aligned NFM versus tissue culture plates, and random versus aligned NFMs. (C) Reverse transcriptase
polymerase chain reaction analysis of integrin a5, integrin aV, and integrin b1 expression from HCAECs cultured on tissue culture
plates, random NFM, and aligned NFM, which correlate to the genes in a red frame in part A. Color images available online at
www.liebertpub.com/ten.
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stress caused by blood flow in vivo orientates endothelial
cell growth along the direction of the blood flow,33 which
may increase the ability of endothelial cells to resist shear
stress and decrease desquamation of these cells from vas-
cular grafts. Thus, it is important to mimic the orientation
of endothelial cells in vitro on vascular grafts. One way
to orientate cells is through dynamic cell culture in a bio-
reactor. Jeong et al. reported that smooth muscle cells
cultured in a perfusion bioreactor showed contractile phe-
notype, significant cell alignment, and increased collagen
production.34 Similarly, Lee et al. found that human liga-
ment fibroblast cultured on the aligned polyurethane
nanofibers were oriented along the fiber direction and se-
creted more collagen than on the randomly orientated
nanofibers.35 Thus, aligned NFMs might be used as sub-
stitute for a bioreactor, which necessitates a complicated
fluid systems, in this specific application where cell align-
ment is important.
Phenotype and gene expression studies of cells on bio-
materials can characterize the biological state and func-
tional development of cells. Phenotype studies of PECAM-
1, fibronectin, and collagen type IV expression in protein
levels indicate that HCAECs remained differentiated and
may be able to remold ECM when cultured on NFMs
in vitro (Fig. 6). Functional study of HCAECs through
screening 112 genes with cDNA microarray shows the
similar gene expression pattern of HCAECs (Fig. 7), indi-
cating the functional maintenance of HCAECs cultured on
the P(LLA-CL) NFMs and tissue culture plates. These
findings suggest effective and fast endothelialization on the
NFMs.
We fabricated collagen-coated random and aligned
P(LLA-CL) NFMs that featured ECM-like architecture,
high porosity, adjustable mechanical properties, suitable
surface chemistry, and controllable fiber alignment. Col-
lagen was evenly coated throughout the NFMs. The aligned
P(LLA-CL) NFMs have higher mechanical strength and
modulus than the random NFMs. HCAECs grew along the
direction of nanofiber alignment and showed elongated
morphology. Both random and aligned NFMs can support
phenotypic and functional maintenance of HCAECs. These
findings suggest that effective and quick endothelialization
onto the NFMs can be established.
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Abstract
Endothelialization of biomaterials is a promising way to prevent intimal hyperplasia of small-diameter vascular grafts. The aim of
this study was to design a nanoﬁber mesh (NFM) that facilitates viability, attachment and phenotypic maintenance of human
coronary artery endothelial cells (HCAECs). Collagen-coated poly(L-lactic acid)-co-poly(e-caprolactone) P(LLA-CL 70:30) NFM
with a porosity of 64–67% and a ﬁber diameter of 4707130 nm was fabricated using electrospinning followed by plasma treatment
and collagen coating. The structure of the NFM was observed by SEM and TEM, and mechanical property was studied by tensile
test. The presence of collagen on the P(LLA-CL) NFM surface was veriﬁed by X-ray photoelectron spectroscopy (XPS) and
quantiﬁed by colorimetric method. Spatial distribution of the collagen in the NFM was visualized by labelling with ﬂuorescent
probe. The collagen-coated P(LLA-CL) NFM enhanced the spreading, viability and attachment of HCAECs, and moreover,EC’s phenotype. The P(LLA-CL) NFM is a potential material for tissue engineered vascular graft.
ier Ltd. All rights reserved.
ls; TisKeywords: Nanoﬁber; PLLA; PCL; Collagen; Coating; Endothelial cel
1. Introduction
The main reason for the long-term failure of small-
diameter (o6mm) vascular grafts is due to the occlusion
(thrombus formation) in the early phase followed by a
continuous and excessive tissue ingrowth (intimal
hyperplasia) in the chronic phase, both of which are
caused by the immunoreactions towards the implanted
materials [1]. Tissue engineered vascular grafts fabri-iodegradable materials provide an approach
scular substitute with long-term patency.
lete degradation, the scaffold will not leave
aterials to keep stimulating foreign body
e front matter r 2005 Elsevier Ltd. All rights reserved.
omaterials.2005.05.049
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reactions. However, methods still need to be taken to
prevent the intimal hyperplasia during the early days
after the implantation of the scaffold. One of the
effective approaches to prevent thrombus and enhance
graft survival includes endothelial cells (ECs) seeding
onto synthetic materials to render the surface anti-
thrombogenic [2] because endothelial cells can release
factors to control thrombogenesis or ﬁbrinolysis, and
platelet activation or inhibition [3]. However endothe-
lialization has always been limited because attached ECs
often detach from the surface upon exposure to blood
circulation [4]. Thus natural extracellular matrix (ECM)
proteins have been used to modify the surface of
vascular graft to introduce cell recognition sites to
induce cell–material interactions [2].
Polymeric nanoﬁbers fabricated by electrospinning
technology has received great interest in recent years due
to the nanostructured morphology of the nanoﬁbers
IN
erialsmimicking the natural extracellular matrix, which is
composed of three-dimensional networks of nanoscaled
ﬁbrous proteins embedded in a glycosaminoglycan
(GAG) hydrogel [5]. Studies have already been made
in the application of polymer nanoﬁbers for tissue
engineering of bone [6], blood vessel [7–10], cartilage
[11–12], cardiac tissue [13], peripheral nerve system
(PNS) [14], ligament [15], liver [16] and skin [17]. More
importantly, the non-woven polymer nanoﬁber mesh
(NFM) has a similar structure with natural basement
membrane, which lies under the monolayer of endothe-
lial cells in blood vessel [18]. Also the basement
membrane shows a nano- to submicron-scale topogra-
phy of ECM macromolecules, including ﬁber mesh,
pores, ridges, grooves and peak valleys [19], which are
also the features of the NFM.
The objective of this study was to fabricate collagen-
coated biodegradable NFM, and evaluate the EC
behaviors on it. We chose the copolymer from the
biodegradable aliphatic polyesters family, random
poly(L-lactic acid)-co-poly(e-caprolactone) P(LLA-CL
70:30), because the degradation rate of the copolymer
can be controlled readily by adjusting the ratio of two
components. The collagen-coated P(LLA-CL) NFM
was fabricated through plasma treatment of the electro-
spun P(LLA-CL) NFM followed by the collagen coat-
ARTICLE
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cells (HCAECs) on the collagen-coated polymer NFM
was analyzed with respect to cell morphology, viability
and attachment and phenotypic studies.
2. Materials and methods
2.1. Materials
The random poly(L-lactic acid)-co-poly(e-caprolactone)
P(LLA-CL 70:30) was bought from Boehringer Ingelheim
(Germany) with a molecular weight of 150 kDa. Dichloro-
methane (DCM), N,N-dimethylformamide (DMF) and hy-
drochloric acid (HCl) were bought from Merck (USA).
Collagen Type I (calf skin) and 1, 1, 1, 3, 3, 3-hexaﬂuoro-2-
propanol (HFP) were purchased from Sigma (Sigma-Aldrich,
MO, USA). HCAECs were obtained from Biowhittaker (New
Jersey, USA). The endothelial cell basal medium (CloneticsTMEBMs-2) and the growth factors were purchased fromCambrex (New Jersey, USA). CMFDA ﬂuorescent CellTrack-
er probe was purchased from Molecular Probe (Eugene, OR,
USA).
2.2. Methods
2.2.1. Fabrication of the P(LLA-CL) NFMFor electrospinning of the P(LLA-CL) NFM, the P(LLA-
CL 70:30) (10wt %) solution in DCM and DMF (70:30 wt:wt)
was added into a plastic syringe with a needle (inner diameter,
0.21mm). With the aid of a syringe pump, the solution wasinjected out at a feed-rate of 0.5ml/h. Electrospinning voltage
was applied to the needle at 10 kV using a high-voltage power
supply (Gamma High Voltage Research, USA). The resultant
nanoﬁbers were collected on an aluminum collector [7]. For
the cell culture in the 24-well plate, coverslips (15mm in
diameter) were put onto the aluminum to collect the NFM.
The thickness of the P(LLA-CL) NFM was measured
by a micrometer (Mitutoyo, Japan) and its apparent
density and porosity were calculated using the following
equations [10]:
NFM apparent density ðg=cm3Þ
¼ NFM mass ðgÞ
NFM thickness ðcmÞ NFM area ðcm2Þ ,
NFM porosity ¼ 1 NFM apparent density ðg=cm
3Þ
bulk density of PðLLA-CLÞ ðg=cm3Þ
 
 100%.
2.2.2. Collagen coating on the P(LLA-CL) NFM
The complete surface modiﬁcation scheme for P(LLA-CL)
NFM is shown in Fig. 1. Brieﬂy, air plasma treatment of the
P(LLA-CL) NFM was carried out in an inductive coupled
radio frequency glow discharge plasma cleaner (Harrick, PDC-
001, USA). The air plasma treatment lasted for 5min with the
radio frequency power set as 30W. Plasma treatment can
increase the surface hydrophilicity of materials [20,21], which
make the NFM wettable by collagen solution. The plasma-
treated NFM was immersed into the collagen solution in
0.01M HCl with a concentration of 290 mg/ml at 4 1C
overnight, and then was dried under room temperature.
2.2.3. Characterization of the NFM
SEM micrographs of the NFM were obtained on a JSM-
5800LV scanning electron microscope (JEOL, Japan). TEM
micrographs of the NFM were obtained from a JEM-2010F
FasTEM ﬁeld emission electron microscope (JEOL, Japan)
operated at 100 keV. Tensile tests were carried out using a 5848
microtester (Instrom, Canton, MA) at a stroke rate of 10mm/
min with a 40mm gauge length. The NFM was prepared in a
rectangular (10 60mm) shape with a thickness around 20mm
for the test.
Wettabilities of the P(LLA-CL) NFM and ﬁlm before and
after plasma treatment were measured by sessile drop contact
angle measurement using a VCA Optima Surface Analysis
System (AST products, Billerica, MA). To get water contact
angle on plane P(LLA-CL) surface, P(LLA-CL) ﬁlms were
prepared by a solvent casting (SC) method described in [7] in
detail.
XPS spectra of the NFM were obtained on a VG Escalab
2201-XL Base System (Thermo VG Scientiﬁc, England) with a
take-off angle of 901.To get pure collagen NFM’s spectrum,
collagen nanoﬁbers were fabricated by dissolving collagen in 1,
1, 1, 3, 3, 3-hexaﬂuoro-2-propanol (HFP) and then electro-
spinning into nanoﬁbers.
The amount of collagen coated onto the P(LLA-CL) NFM
PRESS
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according to the RT (room temperature) Test Tube Protocol
provided by the manufacturer. Brieﬂy, the collagen-coated
P(LLA-CL) NFM was immersed in 0.1ml PBS together with
ARTICLE IN PRESS
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absorbance at 562 nm was measured. The collagen concentra-
tion was calculated from the collagen standard curve.
To visualize the collagen distribution, P(LLA-CL) NFM
coated with rhodamine B isothiocyanate (RBITC, Sigma,
USA) labeled collagen was observed on a laser scanning
confocal microscope (LSCM, Leica, Germany). The RBITC-
labeled collagen was prepared as follows: collagen
(Mw ¼ 285k) solution (1mg/ml) in 0.01M HCl was mixed
with the RBITC (Mw ¼ 536.1) at the molar ratio of rhodamine
to collagen 50:1. The mixed solution was incubated in darkness
at RT for 3 h and then added into a dialysis tubing cellulose
membrane (molecular weight cutoff, MWCO ¼ 12,400) and
dialysed in 0.01M HCl solution until no more RBITC can be
released into the HCl solution.
2.2.4. In vitro culture of HCAECs
HCAECs were bought at passage 3. The cells were cultured
in CloneticsTM EBMs-2 complete medium supplemented with
5% fetal bovine serum, penicillin (100 units/ml) and strepto-
mycin (100mg/ml). The medium was replaced every 4 days and
cultures were maintained in a humidiﬁed incubator at 37 1C
with 5% CO2. When the cells reached 80–90% conﬂuence
(5 104 cells/cm2), they were trypsinized and subcultured at
1:3 ratios.
Fig. 1. Schematic representation of the plasma treatmen2.2.5. HCAECs morphology, viability and attachment study
Cell morphology was studied using LSCM and SEM.
HCAECs were seeded at a density of 3 104 cells/cm2 andobserved 3 days later. For LSCM observation, live cells were
stained with green ﬂuorescent probe 5-chloromethyl ﬂuores-
cein diacetate (CMFDA) and observed under LCSM (excita-
tion 492 nm, emission 517 nm). Cells viability and attachment
were determined by the colorimetric MTS assay (CellTiter 96s
AQueous One Solution Cell Proliferation Assay, Promega,
USA).
2.2.6. HCAECs phenotype study
After 3 days’ culturing at a seeding density of 3 104 cells/
cm2, HCAECs were washed with PBS, ﬁxed with 2.5%
paraformaldehyde and blocked by 2% BSA. HCAECs were
then incubated for 2 h at 37 1C with primary antibody (mouse
anti-human platelet endothelial cell adhesion molecule-1
(PECAM-1, CD 31)) (Cymbus Biotechnology, UK) diluted
at 1:50. After washing, ﬂuorescein isothiocyanate (FITC)
labeled rabbit anti-mouse IgG (Chemicon, USA) diluted at
1:50 was added and incubated for 2 h at 37 1C, followed by
washing and counterstaining with PI (2.5 mg/ml) for 1min at
37 1C. The immunostained cellular construct samples were
then mounted on glass slides with FluorSaveTM reagent
(CALBIOCHEM, Germany), and viewed under LSCM.
2.2.7. Statistical analysis
Data were made at least in triplicate and expressed as
collagen coating of the electrospun P(LLA-CL) NFM.mean7standard deviation (SD). Each experiment was re-
peated two or three times. Statistical analysis was carried out
for HCAECs viability and attachment studies using one-way
ANOVA testing by SPSS for Windows (SPSS Inc., Copyright
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post hoc test (po0:05).
3. Results and discussion
3.1. Morphology of the P(LLA-CL) NFM
Morphology of the P(LLA-CL) NFM, plasma-
treated (5min) P(LLA-CL) NFM and collagen-coated
P(LLA-CL) NFM is shown in Fig. 2, which shows the
randomly interconnected structure and smooth mor-
phology of the NFM. TEM analysis of a single P(LLA-
CL) nanoﬁber with a diameter of 390 nm veriﬁed the
nanometer scale of the NFM. The diameter of the
nanoﬁber was in the range of 200–600 nm (90%
nanoﬁbers) with a mean diameter of 4707130 nm by
image analysis software (ImageJ, National Institutes of
Health, USA). NFM with a thickness of around 26 mm
was obtained through 2 h electrospinning. With the
known bulk density of the P(LLA-CL) (1.2–1.3 g/cm3),
the porosity of the P(LLA-CL) NFM can be calculated
by measuring its apparent density, the results of which
are summarized in Table 1.
Porosity is an important parameter for tissue en-
gineering scaffolds. Vascular grafts should be porous,
the porosity of which should allow cell inﬁltration from
the adventitial side while maintaining hemostasis, as
well as sufﬁcient mass transfer of gases and nutrients
[22]. It is generally accepted that a higher-porosity
vascular graft exhibits high patency [23]. Longer ﬁbril
ePTFE (60 and 90 mm) provided a much higher degree of
Fig. 2. SEM (a, b, c) and TEM (d) micrographs of the (a, d) P(LLA-CL)
P(LLA-CL) NFM.endothelialization and collagen production than the
shorter ﬁbril groups (20 and 40 mm) [24].
The porosity of the electrospun P(LLA-CL) NFM
with diameter 4707130 nm is around 60–70%, which is
comparable to the porosity of scaffolds made from
phase separation and solid free-form fabrication, which
is between 60% and 90% [25]. Pores of the NFM are
formed by nanoﬁbers lying loosely upon each other
which are different from ‘‘real’’ isotropic pores made by
using particles or bubbles when the scaffold is solidiﬁed.
It is also not easy to create pores by electrospinning with
well-deﬁned shape as the solid free-form fabrication
made. However, the overall nanoﬁber-network archi-
tecture of NFM could better mimic the natural ECM
such as basement membrane which shows a nano- to
submicron-scale topography of macromolecules, includ-
ing ﬁber mesh, pores, ridges, grooves and peak valleys
[19]. This bio-mimicry property of nanoﬁbers may
possess unique advantage in application for tissue
engineering scaffolds.
3.2. Mechanical properties of the P(LLA-CL) NFM
Fig. 3 shows the typical stress–strain curve of the
P(LLA-CL) NFM under tensile loading. Tensile proper-
ties obtained from two independent experiments,
together with that for Dacron and coronary artery,
were summarized in Table 2. For P(LLA-CL) NFM, the
average tensile modulus is 4474MPa and tensile
PRESS
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175749%. The desirable distension property of the
P(LLA-CL) NFM quantiﬁed in ultimate strain may
result from randomly orientated ﬁbers rearranging
NFM, (b) plasma-treated P(LLA-CL) NFM and (c) collagen-coated
ARTICLE IN PRESS
Table 1
Diameter, thickness, apparent density and porosity of the P(LLA-CL) NFM
Diameter (nm) Thickness (mm) Mass per unit area (mg/cm2) Apparent density (g/cm3) Porosity (%)
4707130 2675 1.1370.20 0.4370.08 64–67
Data are representative of three independent experiments and represented as mean7SD (n ¼ 6).















Fig. 3. Stress–strain curve for the electrospun P(LLA-CL) NFM under tensile loading.
Table 2
Tensile properties of the electrospun P(LLA-CL) NFM, Dacron (PET) and coronary artery
P(LLA-CL) NFM Dacron (PET)a Coronary arteryb
Tensile modulus (MPa) 4474 14,000 —
Tensile strength (MPa) 6.371.4 170–180 1.40–11.14
Ultimate strain (%) 175749 — 45–99
ed as
W. He et al. / Biomaterials 26 (2005) 7606–76157610themselves in the direction of stress [26]. In theory, the
random NFM would become gradually aligned during
uniaxial tensile test; thus the tensile modulus of it would
increase accordingly. Such a phenomenon was not
found from the stress–strain curve where the slope was
maintained initially and then began to decrease. Similar
results were also reported by other researchers [19,26].
One of the possible reasons may be due to the fracture of
ﬁbers simultaneously during ﬁber rearrangement.
Data are representative of two independent experiments and represent
aSee Ref. [27].
bSee Ref. [9].The P(LLA-CL) NFM shows much smaller stiffness
compared to the Dacron (PET), the commonly used
large-diameter vascular grafts, which has a tensile
strength of 170–180MPa in orientated form and atensile modulus of about 14,000MPa [27]. The tensile
properties of the NFM are closer to that of the natural
coronary artery than Dacron (Table 2). Ideally less stiff
(more compliant) and biodegradable scaffolds like
P(LLA-CL) NFM are better choices for constructing a
completely biological and fully functional neo-artery
[27].
3.3. Plasma treatment of the P(LLA-CL) NFM
mean7SD (n ¼ 3) for P(LLA-CL) NFM group.To make the collagen solution easily go into the
porous NFM, the hydrophobic P(LLA-CL) NFM was
treated by air plasma to make it highly wettable. The
in Table 3 that plasma treatment of 5min is enough to
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erialseffectiveness of the plasma treatment to increase NFM’s
wettability was checked by water contact angle measure-
ment, the results of which were summarized in Table 3.
P(LLA-CL) NFM exhibited different water contact
angles from the ﬁlm due to different surface structure.
The P(LLA-CL) NFM and ﬁlm were both hydrophobic
in nature before plasma treatment and the NFM showed
higher contact angle than the ﬁlm. Although the original
P(LLA-CL) NFM showed high water contact angle,
after plasma treatment, it became highly wettable. The
ARTICLE
W. He et al. / Biomatwater drop, upon contact with the plasma treated
P(LLA-CL) NFM, was immediately absorbed into the
NFM, giving a zero apparent water contact angle.
Although the ﬁlm also tended to be more hydrophilic
Table 3
Water contact angles of the P(LLA-CL) NFM and P(LLA-CL) ﬁlm












Data are representative of three independent experiments and
represented as mean7SD (n ¼ 6).
Table 4
Atomic ratio of C, N and O on the surface of the P(LLA-CL) NFM, the colla
determined by XPS




Fig. 4. 2-D (a) and 3-D (b) LSCM micrographs of the collagen-coated P(LL
images for 3D micrographs were constructed from 20 horizontal slices of steafter plasma treatment, the contact angle difference is
not so big compared with the NFM. It was also shown
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26 (2005) 7606–7615 7611increase the NFM’s wettability. The big difference of
electrospun polymer NFM’s wettability before and after
plasma treatment was explained in [10] in detail.
3.4. Characterization of the collagen-coated P(LLA-
CL) NFM
The presence of collagen on the nanoﬁber’s surface
was conﬁrmed by the appearance of the N1S peak
(indicated in N atomic ratio) in the XPS spectrum of the
collagen-coated P(LLA-CL) NFM (Table 4), while no
nitrogen peak was found in the pure P(LLA-CL) NFM’s
spectrum. Compared with the pure electrospun collagen
NFM (15.1%), much less nitrogen was found on the
collagen-coated P(LLA-CL) NFM (5.2%).
To visualize spatial distribution of the collagen coated
in the P(LLA-CL) NFM, rhodamine-labeled collagen
was coated onto the NFM and observed under LSCM.
It is shown in the 2D image of NFM (Fig. 4a) that
collagen was uniformly coated on the surface of every
nanoﬁber. Depth projection images for 3D micro-
graphs (Fig. 4b), constructed from 20 horizontal slices
of step size 1 mm, also exhibit the uniform collagen
coating.
gen-coated P(LLA-CL) NFM and the pure electrospun collagen NFM




A-CL) NFM. The collagen was labeled with RBITC. Depth projection
p size 1 mm.
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rate as on the TPCS. This is because collagen is the mostcollagen in the P(LLA-CL) NFM was measured and
normalized by NFM’s weight. It was found that
1575 mg collagen was coated per 1mg NFM.
3.5. Morphology of HCAECs
Fig. 5 shows the ﬂuorescent and SEM micrographs of
HCAECs on TCPS (a, d), P(LLA-CL) NFM (b, e) and
the collagen-coated P(LLA-CL) NFM (c, f). HCAECs
cultured on the P(LLA-CL) NFM were rounded in
shape instead of a spreading morphology, whereas on
the collagen-coated P(LLA-CL) NFM HCAECs
adopted a spreading polygonal shape which is typical
pattern of PECAM-1 staining (Fig. 8b) as compared
to the cells on TCPS (Fig. 8a). The results indicatedof the normal cell morphology on TCPS. These
characteristics are prerequisites for an effective endothe-
lialization of vascular graft materials.
3.6. HCAECs viability and attachment studies
Viability of HCAECs at day 1, 3, 5, 7 cultured on the
TCPS, collagen-coated P(LLA-CL) NFM and unmodi-
ﬁed P(LLA-CL) NFM after cell seeding is shown in Fig.
6. HCAECs viability on the collagen-coated P(LLA-CL)
NFM was obviously increased compared with the
unmodiﬁed NFM from day 3 onwards (po0:05).
The attachment of HCAECs to TCPS, collagen-coated P(LLA-CL) NFM and unmodiﬁed P(LLA-CL)
NFM is shown in Fig. 7. More cells attached on the
collagen-coated P(LLA-CL) NFM than the unmodiﬁed
P(LLA-CL) NFM. HCAECs were found to attach on
Fig. 5. LSCM and SEM images of HCAECs cultured on (a, d) TCPS, (b
HCAECs were seeded at a density of 3 104 cells/cm2 and stained with CMthe collagen-coated P(LLA-CL) NFM at very similar
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26 (2005) 7606–7615abundant ECM protein with both structural and
adhesive functions, facilitating cell adhesion through
the integrin receptors [28].
3.7. HCAECs phenotype analysis
The surface adhesion protein characteristically ex-
pressed by ECs was studied using immunoﬂuorescent
microscopy. Platelet endothelial cell adhesion molecule-
1 (PECAM-1, CD31) is an universal EC marker,
expression of which can represent the differentiation
status of endothelial cells. Fig. 8 shows the LSCM
images of immuno-stained HCAECs cultured on TCPS
and the collagen-coated P(LLA-CL) NFM. The P(LLA-
CL) NFM was red in color because rhodamine-labeled
collagen was coated on the nanoﬁber’s surface. The
white arrows indicate that PECAM-1 staining occurs
mainly at cell–cell interfaces. HCAECs cultured on the
collagen-coated P(LLA-CL) NFM have a similarpreservation of EC’s characteristic phenotype on both
TCPS and the collagen-coated P(LLA-CL) NFM.4. Conclusions
After the electrospun P(LLA-CL 70:30) NFM
was treated with air plasma, collagen was effectively
, e) P(LLA-CL) NFM and (c, f) collagen-coated P(LLA-CL) NFM.
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Fig. 6. Viability of HCAECs on the TCPS, P(LLA-CL) NFM and collagen-coated P(LLA-CL) NFM. Cells were seeded at a density of
1.5 104 cells/cm2 and cultured for a period of 7 days. Data are representative of three independent experiment and all data points plotted as
mean7SD (n ¼ 3) (*po0.05 compared to the P(LLA-CL) NFM group).
W. He et al. / Biomaterials 26 (2005) 7606–7615 7613coated onto nanoﬁber’s surface. The collagen was
Fig. 7. Attachment of HCAECs on the TCPS, P(LLA-CL) NFM a
3 104 cells/cm2. Data are representative of three independent experim
the P(LLA-CL) NFM group).found to be evenly coated throughout the NFM.
The amount of collagen was quantiﬁed to be 1575 mg
per mg of NFM. The collagen-coated P(LLA-CL)
NFM enhanced endothelialization, as observed in aspreading cell morphology, increased cell viability
llagen-coated P(LLA-CL) NFM. Cells were seeded at a density of
d all data points plotted as mean7SD (n ¼ 3) (*po0.05 compared toand attachment, and phenotypic maintenance of the
cells. The collagen-coated P(LLA-CL) NFM also
showed mechanical properties suitable for vascular
graft.
ARTICLE IN PRESS
Fig. 8. Immunoﬂuorescent staining of PECAM-1(CD31) on HCAECs cultured for 3 days on TCPS (a) and the collagen-coated P(LLA-CL) NFM.
HCAECs were seeded at a density of 3 104 cells/cm2. The RBITC-labeled collagen-coated NFM was red color. White arrows indicate strong
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Fabrication and Endothelialization of Collagen-Blended
Biodegradable Polymer Nanofibers: Potential Vascular Graft
for Blood Vessel Tissue Engineering
WEI HE, M.Sc.,1 THOMAS YONG, Ph.D.,1 WEE EONG TEO, B.Sc.,2 ZUWEI MA, Ph.D.,3
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ABSTRACT
Electrospun collagen-blended poly(L-lactic acid)-co-poly(-caprolactone) [P(LLA-CL), 70:30]
nanofiber may have great potential application in tissue engineering because it mimicks the extra-
cellular matrix (ECM) both morphologically and chemically. Blended nanofibers with various weight
ratios of polymer to collagen were fabricated by electrospinning. The appearance of the blended
nanofibers was investigated by scanning electron microscopy and transmission electron microscopy.
The nanofibers exhibited a smooth surface and a narrow diameter distribution, with 60% of the
nanofibers having diameters between 100 and 200 nm. Attenuated total reflectance-Fourier trans-
form infrared spectra and X-ray photoelectron spectroscopy verified the existence of collagen mol-
ecules on the surface of nanofibers. Human coronary artery endothelial cells (HCAECs) were seeded
onto the blended nanofibers for viability, morphogenesis, attachment, and phenotypic studies. Five
characteristic endothelial cell (EC) markers, including four types of cell adhesion molecule and one
EC-preferential gene (von Willebrand factor), were studied by reverse transcription-polymerase
chain reaction. Results showed that the collagen-blended polymer nanofibers could enhance the vi-
ability, spreading, and attachment of HCAECs and, moreover, preserve the EC phenotype. The
blending electrospinning technique shows potential in refining the composition of polymer nanofibers
by adding various ingredients (e.g., growth factors) according to cell types to fabricate tissue-engi-
neering scaffold, particularly blood vessel-engineering scaffold.
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INTRODUCTION
ELECTROSPUN POLYMER NANOFIBERS have elicited greatinterest in tissue engineering because the nanostruc-
tured morphology of the nanofibers mimicks the natural
extracellular matrix (ECM), which is composed of a
three-dimensional network of nanoscaled fibrous proteins
embedded in a glycosaminoglycan (GAG) hydrogel.1 In
addition to their morphology, which is similar to natural
ECM, polymer nanofibers have additional desirable fea-
tures as a tissue-engineering scaffold, such as their high
porosity and high surface area-to-volume ratio.2 Many
studies have been carried out in the application of poly-
mer nanofibers in the tissue engineering of bone,3 blood
vessels,4–7 cartilage,8,9 cardiac tissue,10 peripheral ner-
vous system (PNS),11 ligament,12 liver,13 and skin.14 In
most of these studies, biodegradable polymer materials
such as poly(caprolactone) (PCL), poly(L-lactide) (PLA),
and poly(glycolide) (PGA) were used.
In addition to synthetic materials, naturally occurred
materials such as collagen,15,16 elastin,17 silk protein,18
fibrinogen,19 chitosan,20 dextran,21 hyaluronic acid,22 ca-
1Division of Bioengineering, 2Department of Mechanical Engineering, and 3Nanoscience and Nanotechnology Initiative, Na-
tional University of Singapore, Singapore.
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sein and lipase enzyme,23 and even DNA24 and virus25
have also been electrospun into nanofibers, but far fewer
works using these nanofibers as tissue-engineering scaf-
folds have been reported, perhaps because of the poor
mechanical properties of natural materials on contacting
water. For synthetic materials, the biggest disadvantage,
however, is the lack of cell recognition signals.26 These
problems can be overcome by surface immobilization of
natural materials on synthetic materials or simply by
physically blending the two materials, which may im-
prove the biocompatibility of the synthetic nanofibers
while preserving the mechanical strength, thus combin-
ing the advantages of two types of materials.
The objective of our present study was to fabricate col-
lagen-blended biodegradable polymer nanofibers, and 
to evaluate the behavior of cells on it. We chose a random
copolymer from the biodegradable aliphatic polyester fam-
ily, poly(L-lactic acid)-co-poly(-caprolactone) [P(LLA-
CL), 70:30], because the degradation rate of this copoly-
mer can be controlled readily by adjusting the ratio of the
two components. The collagen-blended polymer [P(LLA-
CL), 70:30] nanofibers were fabricated by electrospinning
the collagen–polymer mixture solution with 1,1,1,3,3,3-
hexafluoro-2-propanol (HFP) as solvent. The blended
nanofibers, as a new type of a composite material, could
be a biomimetic synthetic ECM both in fiber diameter and
constituent components. The biocompatibility study was fo-
cused on the behaviors of human coronary artery endothe-
lial cells (HCAECs) with respect to cell viability, mor-




CL), 70:30] copolymer was bought from Boehringer In-
gelheim (Ingelheim, Germany), at a molecular mass of
150 kDa. 1,1,1,3,3,3-Hexafluoro-2-propanol (HFP) and
collagen type I from calf skin were purchased from
Sigma-Aldrich (St. Louis, MO). Human coronary artery
endothelial cells (HCAECs) were obtained from Cam-
brex Bio Science Walkersville (Walkersville, NJ). En-
dothelial cell basal medium (Clonetics EBM-2) and
growth factors were purchased from Cambrex Bio Sci-
ence Walkersville. CMFDA fluorescent CellTracker
probe was purchased from Molecular Probes (Eugene,
OR). CellTiter 96 AQueous One Solution assay was pur-
chased from Promega (Madison, WI).
Fabrication of collagen-blended 
P(LLA-CL) nanofibers
P(LLA-CL) and collagen solutions (5 wt%) were pre-
pared by mixing the components for 2 h at room tem-
perature in 1,1,1,3,3,3-hexafluoro-2-propanol (HFP). The
mixture was then placed in a plastic syringe with a nee-
dle tip diameter of 0.21 mm. With the aid of a syringe
pump, the solution was dispersed at a feed rate of 1.2
mL/h. Electrospinning voltage was applied to the needle
at 12-kV DC voltage, using a high-voltage power supply
(Gamma High Voltage Research, Ormond Beach, FL).
The electric field generated by the surface charge caused
the solution drop at the tip of the needle to distort into a
Taylor cone. Once the electric potential at the surface
charge exceeded a critical value, the electrostatic forces
would overcome the solution surface tension and a thin
jet of solution would erupt from the surface of the cone.
The schematic setup and the optimized parameters for
fabrication of collagen-blended P(LLA-CL) nanofibers
are shown in Fig. 1. The resultant nanofibers were col-
lected on an aluminum collector located 12 cm from the
needle tip. For cells cultured in a 24-well plate, cover-
slips (Assistent, 15 mm in diameter; Karl Hecht, Sond-
heim, Germany) were placed on top of the aluminum to
collect the nanofiber sheet directly. The thickness of the
nanofiber sheet was determined by the collection time.
The thickness of the collagen-blended P(LLA-CL)
nanofiber mesh (NFM) was measured with a microme-
ter (Mitutoyo, Kawasaki, Japan) and its apparent density
and porosity were calculated according to the following
equations:
NFM apparent density (g/cm3) 
NFM porosity (%) 
1    100
where PET is polyethylene terephthalate (see Ma et al.7).
Fabrication of P(LLA-CL)–collagen films by
solvent casting
Uniform smooth films of P(LLA-CL)–collagen (1:1,
w/w) were generated by a solvent-casting (SC) method.
Briefly, P(LLA-CL) and collagen were first dissolved at
a concentration of 5 wt% in HFP. The resulting solution
was then cast onto tissue culture polystyrene (TCPS). Af-
ter solvent evaporation, the P(LLA-CL)–collagen-coated
TCPS [hereafter referred to as P(LLA-CL)–collagen
film] was placed in a vacuum dryer overnight to remove
any remaining solvent.
Characterization of collagen-blended 
P(LLA-CL) nanofibers
Scanning electron microscopy (SEM) micrographs of
collagen-blended P(LLA-CL) nanofibers were obtained
NFM apparent density (g/cm3)

bulk density of PET (g/cm3)
NFM mass (mg)  10

NFM thickness (m)  NFM area (cm2)
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with a JSM-5800LV scanning electron microscope
(JEOL, Tokyo, Japan). Transmission electron mi-
croscopy (TEM) micrographs of the nanofibers were 
obtained with a JEM-2010F FasTEM field emission 
electron microscope (JEOL) operated at 100 keV. Elec-
trospun nanofibers for the TEM observation were pre-
pared by directly depositing the as-spun nanofibers onto
copper grids that had been coated with a supportive For-
mvar film (Structure Probe, SPI Supplies Division, West
Chester, PA).
Diameter range of the fabricated nanofibers was
measured on the basis of SEM images, using image
analysis software (ImageJ; National Institutes of
Health, Bethesda, MD). Attenuated total reflectance
Fourier transform infrared (ATR-FTIR) spectra were
obtained with an AVATAR 380 FTIR machine
(Thermo Electron, Waltham, MA). Surface chemistry
analysis of the nanofibers was performed by X-ray pho-
toelectron spectroscopy (XPS) (VG Escalab 2201-XL;
Thermo VG Scientific/Thermo Electron, East Grin-
stead, UK) with a takeoff angle of 90°. The binding en-
ergy was referenced to the C1s of saturated hydrocar-
bon at 285.0 eV.
Tensile tests were carried out with a 5848 microtester
(Instron, Norwood, MA) at a stroke rate of 10 mm/min
and with a 40-mm gauge length. Nanofibers were rec-
tangular (10  60 mm) in shape. This tensile test was
performed in the same manner as standard mechanical
tests for fabric materials.
In vitro culture of human coronary artery
endothelial cells
Human coronary artery endothelial cells (HCAECs)
were bought at passage 3. The cells were cultured in en-
dothelial cell basal medium supplemented with EC
growth supplements (vascular endothelial growth factor
[VEGF], human epidermal growth factor [hEGF], human
fibroblast growth factor-B [hFGF-B], insulin-like growth
factor type I [IGF-I], hydrocortisone, and ascorbic acid),
5% fetal bovine serum, penicillin (100 units/mL), and
streptomycin (100 g/mL). The medium was replaced
every 4 days and cultures were maintained in a humidi-
fied incubator at 37°C with 5% CO2. When the cells
reached 80–90% confluence (confluence density, 5 
104 cells/cm2), they were trypsinized and subcultured at
1:3 ratios.
Collagen-blended P(LLA-CL) nanofiber mesh was de-
posited on round 15 mm-diameter coverslips, which were
placed into the wells of a 24-well tissue culture plate to
exactly cover the well bottom. A small amount of im-
plant-grade silicone adhesive (Silbione, MED ADH 4300
RTV; Rhodia, Boulogne-Billancourt, France) was ap-
plied along the edge of the nanofiber sheet to immobi-
lize it on the glass surface. Experiments had been con-
ducted in our laboratory to show that the highly inert
silicone adhesive has no toxic effects on the cells. Etha-
nol solution (75%) was used to sterilize the samples and
was removed by exchanging with phosphate-buffered
saline (PBS).
HCAEC morphology study
Cell morphology was studied by laser scanning con-
focal microscopy (LSCM; Leica Microsystems, Wetzlar,
Germany) and SEM (JSM-5800LV; JEOL). For fluores-
cence microscopic observation, live cells were stained
with green fluorescent probe CMFDA (5-chloromethyl
fluorescein diacetate) without fixation. A stock solution
of CMFDA (25 M in dimethyl sulfoxide [DMSO]) was
diluted with serum-free cell culture medium to obtain a
2.5 M working solution (concentration range for short-
term staining of cells, 0.5 to 5 M). Prewarmed CMFDA
working solution (200 L) was added to cover the bot-
tom of the wells of the 24-well plate for 45 min. Cells
were washed three times with 1  PBS and incubated
with 200 L of EC culture medium for another 30 min.
Subsequently, the culture medium was replaced with an-
other 1 mL of culture medium, in which the cells were
cultured further. Cells were observed by LCSM (excita-
tion, 492 nm; emission, 517 nm).
SEM micrographs were taken for detailed cell mor-
phology studies on different substrates. Cells cultured on
coverslips were washed with 1  PBS to remove nonad-
herent cells and then fixed with 2.5% glutaraldehyde for
45 min at 4°C. Thereafter, the samples were dehydrated
FIG. 1. Schematic setup and optimized operation parameters
such as the voltage, feed rate, and collector distance for fabri-
cation of the random collagen-blended P(LLA-CL) nanofibers
by electrospinning. HFP, 1,1,1,3,3,3-hexafluoro-2-propanol.
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in 75% alcohol solutions and dried under vacuum. The
samples were sputter coated with gold (JFC-1200 fine
coater; JEOL) and observed with an SEM at an acceler-
ating voltage of 15 or 20 kV.
MTS assay for HCAEC viability and 
attachment studies
Cell viability and attachment on the nanofibers were
determined by colorimetric MTS assay (CellTiter 96
AQueous One Solution cell proliferation assay; Promega).
Briefly, the cell–nanofiber complex was incubated with
20% 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxy-
phenyl)-2-(4-sulfophenyl)-2H-tetrazolium) (MTS) reagent
in complete medium for 4 h. Thereafter aliquots were
pipetted into the wells of a 96-well plate and placed into
a spectrophotometric plate reader (FLUOstar OPTIMA;
BMG Labtech, Offenburg, Germany), and the absorbance
at 490 nm for each well was measured.
For the cell viability test, cells were seeded onto
nanofiber substrate at a density of 1.5  104 cells/cm2
(30% confluence). On days 1, 3, 5, and 7 after cell seed-
ing, unattached cells were washed out and the attached
cells were quantified by MTS assay. For the cell attach-
ment study, cells were seeded at a density of 3  104
cell/cm2 (60% confluence). One, 2, 4, 6, and 8 h after
cell seeding, unattached cells were washed out and the
attached cells were quantified by MTS assay. A lower
seeding density was used for viability studies as com-
pared with attachment studies. The reason was that there
would be more available area for cells to proliferate so
as to avoid their reaching confluence prematurely.
Analysis of HCAEC gene expression
Four typical cell adhesion molecules (CAMs) charac-
teristic of endothelial cells (platelet endothelial cell ad-
hesion molecule-1 [PECAM-1 or CD31], intercellular ad-
hesion molecule-1 [ICAM-1 or CD54], vascular cell ad-
hesion molecule-1 [VCAM-1 or CD106], and E-selectin
[or CD62E]) and the endothelial cell universal marker
von Willebrand factor (vWF) were studied by reverse
transcription-polymerase chain reaction (RT-PCR) for
gene expression analysis. Total RNA was extracted from
2.5  106 subconfluent HCAECs cultured in a 75-cm2
flask or from nanofiber mesh deposited on a petri dish
(86 mm in diameter; 58 cm2 in area), using an RNeasy
mini kit (Qiagen, Hilden, Germany). Cells were lysed and
homogenized in guanidine isothiocyanate (GITC)-con-
taining buffer and then applied to a column in which 
total RNA bound to the silica gel-based membrane and
contaminants were efficiently washed away. Last, high-
quality RNA was eluted in 30 L of RNase-free water
and RNA yields were measured on the basis of ab-
sorbance at 260 nm.
For RT-PCR, cDNA was reverse transcribed from 1
g of total RNA and then stored at 20°C. Briefly, a
10.5-L reaction mixture containing 1 g of total RNA,
0.5 g of oligodeoxythymidine [oligo(dT)18; 1st BASE,
Singapore], and distilled water was heated at 75°C for 5
min and then put on ice for 5 min. Next, dNTPs (dATP,
dTTP, dGTP, and dCTP; 2 mM each), 20 units of re-
combinant ribonuclease inhibitor (RNasin; Promega),
and 200 units of Moloney murine leukemia virus (M-
MLV) reverse transcriptase (Promega) were added in a
final 20-l reaction mixture. This mixture was incubated
for 1 h at 37°C followed by heating for 5 min at 95°C,
and then put on ice for 5 min.
A 1-L aliquot of the reaction mixture was subjected
to PCR amplification in a final 20-l reaction mixture
that contained 20 pmol of each forward and reverse
primer (Table 1), 1.5 mM MgCl2, a 0.3 mM concentra-
tion of each of the four deoxynucleotides, and 1 unit of
TABLE 1. POLYMERASE CHAIN REACTION PRIMERS FOR REVERSE TRANSCRIPTION-POLYMERASE CHAIN REACTION ANALYSIS
Size
Gene GenBank no. (bp) Primer pair sequences
-Actin BC002409 318 5-GAG TCC TGT GGC ATC CAC G-3
5-GAA GCA TTT GCG GTG GAC G-3
PECAM-1 (CD31) BC051822 367 5-TCA TCG GAG TGA TCA TTG CTC-3
5-CTA GAG TAT CTG CTT TCC ACG-3
von Willebrand factor BC022258 274 5-TGA GGC TGG GTA CTA CAA GC-3
(vWF) 5-GGA GAT GTT GCA TGA GCT GC-3
ICAM-1 (CD54) J03132 352 5-GCT TCG TGT CCT GTA TGG C-3
5-CTG GCG GTT ATA GAG GTA CG-3
VCAM-1 (CD106) X53051 297 5-TTC TGA GAG TGT CAA AGA AGG-3
5-AAG GAG GAT GCA AAA TAG AGC-3
E-selectin (E-SEL, CD62E) NM_000450 280 5-GCA CTG TGT GCA AGT TCG C-3
5-GGC TTT TGG TAG CTT CCG TC-3
Abbreviations: ICAM, intercellular adhesion molecule; PECAM, platelet endothelial cell adhesion molecule; VCAM, vascular
cell adhesion molecule.
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Taq polymerase (Promega). Amplification of endothelial
cells specific genes by PCR was carried out in a PTC-
100 Peltier thermal cycler (MJ Research, Waltham, MA)
for 30 cycles. In each cycle, an initial denaturation at
94°C for 1 min was carried out, followed with primer an-
nealing at 55°C for 1 min and polymerization at 72°C for
1 min. This was followed by a final extension step at
72°C for 10 min and storage at 4°C. The PCR products
were analyzed by electrophoresis of 10 L of each sam-
ple in a 1% agarose gel, with the bands visualized under
ultraviolet light by ethidium bromide staining, using the
Gel Doc 2000 gel documentation system (Bio-Rad, Her-
cules, CA).
Statistical analysis
Values (at least triplicate) were averaged and ex-
pressed as means  standard deviation (SD). Each ex-
periment was repeated two or three times. Statistical
differences were determined by Student two-tailed t
test. Differences were considered statistically signifi-
cant at p  0.05.
RESULTS
Morphology and diameter range of collagen-
blended P(LLA-CL) nanofibers with various
weight ratios of P(LLA-CL) to collagen
SEM and TEM micrographs of collagen-blended
P(LLA-CL) nanofibers with various weight ratios of
P(LLA-CL) to collagen are shown in Fig. 2, revealing
the nonwoven and interconnected structure of the
nanofibers. Similar morphology of the blended
nanofibers was also observed, suggesting that the ratios
of the two compositions did not affect nanofiber mor-
phology. TEM analysis of blended nanofibers with a di-
ameter of 114 nm and of collagen nanofibers with a di-
ameter of 100 nm verified the nanometer scale and
smooth morphology of the blended nanofibers.
The diameter range of the blended nanofibers was fur-
ther determined by directly measuring nanofiber diame-
ters from Fig. 2; the result is shown in Fig. 3. It shows
the well-controlled diameter distribution of blended
nanofibers with various weight ratios of P(LLA-CL) to
collagen. Basically, more than 60% of the blended
FIG. 2. SEM (A–D; original magnification, 10,000) and TEM (E and F) micrographs of collagen-blended P(LLA-CL)
nanofibers with various weight ratios of P(LLA-CL) to collagen. Ratios of P(LLA-CL) to collagen: (A) 4:1; (B) 2:1; (C and E)
1:1; (D and F) 0:1 (pure collagen nanofiber).
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nanofibers ranged from 100 to 200 nm in diameter, with
about 20% of nanofibers ranging from 200 to 300 nm.
The diameter range of the blended nanofibers was af-
fected by the concentration of the mixture solution of
P(LLA-CL) and collagen (data not shown) rather than by
the ratio of P(LLA-CL) to collagen.
Diameter, thickness, and apparent density of blended
nanofibers with various weight ratios of P(LLA-CL) to
collagen are summarized in Table 2. The thickness of
blended nanofibers was controlled by the deposition time
if electrospinning operation parameters such as voltage,
feed rate, and collector distance were fixed. Table 2
shows that blended nanofiber [P(LLA-CL):collagen, 1:1]
deposited for 1 h was thicker than others deposited for
30 min. The apparent density of all the blended
nanofibers was in the range of 0.30–0.40 g/cm3. No ob-
vious relationship existed between the apparent density
and weight ratio of P(LLA-CL) to collagen. As the elec-
trospun collagen-blended P(LLA-CL) nanofibers are
highly porous materials, with the known bulk density of
P(LLA-CL)–collagen blends, the porosity of the blended
nanofibers can be calculated on the basis of apparent den-
sity. However, it is not easy to accurately measure the
bulk density of the P(LLA-CL)–collagen blend because
it contains a mixture of different compositions, so the
bulk density was estimated to be in the range of 1.2–1.3
g/cm3 on the basis of the bulk density range of P(LLA-
CL) copolymer, and the porosity of the blended
nanofibers was calculated to be in the range of 68–76%.
In this work the electrospun nanofibers were in the
shape of a sheet. The thickness of nanofiber mesh could
be further increased by extruding solution through addi-
tional orifices during electrospinning, with electrospin-
ning speed proportional to the number of orifices. This
method, called mixing or multiple-jet electrospinning,
may be used to quickly produce three-dimensional (3-D)
nanofibrous scaffolds in future.
Mechanical properties of collagen-blended
P(LLA-CL) nanofibers
One of the main failure modes of synthetic vascular
grafts is intimal hyperplasia (IH), which is caused by the
shear stress disturbances caused by compliance mismatch
TABLE 2. DIAMETER, THICKNESS, APPARENT DENSITY, AND POROSITY OF COLLAGEN-BLENDED POLY(L-LACTIC ACID)-CO-
POLY(-CAPROLACTONE) [P(LLA-CL)] NANOFIBERS WITH VARIOUS WEIGHT RATIOS OF P(LLA-CL) TO COLLAGENa
P(LLA-CL):
collagen Diameter Thickness Apparent density Porosity
(wtwt) (nm) (mm) (g/cm3) (%)
41 160  68 9  2 0.31  0.01 74–76
21 168  40 6  1 0.39  0.05 68–70
11b 181  47 15  3 0.38  0.08 68–71
12 191  63 9  0 0.33  0.06 73–75
aData are representative of two independent experiments and represent means  SD (n  5).
bElectrospinning deposition time is 60 min. For other blended nanofibers, deposition time is 30 min.
FIG. 3. Diameter ranges of collagen-blended P(LLA-CL) nanofibers (BNF) with various weight ratios of P(LLA-CL) to col-
lagen.
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at the end-to-end anastomosis between artery and rigid
graft.27 Thus the mechanical properties of nanofibers are
critical for their successful application in tissue-engi-
neered vascular grafts. The compliance of a tube is a me-
chanical property, the value of which depends on the tube
dimensions and modulus. In this work we studied mainly
the elastic modulus, tensile strength, and tensile modu-
lus of nanofibers, from which we intend to fabricate elas-
tic tubelike structures, to predict the compliance value.
Figure 4 shows the typical stress–strain curve of colla-
gen-blended P(LLA-CL) nanofibers (NF) and P(LLA-
CL) NF under tensile loading. Mechanical evaluation of
both nanofibers revealed the typical nonlinear
stress–strain behavior of biological tissue. Incorporation
of collagen at a P(LLA-CL)-to-collagen weight ratio of
1:1 led to a significant decrease in tensile strength and
ultimate strain (p  0.05) of nanofibers. No significant
difference in tensile modulus was observed (p  0.05).
Tensile properties of the nanofibers obtained from two
independent experiments are summarized in Table 3.
Tensile properties of the nanofibers were comparable to
those of human coronary artery. Compared with P(LLA-
CL) NF, blended NF has a more desirable ultimate strain
value, one closer to the value of coronary artery. Also,
both nanofibers showed much less stiffness compared
with Dacron (PET; commonly used in large-diameter
vascular grafts), which has a tensile strength of 170–180
MPa in oriented form and a tensile modulus of about
14,000 MPa.27 Ideally, less stiff (compliant) and
biodegradable scaffolds such as P(LLA-CL) nanofibers
are a better choice for constructing a completely biolog-
ical and fully functional neoartery.
It is perhaps not feasible to increase the mechanical
strength of blended nanofibers only by cross-linking (al-
though it is easy to cross-link pure collagen nanofibers
with a fixative such as glutaraldehyde vapor), because
polymer molecules in blended nanofibers are difficult to
cross-link. Other methods, such as adjusting the orienta-
tion and diameter of the nanofibers, could be used to fur-
ther tailor the mechanical strength of nanofibers more
readily.15 Thus the mechanical properties of blended
nanofibers may be adjusted according to the requirements
of tissue-engineered vascular grafts.
Characterization of collagen-blended 
P(LLA-CL) nanofibers
The chemical composition of collagen-blended
P(LLA-CL) nanofibers was verified by attenuated total
reflectance-Fourier transform infrared (ATR-FTIR) spec-
trometry. Figure 5 shows the infrared spectra of pure
P(LLA-CL) nanofiber (Fig. 5A), pure collagen nanofiber
(Fig. 5B), and collagen-blended P(LLA-CL) nanofiber
(Fig. 5C). Spectra of blended nanofibers revealed peaks
characteristic of type I collagen at wavenumbers of 1651
cm1 (amide I band) and 1537 cm1 (amide II band),
and a P(LLA-CL) peak at 1747 cm1, together with a
peak at 3310 cm1 (N–H stretch), demonstrating that
blended nanofibers are a mixture of P(LLA-CL) and col-
lagen. ATR-FTIR cannot analyze the surface chemistry
of nanofibers accurately because it probes 100 nm into
the surface of materials. For nanofibers with a diameter
range from 100 to 200 nm, ATR-FTIR may show the
composition inside the nanofibers. Therefore XPS was
FIG. 4. Typical stress–strain curve for the electrospun
P(LLA-PCL) nanofibers (NF) and collagen-blended P(LLA-
CL) (BNF) with the weight ratio of the P(LLA-CL) to colla-
gen 1:1 under tensile loading.
TABLE 3. TENSILE PROPERTIES OF ELECTROSPUN P(LLA-CL) NANOFIBERS, COLLAGEN-BLENDED P(LLA-CL) 
NANOFIBERS WITH P(LLA-CL)COLLAGEN WEIGHT RATIO OF 11, AND CORONARY ARTERYa,b
BNF 11 P(LLA-CL) Coronary arteryb
Tensile modulus (MPa) 26.33  6.66 43.99  4.04 —
Tensile strength (MPa) 1.54  0.32 6.27  1.38 1.40–11.14
Ultimate strain (%) 66  22 176  49 45–99.
Abbreviations: BNF, collagen-blended P(LLA-CL) nanofiber.
aData are representative of two independent experiments and represent means  SD (n  3).
bSee Ref. 6.
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required to check whether collagen was present on the
surface of nanofibers.
The surface chemistry of blended nanofibers was further
verified by XPS spectroscopy. Table 4 shows the atomic
ratios of carbon, nitrogen, and oxygen on blended
nanofibers with various weight ratios of P(LLA-CL) to 
collagen, together with those of pure P(LLA-CL) nano-
fibers and pure collagen nanofibers. Concerning blended
nanofibers, more collagen was found to be present on the
surface of nanofibers with increased collagen weight ratios.
Pure collagen nanofibers showed the highest amount of sur-
face collagen compared with other, blended nanofibers.
FIG. 5. ATR-FTIR spectra of (A) P(LLA-CL) nanofibers, (B) collagen nanofibers, and (C) collagen-blended P(LLA-CL)
nanofibers with a 1:1 weight ratio of P(LLA-CL) to collagen.
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Viability of HCAECs on collagen-blended 
P(LLA-CL) nanofibers
The viability of HCAECs on days 1, 3, 5, and 7 after
seeding on collagen-blended P(LLA-CL) nanofibers with
various weight ratios of P(LLA-CL) to collagen is shown
in Fig. 6. The viability of HCAECs cultured on blended
nanofibers was compared with that of cells cultured on
tissue culture polystyrene (TCPS), pure collagen
nanofibers, pure P(LLA-CL) nanofibers, and P(LLA-
CL)–collagen film (blended film). It was revealed that
HCAEC viability increased with increased collagen
weight ratio in the blended nanofibers, which was con-
sistent with previous results showing that more collagen
was present on the surface of nanofibers with increased
collagen weight ratios. It is crucial to adjust the weight
ratios of P(LLA-CL) to collagen for optimal cell growth.
From this study, we found that at a P(LLA-CL)-to-col-
lagen weight ratio of 1:1, blended nanofibers have nor-
mal morphology, a well-controlled diameter, and good
cell viability. The following studies therefore focused on
blended nanofibers at this ratio. Although pure collagen
nanofibers showed the best cell viability among all the
samples, it was not chosen because collagen nanofibers
swollen into hydrogels in cell culture medium showed
poor mechanical strength (data not shown).
To show the specific effect of collagen in blended
nanofibers on HCAEC growth, HCAECs were culture on
three substrates [TCPS, blended nanofibers, and P(LLA-
CL) nanofibers] in three kinds of medium: (1) serum-
containing medium (SCM), that is, EC culture medium
with 5% FBS and growth supplements, including four
growth factors (VEGF, hEGF, hFGF-B, and IGF-I); (2)
serum-free medium (SFM), that is, EC culture medium
without FBS but with growth factors; and (3) blank
medium (BM), that is, EC culture medium without FBS
and without growth factors. HCAECs were seeded at a
density of 3  104 cells/cm2 and were stained with
CMFDA 1 and 3 days later for fluorescence observation.
It can be seen in Fig. 7 that fewer HCAECs attached to
pure P(LLA-CL) nanofibers and cells had a round mor-
phology compared with those on collagen-blended
P(LLA-CL) nanofibers. The results also revealed that
blended nanofibers could enhance HCAEC adhesion and
spreading in culture medium without serum and growth
factors. This may reflects the direct effect of collagen on
HCAEC growth. Figure 7 shows the morphology of
HCAECs after 3 days of culture. Similar results were also
observed for day 1 (data not shown). More interestingly,
HCAECs organized into longer shapes when cultured in
TABLE 4. ATOMIC RATIOS OF CARBON, NITROGEN, AND OXYGEN ON THE SURFACE OF P(LLA-CL) NANOFIBERS,
COLLAGEN-BLENDED P(LLA-CL) NANOFIBERS WITH VARIOUS WEIGHT RATIOS OF P(LLA-CL) TO COLLAGEN, AND
COLLAGEN NANOFIBERS AS DETERMINED BY X-RAY PHOTOELECTRON SPECTROSCOPY
C atomic ratio N atomic ratio O atomic ratio
Nanofibers (%) (%) (%)
P(LLA-CL) 65.9 0.0 34.1
P(LLA-CL)collagen, 41 67.0 Not detectable 33.0
P(LLA-CL)collagen, 21 56.2 9.2 34.6
P(LLA-CL)collagen, 11 59.0 11.7 29.3
P(LLA-CL)collagen, 12 63.3 13.3 23.4
Collagen 61.6 15.1 23.3
FIG. 6. Viability of HCAECs cultured on TCPS, collagen
nanofibers (NF), collagen-blended P(LLA-CL) nanofibers
(BNF) with various weight ratios of P(LLA-CL) to collagen
(BNF 1:1, BNF 2:1, and BNF 4:1), P(LLA-CL) NF, and col-
lagen-blended P(LLA-CL) film (Blended Film). HCAECs cul-
tured on TCPS and collagen NF acted as positive controls.
P(LLA-CL) NF acted as a negative control. Collagen-blended
P(LLA-CL) film served as a control specifically for BNF 1:1.
HCAECs were seeded at a density of 1.5  104 cells/cm2 and
were cultured for 7 days. Results showed that HCAEC viabil-
ity increased with increased collagen weight ratio in blended
nanofibers. Data are representative of three independent exper-
iments and all data points are plotted as means  SD (n  3).
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serum-free medium, compared with the normal cobble-
stone morphology of HCAECs in serum-contained
medium. A similar phenomenon was also observed for
cells on blended nanofibers. In summary, several con-
clusions can be drawn from the above-described study.
First, HCAECs require serum and growth factors for nor-
mal phenotypic morphology. Second, collagen could im-
prove HCAEC growth directly, even without serum or
growth factors, compared with cells on pure polymer
nanofibers.
Morphology of HCAECs on nanofibers
Figure 8 shows fluorescence and SEM micrographs of
HCAECs on TCPS (Fig. 8a and d), P(LLA-CL)
nanofibers (Fig. 8b and e), and collagen-blended P(LLA-
CL) nanofibers (Fig. 8c and f). HCAECs were seeded at
a density of 3  104 cells/cm2 and observed 5 days later
for fluorescence microscopic observation or were fixed
for SEM study. It was observed that HCAECs cultured
on P(LLA-CL) nanofibers were rounded in shape instead
of spreading (Fig. 8b and e), whereas on collagen-blended
P(LLA-CL) nanofibers HCAECs adopted a spreading
polygonal shape that is typical of normal cell morphol-
ogy on TCPS (Fig. 8a and d). On day 5, HCAECs reached
subconfluence on blended nanofibers (Fig. 8c and f),
whereas few HCAECs remained on P(LLA-CL)
nanofibers.
Figure 9 shows higher magnification SEM micro-
graphs of the interactions between HCAECs and
nanofibers. Compared with HCAECs on P(LLA-CL)
nanofibers, on which cells adopted a rounded shape pos-
sibly indicating apoptosis (Fig. 9a), HCAECs on blended
nanofibers showed better phenotypic spreading. It was
also observed that HCAECs interconnected well with the
nanofibers and that pseudopods of the cells were oriented
along the blended nanofibers (Fig. 9b). Thus cells main-
tained a typical motility shape: broad, flat lamella ex-
tending in the direction of migration and terminating in
a narrow ruffling lamellipodium.28 Thus blended
nanofibers clearly increased cytocompatibility compared
with P(LLA-CL) nanofibers.
FIG. 7. Morphology of HCAECs (original magnification, 200) cultured for 3 days on TCPS, collagen-blended P(LLA-CL)
nanofibers (BNF), and pure P(LLA-CL) nanofibers. HCAECs were seeded at a density of 3  104 cells/cm2 and stained with
CMFDA for fluorescence observation. HCAECs were cultured in three kinds of medium: (1) serum-containing medium (SCM),
that is, culture medium with serum and all growth factors (VEGF, hEGF, hFGF-B, and IGF-I); (2) serum-free medium (SFM),
that is, medium without serum but with growth factors; and (3) bland medium (BM), that is, culture medium without serum and
without growth factors. Similar results were also observed for HCAECs cultured for 1 day (data not shown).
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Attachment of HCAECs on nanofibers
The attachment of HCAECs to TCPS, P(LLA-CL)
nanofibers, and collagen-blended P(LLA-CL) nanofibers
is shown in Fig. 10. Significantly more HCAECs attached
to collagen-blended P(LLA-CL) nanofibers than to pure
P(LLA-CL) nanofibers in the first 4 h (p  0.05). Colla-
gen is the most abundant ECM protein having both struc-
tural and adhesive functions facilitating cell adhesion
through integrin receptors.29 HCAECs were shown to at-
tach to blended nanofibers at a rate similar to that at which
they attached to TPCS. Similar results were also observed
with collagen-coated P(LLA-CL) nanofibers (data not
shown).
EC-characteristic gene expression
Platelet endothelial cell adhesion molecule-1
(PECAM-1, CD31), intercellular adhesion molecule-1
(ICAM-1, CD54), vascular cell adhesion molecule-1
(VCAM-1, CD106), and endothelial leukocyte adhesion
molecule-1 (E-selectin, ELAM-1, CD62E) are important
homotypic or heterotypic adhesion molecules. PECAM-
1 is involved mainly in homotypic cell–cell adhesion,
which favors maintenance of endothelium integrity, and
can be used to indicate reduced adhesion to materials.30
It is also a universal EC marker, together with von Wille-
brand factor, which can represent the differentiation sta-
tus of endothelial cells. Upregulated expression of
ICAM-1, VCAM-1, and E-selectin indicates the onset of
the inflammatory response.30 Figure 11 shows the gene
expression of HCAECs cultured on blended nanofibers
for 10 days. The expression of all these genes indicates
preservation of the characteristic phenotype of ECs. The
expression of PECAM-1 and vWF revealed that the en-
dothelial cells maintained their differentiated status after
10 days of culture on blended nanofibers. The similar ex-
pression level of PECAM-1 further represented the nor-
mal attachment of cells on blended nanofibers compared
with cells on TCPS, which is important especially for en-
dothelial cells to function well under shear force in a nat-
ural environment. The upregulated expression of ICAM-
1, VCAM-1, and E-selectin perhaps indicates a higher
degree of undesirable preinflammatory reactions.
DISCUSSION
In this study, we fabricated collagen-blended bio-
degradable P(LLA-CL) biohybrid nanofibers for endo-
thelial cell growth because the naturally occurring colla-
gen may improve the bioactivity of the P(LLA-CL)
nanofibers. Although previous studies in our laboratory
FIG. 8. LSCM [original magnification: (a) 400; (b and c) 200] and SEM [original magnification: (d–f) 500] images of
HCAECs cultured on (a and d) TCPS, (b and e) P(LLA-CL) nanofibers, and (c and f) collagen-blended P(LLA-CL) nanofibers.
HCAECs were seeded at a density of 3  104 cells/cm2 and stained with CMFDA for fluorescence observation or were fixed for
SEM study 5 days later. HCAECs on collagen-blended P(LLA-CL) nanofibers exhibited a morphology similar to that of cells on
TCPS. Compared with collagen-blended P(LLA-CL) nanofibers (c and f), fewer HCAECs attached to uncoated P(LLA-CL)
nanofibers (b and e) and cells had a rounded-up morphology.
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have demonstrated that human coronary artery smooth
muscle cells cultured on synthetic polymer P(LLA-CL)
nanofibrous scaffolds showed normal morphology and
good proliferation, human coronary artery endothelial
cells were found not to be able to grow well on un-
modified nanofibers,6 which may be due to the lack 
of endothelial cell recognition sites on P(LLA-CL)
nanofibers. Collagen is the native ECM component serv-
ing as adhesion proteins that enhance cell attachment and
proliferation through specific interactions between do-
mains, such as RGD in collagen molecules and integrins
in cell membranes.29 Their specific bindings result in
focal contact of cells on the substratum, which benefit
cell attachment and movement. Therefore, it is probable
that the inclusion of collagen in P(LLA-CL) nano-
fiber would increase its biocompatibility. Herein we
fabricated collagen-blended biodegradable P(LLA-CL)
(70:30) nanofibers by electrospinning a mixed solution
of collagen and P(LLA-CL).
Some of the methods used to introduce proteins onto
a substrate surface include physical coating31 and chem-
ical grafting.7 However, one of the problems these sur-
face modification techniques face is the slow mass trans-
fer of proteins into the three-dimensional porous
materials. For example, it took more than 3 days to ef-
fectively graft gelatin molecules onto poly(ethylene
terephthalate) (PET) nanofiber surfaces.7 Compared with
the surface modification of polymer nanofibers, direct
electrospinning of a blended collagen–polymer mixture
is much simpler because it avoids the slow mass trans-
fer process and also uses lesser amounts of chemical
reagents during protein immobilization. The blending
method has additional potential to readily refine the com-
position of nanofibers by adding new components such
as growth factors, proteoglycan, and glycoproteins to the
nanofibers according to cell type. Moreover, the exis-
tence of collagen molecules on the surface and inside the
nanofibers provides sustained cell recognition signals
with polymer degradation, which is important for cell
function development. Also, blended nanofibers may
have improved mechanical strength compared with pure
non-cross-linked collagen nanofibers, which would com-
bine the advantages of both synthetic and natural mate-
rials.
There are some important parameters for blended
nanofibers that might affect the nanofiber diameter dis-
tribution and cell response. In this study, blended
FIG. 9. Higher magnification SEM micrographs (original
magnification, 3000) showing the detailed interaction be-
tween HCAECs and (a) P(LLA-CL) nanofibers and (b) colla-
gen-blended P(LLA-CL) nanofibers after 5 days of culture at a
seeding density of 3  104 cells/cm2.
FIG. 10. Attachment of HCAECs to TCPS, P(LLA-CL)
nanofibers (NF), and collagen-blended P(LLA-CL) nanofibers
(BNF). HCAECs were seeded at a density of 3  104 cells/cm2.
Significantly more HCAECs attached to collagen-blended
P(LLA-CL) nanofibers than to P(LLA-CL) nanofibers in the
first 4 h (p  0.05). Data are representative of three indepen-
dent experiments and all data points are plotted as means  SD
(n  3).
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nanofibers with diameter ranging from 100 to 200 nm
(60% of nanofibers) were obtained by electrospinning
mixtures of collagen and polymer at a concentration of
5 wt%. The diameter range of the blended nanofibers was
affected by the concentration of the mixture of polymer
and collagen (data not shown). Other parameter such as
the weight ratio of polymer to collagen did not affect the
diameter distribution of nanofibers (Fig. 3), but did in-
fluence HCAEC viability (Fig. 6). With a higher content
of collagen in the blended nanofibers, cells accordingly
showed enhanced viability.
In addition to biocompatibility, biodegradation is a
critical issue for tissue-engineering application of
nanofibers. Although the speed of degradation of colla-
gen-blended P(LLA-CL) nanofibers may be difficult to
predict precisely, it is possible that the nanoscaled mate-
rial will degrade faster than large bulk materials because
the high surface area-to-volume ratio of the nanofibers
provides a large contact area between the materials and
the water or enzymes involved in the degradative pro-
cess. Although the effect of material size on the degra-
dation rate is still a controversial subject, some authors
believe that a nanoscaled object, consisting of only a few
polymer chains, should degrade fast.32 Other authors
have also predicted that because nanofibers possess a spe-
cific surface area between that of films and nano- or mi-
croparticles, among which nanoparticles degrade most
quickly, intermediate biodegradation rates are ex-
pected.33 P(LLA-CL) and collagen may also affect each
other’s degradation processes. The degradation products,
lactic acid and hydroxyhexanoic acid for P(LLA-CL) and
amino acid for collagen, will all affect the pH value, thus
further affecting the degradation speed of P(LLA-CL)
and collagen. Generally speaking, the biodegradative be-
havior of nanofibers with different compositions has been
little studied.34 The degradation behavior of these mate-
rials needs to be studied systematically in future in terms
of molecular weight decrease, mass loss, and mechani-
cal strength loss.
Another critical issue for the tissue-engineering appli-
cation of nanofiber scaffolds is mechanical strength,
which depends both on the physical properties of
nanofibers such as orientation, diameter, pore size, and
porosity and on chemical properties such as the compo-
sition of the nanofibers. Nanofiber scaffolds should not
only act as a residence for cells but also provide suffi-
cient mechanical support during tissue regeneration and
structure degradation. As highly porous materials, the
mechanical properties of nanofibers under cell culture
conditions may change with the biodegradation of
nanofibers and cell migration, which will exert force on
the nanofibers. The dynamic cell–nanofiber interaction
observed in some studies indicated that cells could ad-
just the pore size for ingrowth into a nanofiber mesh.9
This kind of cellular ingrowth may further change the
mechanical properties of the loosened nanofiber mesh.
As for blended nanofibers described here, the diameter
range was from 100 to 200 nm (60% of nanofibers),
which is much smaller and better distributed than that of
most nanofibers we have reported previously.4–7 The pore
size (the length of the diagonals of the pore square) of
the blended nanofibers was about 2–5 m, which is much
smaller compared with the size of HCAECs (average,
25  50 m). The ingrowth of cells into the nanofibers
was not obvious on the basis of the SEM study (Fig. 9).
Thus the cell–nanofiber interaction may not be the dom-
inant factor affecting the mechanical properties of
nanofibers. However, because of the collagen in the
nanofibers, the biodegradation by collagenase secreted by
the cells may degrade the nanofibers faster and weaken
FIG. 11. RT-PCR analysis of expression of endothelial cell-characteristic genes in HCAECs seeded onto TCPS and collagen-
blended P(LLA-CL) nanofibers (BNF) for 10 days of culture. On day 10, total RNA was extracted and RT-PCR was performed
with the gene-specific primer pairs shown in Table 1, including E-selectin (E-SEL), VCAM-1, ICAM-1, von Willebrand factor
(vWF), PECAM-1, and -actin as a housekeeping gene. The expression of all these genes of HCAECs on TCPS or BNF indi-
cates preservation of the characteristic phenotype of ECs. The upregulated expression of ICAM-1, VCAM-1, and E-selectin of
HCAECs on BNF perhaps indicate a higher degree of undesirable preinflammatory reactions.
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their mechanical strength. Thus to systematically study
the mechanical strength changes of nanofibers, two as-
pects will need further study: in vitro biodegradation of
nanofibers, and ECM secretion and remolding of blended
nanofibers by HCAECs.
HCAECs cultured on collagen-blended P(LLA-CL)
nanofibers showed spreading and subconfluent morphol-
ogy similar to that of cells cultured on TCPS. In contrast,
HCAECs cultured on pure P(LLA-CL) nanofibers were
rounded in shape (Figs. 7–9). In addition, cell viability
and attachment on blended nanofibers were obviously in-
creased compared with that on pure polymer nanofibers
(Figs. 6 and 10). These results are the basis for endothe-
lialization of vascular grafts, which can prevent the
thrombogenicity and intimal hyperplasia (excess tissue
ingrowth) that are the most common causes of graft fail-
ure.35 However, tissue-engineered vascular grafts should
not only possess good phenotypic properties such as
spreading morphology, cell viability, and cell attachment
but also encourage endothelial cell functions, which can
be assessed through expression of cell adhesion mole-
cules.36 This is more important because, for suitable vas-
cular prosthesis, the material should not hamper the ad-
hesion of endothelial cells or favor inflammation
phenomena.30 Thus for proper prediction of material ef-
ficacy and the endothelialization process, study of endo-
thelial cell adhesion to the substratum and of endothelial
cell involvement in the inflammatory response is re-
quired.24 In this study, endothelial cell functions were as-
sessed mainly through gene expression analysis for cell
adhesion molecules and endothelial cell universal mark-
ers. The functions of cell adhesion molecules are to me-
diate cell–cell or cell–matrix interactions; ICAM-1,
VCAM-1, and E-selectin are important mediators of the
adhesion and migration of leukocytes or lymphocytes
from the blood to tissues during the immune response,
whereas PECAM-1 is involved mainly in homotypic
cell–cell adhesion. von Willebrand factor, the universal
EC marker, is an adhesive glycoprotein synthesized ex-
clusively in endothelial cells and megakaryocytes. It
plays a central role in hemostasis by mediating the ad-
hesion of an initial platelet plug to the subendothelium
of injured blood vessels and serves as the carrier for fac-
tor VIII in plasma.37 We found that day 10 gene expres-
sion levels of the cell adhesion molecules and vWF from
endothelial cells cultured on blended nanofibers were
comparable to those of endothelial cells cultured on
TCPS, demonstrating that normal cell function is pre-
served during in vitro culture.
From this work, we have shown that collagen-blended
P(LLA-CL) nanofibers show great potential as tissue-en-
gineered vascular grafts because they can promote good
endothelial cell viability, attachment, and phenotypic
morphology and preserve the functions of endothelial
cells. The ease of fabricating blended nanofibers provides
more possibilities for adding particular ingredients to
nanofibers according to cell type. Furthermore, blended
nanofibers will most likely possess the advantages of both
natural and synthetic materials. Hence blended
nanofibers could be a practical and effective material for
tissue-engineered vascular grafts.
CONCLUSION
The electrospinning technique was employed to fabri-
cate collagen-blended P(LLA-CL) (70:30) nanofibers
with smooth surface morphology and a well-controlled
diameter distribution ranging from 100 to 200 nm. The
existence of collagen on the surface of blended nanofibers
was verified by ATR-FTIR and XPS. Blended nanofibers
supported endothelialization observed as good cell-
spreading morphology, cell attachment and viability, and
phenotypic maintenance of cells. Blended nanofibers can
improve bioactivity relative to pure polymer nanofibers
and possess the potential to refine the composition of
nanofibers readily by adjusting ingredients according to
cell type. All these data strongly suggest the potential ap-
plication of blended nanofibers as vascular engineering
scaffolds with good endothelialization.
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1 Introduction
Decades of studies have given researchers a greater un-
derstanding of the complex interaction between cells and
their environment. Typically in the range of 10–100 µm in
diameter, cells respond to stimuli from the macro envi-
ronment down to the molecular level. Interaction between
a typical cell and its environment is achieved through an
array of receptor systems that are found on its outer mem-
brane, which responds to adjacent cells, ligands in the
surrounding extracellular matrix (ECM) and secreted sig-
naling molecules.
The ECM in particular is able to influence the cells by
both chemical cues and the physical arrangement of
fibers. The physical structure, composition and arrange-
ment of the ECM are often tissue specific. Fibrils that
make up the ECM of tendon are parallel and aligned, while
those found on the skin are mesh-like. Thus, it is a daunt-
ing task for researchers trying to mimic the natural ECM.
Recently, with the development of new processing meth-
ods, it is possible to synthesize scaffolds that match some
characteristics of tissue-specific ECMs.
The ECM consists mainly of two classes of macromol-
ecules, polysaccharide chains known as glycosaminogly-
cans (GAG) and fibrous proteins. Recently, researchers
have used a process known as electrospinning to fabri-
cate nanofibrous scaffolds to mimic the fibrous structure
of ECM. Perhaps the main advantage is its ability to fab-
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ricate nanometer diameter fibers, while another key ad-
vantage is the range of materials that can electrospun.
Synthetic non-biodegradable polymers, biodegradable
polymers, natural polymers, composites and even ceram-
ic precursors can be electrospun to form nanofibers. Fig-
ure 1 shows the structural similarity between electrospun
nonwoven collagen mesh and the connective stroma
ECM of the small intestine, which is made out of nonwo-
ven collagen bundles [1]. Various other fibrous assemblies
can also be constructed using electrospinning. Although
typical electrospun fiber scaffolds are in the form of a 2-D
non-woven fiber mesh, scaffolds consist of aligned fibers
and tubular scaffold can be made through simple modifi-
cation of the setup.
A schematic for a typical electrospinning setup is
shown in Fig. 2. The material to be electrospun is first dis-
solved in a suitable solvent to obtain a viscous solution.
Although, polymer melt can also be electrospun, the re-
sultant fiber is generally above 1 μm in diameter [2–5],
while for electrospun polymer solution, average fiber di-
ameter of 19 nm has been obtained [6]. The solution is first
passed through a spinneret and a high voltage supply is
use to charge the solution. At a critical voltage, typically
above 200 V/m [7], the repulsive forces of the charged so-
lution particles result in a jet of solution erupting from the
tip of the spinneret. As the jet accelerates toward a
ground target, the solvent evaporates and the semi-dry
fiber is collected as a non-woven mat. Through the use of
high-speed camera and mathematical modeling, Reneker
et al. [8] have shown that the acceleration of the electro-
spinning jet from the tip of the spinneret to the collector
proceeds in a spiraling path when it enters the bending
instability state.
In this review, we discuss several important issues
when tailoring a scaffold to resemble tissue-specific ECM.
Factors such as material selection, modification of scaf-
fold and its structure, and how electrospun fibers can be
used to address these issues are discussed. Current re-
search on using electrospun scaffold tailored to mimic
specific tissues such as cartilage and bone grafts, skin
grafts, vascular grafts, nerve grafts and cardiac grafts are
also reviewed.
2 Material selection
One of the most important factors when tailoring the arti-
ficial graft for the specific tissue is the material to be used.
The variety of biocompatible materials that can be used
in the construction of tissue scaffolds is huge. Several fac-
tors such as mechanical properties, degradation rate and
cell proliferation, and adhesion on the material must be
considered when selecting one for specific tissue or organ
scaffold [9]. Polymers, ceramics, metals and composites
have all been used as scaffold [10] to meet the various de-
mands and requirements.
As seen in Fig. 3, biodegradable polymer made up the
majority of the materials used by researchers in the study
of electrospun tissue scaffolds followed by natural poly-
mers. Generally, biodegradable polymers are preferred
over their non-biodegradable counterpart for tissue im-
plants, as they can be resorbed into the body over a peri-
od of time, and hence long-term complications of a foreign
body may be avoided [11]. Table 1 shows a list of polymers
that had been electrospun and the corresponding me-
chanical properties of their non-woven fibrous scaffold.
Figure 1. Structural comparison between
the nonwoven collagen bundles of the
connective stroma of the small intestine
[1] and the electrospun nonwoven
collagen mesh.
Figure 2. Schematic of the electrospinning setup.
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Several studies have been carried out on the biocompati-
bility and the degradation rate of various biodegradable
polymers [12–14]. A study by Li et al. [15] showed that cell-
matrix interaction and cell proliferation are highly de-
pendent on the stability of the fibrous scaffold thus poly(L-
lactic acid) (PLLA) and polycaprolactone (PCL) with its
slower degradation rate may be more suitable candidate
as tissue scaffold than poly(DL-lactic acid) (PDLLA), polyg-
lycolic acid (PGA) and its copolymers. In cases where me-
chanical strength is important, synthetic polymers gener-
ally have an edge over natural polymers. Figure 4 shows a
bundle of electrospun PCL fibers which can be used as
tendon scaffold. A similar electrospun collagen fiber bun-
dle will probably have a lower mechanical strength.
Although synthetic materials have superior mechani-
cal strength, its lack of cell-recognition signal [25] has
prompted many researchers to use natural polymers in-
stead. The ECM is not merely an inert supporting materi-
al on which cells resides. The matrix has an active and
complex role in regulating cell behavior, influencing their
survival, migration, proliferation, shape and function [26,
27]. Natural polymers, such as collagen, have been wide-
ly used as tissue scaffolds [28] since they may retain the
necessary cell stimuli [29]. Nevertheless, it is vital that the
processed natural polymer retains most of its original
characteristics. Matthews et al. [30] reported that their
electrospun type I collagen had an average diameter of
250 nm and was found to exhibit 67-nm banding typical
of native collagen [31]. Other types of ECM components
such as hyaluronic acid [31] and collagen type II have also
been electrospun [32, 33].
Depending on the application, synthetic, natural or a
mixture of the materials can be used. In most cases, the
Biotechnology
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Table 1. Mechanical properties of some polymer used in tissue engineering
Material Fiber diameter (nm) Stress (MPa) Tensile modulus (MPa)
Poly(glycolic acid) [16] 630 – ~19
Poly(DL-lactide-co-glycolide), (85:15) [17] 500–800 22.67 323.15
Poly(DL-lactide-co-glycolide), (75:25) [18] 550 4.67 110.78
Poly(L-lactide-co-ε-caprolactone), (70:30) [19] 470 6.3 44
Polycaprolactone [20] 950 2.84 - Fibrinogen [21] 700 2 80
Acrylate modified elastomeric protein [22] 300–500 16.2 700
50% Collagen type I:50% polyethylene oxide [23] 100–150 0.37 12
Gelatin [24] 200 5.77 499
Figure 3. Analysis of published literature
based on the biomaterials used from
2001 to mid-2006.
Figure 4. Electrospun PCL fiber bundle that has the potential to be used as
a tendon scaffold.
918_200600044.qxd  15.09.2006  15:00 Uhr  Seite 920
© 2006 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim 921
Biotechnol. J. 2006, 1, 918–929 www.biotechnology-journal.com
scaffold constructed from natural occurring proteins in
the ECM such as collagen allows much better infiltration
of cells into the scaffold. A study by Telemeco et al. [34]
comparing the cellular response on implanted electro-
spun collagen, gelatin, PGA, polylactic acid (PLA) and
polylactic-co-glycolic acid (PLGA) scaffold into the belly
of the vastus lateralis of the rat showed that electrospun
collagen scaffolds were densely infiltrated by interstitial
and endothelial cells with evidence of functional blood
vessels, while the other scaffolds were not infiltrated and
induced fibrosis after 7 days. However, mechanical
strength of the electrospun collagen scaffold is weak, thus
for most applications, modification of the scaffold is re-
quired.
3 Modification of electrospun fibers
Although electrospinning is able to produce fibers made
of selected material, this is often not enough to meet the
complex demands of the tissue scaffold. Modification of
the scaffolds is often necessary to enhance some of its
properties, which just by electrospinning and material se-
lection alone are inadequate. A material that favors the
proliferation and attachment of the specific cell may be
lacking in mechanical strength. Thus, the nanofibrous
scaffold would have to be modified to enhance its stabili-
ty and mechanical strength. Cross-linking is a widely
adopted method of improving the mechanical properties
of the nanofibrous scaffold. Nagapudi et al. [22] intro-
duced an acrylate moiety to an elastin-mimetic pro-
tein polymer, poly[(Val-Pro-Gly-Val-Gly)4(Val-Pro-Gly-Lys-
Gly)]. The acrylate modified elastomeric protein (AMEP)
was electrospun to produce a non-woven mesh of
nanofibers subsequently cross-linked by visible-light-me-
diated photo-irradiation. Tensile strength and the Young’s
modulus of the uncross-linked AMEP was 16.2 ± 6.3 MPa
and 0.7 ± 0.15 GPa, respectively, while cross-linked AMEP
was 43.3 ± 5.2 MPa and 1.8 ± 0.4 GPa, respectively. How-
ever, the strain to failure decreased from 3.9 ± 0.2% to
2.3 ± 0.35%. Nevertheless, upon hydration, the cross-
linked AMEP showed a substantial increase in the strain
to failure to 105 ± 8%, although the Young’s modulus
dropped to 0.45 ± 0.08 MPa. These values are comparable
to published mechanical properties of native elastin,
which has a strain of about 120% and Young’s modulus of
0.17 MPa [35]. There are also other means of cross-linking
of electrospun fibers. N-(3-Dimethylaminopropyl)-N”-car-
bodiimide can be used to couple carboxyl group to pri-
mary amines, or used with N-hydroxysuccinimide [36],
while glutaraldehyde can be used either as a diluted solu-
tion [37] or as saturated vapor [38] for cross-linking.
As mentioned earlier, the ECM has an active role in
several cell functions [26, 27], and since unmodified poly-
mer does not contain any cell surface receptors, several
surface modification methods have been used by various
researchers to introduce proteins and ligands onto the
surface of the scaffold. Fertala et al. [39] electrospun a mix-
ture of PLLA and poly(ε-CBZ-L-lysine), which have free
NH2 groups for the attachment of recombinant collagen II.
The carbobenzoxy (CBZ) protected ε-amino groups of the
L-lysine were activated by submerging the electrospun
fiber mesh in acid solution, which detached the CBZ from
the amino group. Sodium carbonate was subsequently
added to neutralize the sample. The activated amino
groups were able to bind 20 times more collagen onto the
surface of the nanofibers than non-activated nanofibers.
Chua et al. [40] used a photo-polymerization method to
graft polyacrylic acid on the surface of the electrospun
poly(ε-caprolactone-co-ethyl ethylene phosphate) and 1-
O-(6’-aminohexyl)-D-galactopyranoside was subsequent-
ly conjugated onto the scaffold. He et al. [19] used a sim-
pler method of surface modification to coat collagen on
the surface of poly(L-lactide-co-ε-caprolactone) (PLCL)
(70:30). The electrospun polymer scaffold was air plasma
treated for 5 min with a radio frequency set at 30 W. This
increased the surface hydrophilicity of the material,
which made it wettable by collagen solution. The polymer
scaffold was immersed in collagen solution overnight be-
fore being dried at room temperature. Cells cultured on
the collagen-coated fibrous scaffold were well spread out
with good integration between the cell and the fibers
compared to non-treated fibrous scaffold, which exhibit-
ed rounded morphology as shown in Fig. 5. Since natural
ECM contains a multitude of other materials vital for cell
growth and maintaining the structural integrity of the
ECM, other biological substances such as GAG [31] have
been added to the collagen solution before electrospin-
ning [38].
Figure 5. The effect of surface modifica-
tion of fibrous scaffold on endothelial
cells. (A) Untreated PLCL electrospun
fibers. (B) Collagen-coated PLCL electro-
spun fibers.
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In some applications where mechanical strength is re-
quired, the use of natural polymers alone may not be suf-
ficient. A common practice for incorporating the proper-
ties of two materials is by blending the two together. Col-
lagen has been blended with biodegradable synthetic
polymers and electrospun to give a scaffold that promotes
good cell adhesion and proliferation and exhibits superior
mechanical strength [41]. Conductive polymers such as
polyaniline have also been blended with gelatin and elec-
trospun for use as a tissue scaffold [24]. This was based on
the hypothesis that a multitude of cell functions such as
cell proliferation, migration and differentiation can be
modulated by electrical stimulation [42]. For bone grafts,
Kim et al. [43] electrospun nanofibrous composite made
out of hydroxyapatite (HA) nanocrystals and gelatin. The
composite demonstrated improved bone-derived cellular
activity as compared to pure gelatin nanofibers.
4 Electrospun assemblies
The ability to electrospin a variety of nanofibrous assem-
blies has allowed researchers to mimic the structure and
composition of natural ECM. Natural ECM can be consid-
ered as a composite consisting of a complex mixture of
structural and functional proteins, glycoproteins and pro-
teoglycans. To mimic natural ECM, Min et al. [44] fabri-
cated a composite scaffold for dermal reconstruction con-
sisting of electrospun PLGA and electrosprayed chitin
nanoparticles. The electrospinning and electrospraying
were carried out simultaneously such that both the PLGA
fibers and chitin nanoparticles were evenly distributed
throughout the scaffold. Due to the dense mat of deposit-
ed nanofibers, cells have difficulty in migrating into the
interior of the fibrous scaffold. Stankus et al. [45] overcame
this problem by simultaneously electrospinning poly(ester
urethane)urea and electrospraying vascular smooth mus-
cle cells. High cell density integration with the electro-
spun fibers were observed after perfusion culture. Despite
the application of a high voltage, a study by Jayasinghe et
al. [46] suggested no sign of cellular damage after the cells
have been electrosprayed. The rate of cell division after
electrospraying continued as normal.
For more than a decade, researchers have shown that
the topography of a substrate has an effect on the cells,
such as cell orientation and rate of movement [47]. By us-
ing various electrospinning setups, such as using a rotat-
ing collector [30, 48] as shown in Fig. 6, scaffold with
aligned nanofibers can be fabricated [49]. Several studies
have demonstrated the migration and proliferation of cells
in the direction of the electrospun fibers alignment [50,
51] as shown in Fig. 7. This will be suitable for region of
specific tissue regeneration such as the tunica media of
the artery, where the smooth muscle cells are circumfer-
entially aligned.
In the construction of a small diameter tubular scaf-
fold, a rotating tube or rod of appropriate diameter can be
used to collect the electrospun nanofibers. When a suffi-
cient thickness of nanofibers is accumulated on the col-
lector, a tubular fibrous scaffold can be obtained by ex-
tracting the collector. Matsuda et al. [52] was able to fab-
ricate a tubular scaffold with the inner fibrous layer being
circumferentially aligned and the other fibrous layer ran-
domly distributed. This is achieved by rotating a 3-mm di-
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Figure 6. Schematic of rotating collector
to deposit aligned fibers. (A) Rotating
drum to collect large area of aligned fibers
[30]. (B) Knife-edge rotating disk to collect
better aligned fibers on the coverslip [48].
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ameter metallic tube at a speed of 3400 rpm. Other tubu-
lar scaffold consisting of multi-layers of electrospun fibers
have also been fabricated [53, 54]. This way, various de-
sirable properties of the material can be incorporated into
the resultant scaffold.
5 Cartilage and bone grafts
In a cartilage graft, the nanotopography of electrospun
nanofibers has been shown to provide a favorable condi-
tion for the growth of chondrocytes. Comparing electro-
spun fibrous scaffold consisting of 75:25 PLGA and PLGA
solvent-cast film in terms of chondrocytes proliferation
and ECM formation, DNA and GAG content in the elec-
trospun scaffold was higher than in the film from day 7 of
culture onwards [18]. Since cartilage is composed mainly
of type II collagen, electrospinning of type II collagen has
been carried out to form a non-woven mesh of nanofibers
[55]. Chondrocytes seeded on the scaffold were evenly
distributed across the scaffold thickness after 1 week of
culture [33].
Li et al. [56] demonstrated that cell proliferation and
differentiation on a PCL electrospun scaffold were differ-
ently affected by serum-containing media or serum-free
media. In the presence of serum-containing medium, fe-
tal bovine chondrocytes (FBC) seeded on electrospun
fibers showed greater proliferation but less differentiation
than in serum-free medium. The chondrocytes were able
to efficiently maintain their differentiated phenotype in
contrast to those kept as a monolayer on tissue culture
polystyrene (TCPS), which dedifferentiate and lose their
chondrocytic phenotype. Thus, the unique structural fea-
ture of electrospun nanofibrous scaffold combined with
the composition of culture medium has a strong influence
on the biological response of FBCs.
Cell maturation and differentiation are affected by reg-
ulatory molecules. However, it has been suggested that
various mechanical stimuli may play a part in the devel-
opment of articular cartilage [57] and it has been demon-
strated that chondrocytes respond to mechanical stimuli
[58]. Using an electrospun PLGA (75:25) scaffold, Shin et
al. [18] demonstrated that by applying an intermittent hy-
drostatic pressure of 0.2 MPa using a bioreactor on the
scaffold seeded with chondrocytes, cell proliferation and
ECM formation was significantly increased.
In bone tissue engineering, Yoshimoto et al. [59] seed-
ed mesenchymal stem cells (MSC) on an electrospun PCL
scaffold in osteogenic differentiation medium. These
MSCs differentiated into osteoblasts in the rotational
bioreactor system and migrated into the scaffold. The
cells produced ECM of collagen throughout the scaffold.
The electrospun PCL scaffold was able to support miner-
alized tissue formation without compromising its struc-
tural stability, thus making it an attractive candidate for
treatment of bone defects.
Since natural bone is a composite structure made out
of fibrous collagen and other vital minerals, Fujihara et al.
[60] fabricated an electrospun fibrous scaffold consisting
of a blend of PCL nanofibers and calcium carbonate
(CaCO3). Although osteoblast proliferation was greater in
the scaffold with a lower calcium carbonate content, more
granules, indicating mineralization, were observed on the
scaffold with a greater CaCO3 content. Supaphol and col-
leagues [20] have embedded HA nanoparticles in PCL
nanofibers. Osteoblasts were shown to grow slightly
better in PCL/HA nanofibrous composite than in a
PCL/CaCO3 nanofibrous composite scaffold. Kaplan and
colleagues [61] made a detail comparison study of the ef-
fect of electrospun polyethylene oxide (PEO) scaffold with
the addition of silk, bone morphogenetic protein 2 (BMP-
2), and HA nanoparticles on bone formation from human
bone marrow-derived MSCs (hMSCs). Their tests showed
that silk/PEO scaffolds showed the lowest calcium con-
tent but the highest level of DNA, whereas higher calci-
um deposits were found on silk/PEO with HA and/or
BMP-2 added. The highest level of calcium deposition
was found on silk/PEO/HA/BMP-2 scaffold.
In an animal study on guided bone regeneration, Kim
et al. [62] used electrospun silk fibroin to facilitate bone
Figure 7. Comparing the effects of fiber
surface topography on endothelial cells.
(A) Randomly oriented collagen-coated
PLCL copolymer fibers. (B) Aligned colla-
gen-coated PLCL copolymer fibers.
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wound healing. Two 8-mm diameter calvarial defects
were first created in New Zealand White rabbits. In the
rabbits in which an electrospun silk fibroin membrane
was used for guided bone regeneration, the defects com-
pletely healed, and were replaced with new bone after
12 weeks with no evidence of any inflammatory reaction.
In contrast, the control group with no membrane did not
show complete healing of the bone. Shin et al. [63] used
an electrospun PCL scaffold, which was first seeded with
MSCs and cultured with osteogenic supplements in a ro-
tating bioreactor for 4 weeks before implanting in the
omenta of rats for another 4 weeks. Following removal of
the scaffold from the bioreactor, cells and ECM formation
were observed throughout the scaffold with mineraliza-
tion and type I collagen detected.
6 Skin grafts
To develop a stable and biocompatible scaffold for skin
grafting, several researchers have used fiber scaffolds
made out of different polymer blends. Pan et al. [64] elec-
trospun a blend of dextran and PLGA solution, and the re-
sultant fibers were subsequently stabilized by photo-
cross-linking of the dextran component. Dermal fibrob-
lasts seeded onto the scaffold were able to migrate into
the highly porous 3-D matrix of the scaffold and organized
into dense multi-layered structures that resembled der-
mal structure. Min et al. [44] used a mixture of PLGA
fibers, chitin nanoparticles and adsorption of type I colla-
gen or laminin onto the fibrous composite to mimic natu-
ral dermal ECM. Human keratinocytes showed improved
attachment on PLGA-chitin electrospun composites com-
pared to pure PLGA fibers. While type I collagen coated
on the fibrous scaffolds promoted the adhesion and prolif-
eration of normal human keratinocytes and fibroblast,
only human fibroblast responded to laminin coating on
the scaffold with results similar to that of collagen coating.
Since type I collagen is known to promote the adhe-
sion and proliferation of normal human keratinocytes, Rho
et al. [65] used pure type I collagen to electrospin a nanofi-
brous scaffold. The nanofibers were then vapor cross-
linked using glutaraldehyde to improve its stability of the
scaffold in water. However, when normal human ker-
atinocytes were seeded onto the scaffold, unexpectedly
low level of cell adhesion was observed. A possible reason
could be the denaturation of the collagen conformation
caused by electrospinning or cross-linking. The use of sol-
vent and chemicals for the electrospinning and cross-link-
ing process, respectively, may denature the collagen.
Stretching of the viscous collagen solution during the
electrospinning process may destroy the triple-helix
structure of the collagen. To the our knowledge, only
Matthews et al. [30] have reported electrospun collagen
fibers exhibiting 67-nm banding typical of native collagen
[31]. Thus, a more detailed study should be carried out on
the effect of electrospinning and cross-linking on the
structure and properties of electrospun collagen fibers.
Rho et al. [65] reported that the adhesion of type I collagen
or laminin onto the surface of collagen scaffold would
significantly increase the adhesion of proliferating hu-
man keratinocytes compared with pure collagen-only
nanofiber scaffold. In another attempt to incorporate col-
lagen into the nanofibrous scaffold to promote cell adhe-
sion and proliferation, Venugopal et al. [66] used a blend
of type I collagen and PCL for electrospinning. The growth
rate of human dermal fibroblasts cultured on the nanofi-
brous scaffold was shown to be the same as those cul-
tured on TCPS.
7 Vascular grafts
In the selection of materials to be electrospun for arterial
blood vessels, the energy and shape recovery are critical
parameters to be considered. Energy stored during the
expansion of the blood vessel should be recoverable and
used in the contraction of the vessel without any distor-
tion to the vessel. Natural polymers such as elastin have
been used for electrospinning. Huang et al. [67] used re-
combinant protein based on repeating elastomeric pep-
tide sequence of elastin (Val-Pro-Gly-Val-Gly)4(Val-Pro-
Gly-Lys-Gly) to electrospin a non-woven mesh of fibers.
The ultimate tensile strength of the nonwoven fabrics was
35 MPa and the material modulus was 1.8 GPa.
Besides selection of material according to its mechan-
ical properties, another important factor is the cell adhe-
sion and proliferation on it. Constructed vascular graft
should express anti-coagulant activity until the endothe-
lial cell lining is fully achieved. To meet these two charac-
teristics, Kwon and Matsuda [68] electrospun two differ-
ent solution blends. The first blend consisted of PLCL and
collagen fibers, and the second blend consisted of PLCL
and a tri-n-butylamine salt of heparin (heparin-TBA).
Human umbilical vein endothelial cells cultured on elec-
trospun fibrous scaffold containing 5 and 10 wt% collagen
in the blend were highly elongated and well spread on
the fibrous surface but cells on the scaffold containing
30–50 wt% collagen in the blend showed round or re-
stricted-spread morphology. This observation runs con-
trary to reports by other research groups where endothe-
lial cells cultured on collagen and polymer blended (ratio
1: 1) fibers showed spreading with a polygonal shape [41].
With the scaffold containing a blend of heparin and PLCL,
a burst release was observed in the first 12 h when it was
soaked in PBS at 37°C, after which relatively sustained re-
lease rate was observed for 4 weeks. This was probably
due to the degradation of the copolymer. By electrospin-
ning both blends simultaneously on the same collector, it
may be possible to fabricate a scaffold that is able to en-
courage cell adhesion and proliferation and exhibit anti-
thrombogenic properties [68].
Biotechnology
Journal Biotechnol. J. 2006, 1, 918–929
924 © 2006 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
918_200600044.qxd  15.09.2006  15:00 Uhr  Seite 924
© 2006 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim 925
Biotechnol. J. 2006, 1, 918–929 www.biotechnology-journal.com
Stitzel et al. [69] made a comparison between a vas-
cular graft made out of purely electrospun PLA fibers and
a composite consisting of collagen microfibers (~10 µm)
and electrospun PLA fibers. The winding of the collagen
microfibers exerted an outward force on the matrix, which
the outer layers of electrospun PLA fibers must take up,
and this mimics the stressed state of a native artery. When
smooth muscle cells (SMC) were cultured on the two vas-
cular grafts, SMCs on the pure PLA electrospun fibers
were randomly distributed, while those cultured on the
composite showed general orientation along the principal
stress lines. Therefore, it is possible to impose a residual
stress on the electrospun scaffold, which in turn would af-
fect the proliferation and orientation of the SMCs.
An attractive option of using electrospinning to fabri-
cate vascular graft is its ability to electrospin small diam-
eter tubes of different sizes with uniform thickness and
fiber distribution throughout the scaffold as shown in
Fig. 8. Stitzel et al. [37] fabricated a tubular scaffold of
4.75-mm inner diameter consist of randomly oriented
PLGA, type I collagen and elastin electrospun fibers. Axi-
al and circumferential testing of the scaffolds demon-
strated no significant difference in the mechanical prop-
erties. The burst pressure of the cross-linked fibers was
found to be 12 times systolic pressure and the compliance
test was 12–14% compared to 9% of the native vessel. The
tubular scaffold was found to support both smooth mus-
cle cells and endothelial cells. Matsuda and colleagues
[70] used PLCL as the base material in the construction of
a smaller diameter vascular graft. A series of tests carried
out on the electrospun PLCL tubular scaffold showed that
the smaller the wall thickness, the greater the compliance
of the tube. Using a simulated circulatory system, it was
found that at higher flow condition, the strain of the graft
matches well with that of rabbit aorta.
There are various ways to alter the structure, topogra-
phy and material composition of the electrospun tubular
scaffold. Vaz et al. [53] electrospun a bi-layered tubular
scaffold with a stiff oriented PLA outer fibrous layer and a
compliant randomly oriented PCL inner fibrous layer. The
oriented outer layer was achieved by rotating the collec-
tor at high speed. Culturing of human myofibroblasts af-
ter 30 days showed that the cells were mostly concentrat-
ed on the outer layer. This is probably due to the inade-
quate pore size between the fibers. Matsuda and cowork-
ers [54] also fabricated bilayered tubular scaffold with a
thin inner layer of collagen and a thick outer layer of seg-
mented polyurethane.
8 Nerve grafts
In the development of bioresorbable nerve conduits, Ra-
makrishna and colleagues [71] used electrospun
biodegradable fibers to fabricate the conduit. Neural stem
cells (NSC) seeded on the PLA nanofibrous scaffold were
found to interact favorably with the environment with
good cell attachment and differentiation, as shown by the
neurite outgrowth. When the NSCs were cultured on
aligned nanofiber scaffolds, the cells elongated along the
direction of the fiber alignment and the neurite outgrowth
was also along the same direction as shown in Fig. 9.
Compared to the microfibers, the differentiation rate of
the NSCs on the nanofibers was higher [72]. In an animal
study, PLGA (10:90) fibers were collected over a Teflon
tube of 1.27-mm diameter to form a nerve conduit after
the Teflon tube was removed. The conduit was implanted
into the right sciatic nerve of a rat. The porous nanofi-
brous scaffold allowed the entry of nutrients into the lu-
men to promote nerve regeneration but at the same time
Figure 8. Electrospun tubular scaffolds of different diameter made of PCL-
PLA copolymers.
Figure 9. Neural stem cells elongate along the direction of the aligned
electrospun fibers and the neurite outgrowth also occurs along the same
direction [72].
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acted as a barrier to unwanted tissues infiltration. Positive
reflex responses were observed in 45% of the rats 1 month
after implantation and 8out of 11 rats had regenerated ca-
ble inside the conduits [73].
9 Cardiac grafts
In the fabrication of a scaffold as a cardiac graft, Shin et
al. [74] electrospun PCL onto a wire ring of 15-mm diam-
eter. The scaffolds were coated with purified type I colla-
gen solution to promote cell attachment. Neonatal rat car-
diomyocytes were cultured on the electrospun PCL scaf-
folds. The cardiomyocytes attached well to the scaffold
and contraction of the cardiomyocytes was observed on
the 10-µm thick scaffold 3 days after seeding. Tight
arrangement and intercellular contacts of the cardiomy-
ocytes were formed throughout the entire mesh, although
more cells were found on the surface. The electrospun
scaffold was sufficiently soft such that contractions of the
cardiomyocytes were not impeded and stable enough for
handling. By suspending the mesh across a ring, the car-
diomyocytes are allowed to contract at their natural fre-
quency.
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Table 2. Electrospun materials used in tissue grafts
Graft Material
Skin graft
Fibroblast Dextran and poly(lactide-co-glycolide) [64]
Poly(lactide-co-glycolide) [44]
Poly(lactide-co-glycolide) and chitin nanoparticles composite [44]
Normal human keratinocytes Collagen type I coated with collagen type I and laminin [65]
Poly(lactide-co-glycolide) and chitin nanoparticles composite [44]
Vascular graft
Arterial Smooth Muscle Cell 40% Poly(DL-lactide-co-glycolide), 45% collagen type I and 15% elastin [23]
Myofibroblasts Polylactic acid [53]
Human coronary artery endothelial cells 50% Poly(L-lactide acid-co-ε-caprolactone) (70:30), 50% Type I collagen [41]
Cartilage graft
Chondrocytes Collagen Type II [33, 55]
Polycaprolactone [56]
Bone graft
Mesenchymal stem cells Polycaprolactone [59]
Silk/polyethylene oxide/hydroxyapatite / bone morphogenetic protein 2 [61]
Osteoblast Polycaprolactone/calcium carbonate [60]
Polycaprolactone/hydroxyapatite [20]
Nerve graft
Neural stem cells Poly(L-lactic acid) [71]
Cardiac graft
Cardiomyocytes Polycaprolactone coated with collagen Type I [74]
Polylactide [76]
Cardiac myoblast Polyaniline and gelatin [24]
Others
Normal rat kidney cells Polyamide [77, 78]
Rabbit conjunctiva fibroblasts Type I collagen and chondroitin sulfate [38]
Rat hepatocytes Galactosylated poly(ε-caprolactone-co-ethyl ethylene phosphate) [40]
Breast epithelial cells Polyamide [78]
Human ligament fibroblast Polyurethane [51]
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The use of electrical stimulations has been shown to
increase adsorption of serum proteins onto electrically
conducting polymer, which leads to significantly en-
hanced neurite extension [75]. Thus, in developing
“smart” nano-fibrous scaffolds to modulate various cell
functions such as proliferation, differentiation and migra-
tion through electrical simulation, Li et al. [24] electrospun
a blend of polyaniline and gelatin. The resultant scaffold
was found to be biocompatible, supporting attachment,
migration and proliferation of H9c2 rat cardiac myoblasts.
10 Concluding remarks
With the advances in the tissue engineering field, re-
searchers are looking at ways to mimic natural ECM to re-
duce the incidence of rejection by the body when it is im-
planted. The use of electrospinning meant that struc-
turally, the fabricated scaffolds can be made to resemble
the ECM. Progress in elecrospinning will bring the artifi-
cial scaffold closer to that of the fiber arrangement in spe-
cific tissue. Table 2 is a summary of the cells that have
been cultured on electrospun fibers. In the future, ECM
scaffolds needs to be both biomimetic and bioactive. For
this, the fibers will have to be modified to incorporate
chemical cues where electrospinning offers its greatest
flexibility. Through the incorporation of proteins such as
collagen, improved cell proliferation and differentiation
has been achieved on electrospun scaffolds. Selected in
vivo tests such as guided bone regeneration using elec-
trospun scaffold has yielded positive results.
In this review, we have concentrated on the potential
of electrospun scaffold for use in tissue engineering by
mimicking tissue-specific ECM. However, electrospun
fibers have also shown potential in other areas such as
drug delivery and cell encapsulation, which, in some cas-
es, have been mentioned in this paper for tissue engi-
neering purposes. Given the advantages of electrospin-
ning in terms of material flexibility, scaffold assembly, nu-
merous modification possibilities and relative ease of in-
corporation into other processes, electrospininng is one of
the most promising tissue fabrication techniques so far
this century.
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Abstract
Nanofibers exist widely in human tissue with different patterns. Electrospinning
nanotechnology has recently gained a new impetus due to the introduction of the concept of
biomimetic nanofibers for tissue regeneration. The advanced electrospinning technique is a
promising method to fabricate a controllable continuous nanofiber scaffold similar to the
natural extracellular matrix. Thus, the biomedical field has become a significant possible
application field of electrospun fibers. Although electrospinning has developed rapidly over
the past few years, electrospun nanofibers are still at a premature research stage. Further
comprehensive and deep studies on electrospun nanofibers are essential for promoting their
biomedical applications. Current electrospun fiber materials include natural polymers,
synthetic polymers and inorganic substances. This review briefly describes several typically
electrospun nanofiber materials or composites that have great potential for tissue regeneration,
and describes their fabrication, advantages, drawbacks and future prospects.
1. Introduction
From a component perspective, the extracellular matrix
(ECM) is composed of three major classes of biomolecules:
(1) structural proteins: collagen and elastin; (2) specialized
proteins: e.g., fibrillin, fibronectin and laminin;
(3) proteoglycans: these are composed of a protein core
to which are attached long chains of repeating disaccharide
units termed glycosaminoglycans (GAGs), forming extremely
complex high molecular weight components of the ECM.
The ECM also contains many other components: minerals
such as hydroxyapatite, or fluids such as the blood plasma or
serum with secreted free-flowing antigens. From a structural
perspective, natural ECMs consisted of various protein fibrils
and fibers interwoven within a hydrated network of GAG
chains, which provides an important model for the design of
biomaterials [1]. The nanoscale structure of the ECM offers
a natural network of intricate nanofibers to support cells and
present an instructive background to guide their behavior
[3, 4]. Each fiber contains clues that pave the way for cells
to form tissues as complex as bone, liver, heart and kidney.
Typically, cells respond to environmental features at all length
scales from the macro down to the molecular. The outer
membrane of a typical cell is covered by specific carbohydrate
structures and a forest of at least six different receptor systems
that can be activated by interactions with adjacent cells, ligands
in the surrounding ECM and secreted signaling molecules.
Collectively, these extrinsic factors make up a highly defined
and specialized cell microenvironment, which is essential
for correct tissue development and continued function.
Materials composed of naturally occurring (biologically
derived) building blocks, including extracellular matrix
components, are being studied for applications such as direct
tissue replacement and tissue engineering. For example,
collagen has been used for many years in biomedical
applications, and it is now possible to create artificial analogs
of ECM proteins using recombinant DNA technology [2].
However, current artificial biomaterial scaffolds designed to
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support cell and tissue growth have traditionally been aimed
at a macroscopic level to match the properties of the organs
they are to replace, such as hard scaffolds for bone and elastic
for bladder, veins and arteries—without the complexity and
nanoscale detail observed in real organs at the level of the cell
matrix interaction.
The use of nanoscale material structuring to control
cell behavior has important implications when designing
new biomaterials for tissue regeneration. To regenerate
tissue, engineered scaffolds act as hosts to cells harvested
from natural tissue. Since the ability to engineer materials
aided by modern nanotechnology to a similar level of
complexity is becoming a reality, in this review we will
discuss this nanotechnology—electrospinning—for the
fabrication of nanofibers, which could create biomimetic
cellular environments. Electrospinning is a process to make
nanofibers from polymer solution through electrostatic force.
The electrospinning process, in its simplest form, consists of
a pipette to hold polymer solution, two electrodes and a dc
voltage supply in the kilovolt range. The polymer solution
drop from the tip of the pipette is drawn into a fiber due to the
high voltage. These fibers, for example as shown in figure 1(a),
have a large surface area per unit mass so that fabrics of these
nanofibers collected on a screen can be used in biomedical
applications, which include tissue regeneration, drug and gene
delivery, artificial organs and medical facemasks [5, 6]. Here,
we focus on several potential types of electrospun nanofibers
for tissue regeneration.
2. Electrospinning nanotechnology
In 1934, the experimental setup of a process patented by
Formhals [7] was outlined for the production of polymer
microfibers using electrostatic force. When used to spin
fibers in this way, the process is termed electrospinning.
Modern electrospinning technology, developed by a number
of researchers, is able to make continuous fibers with
diameters in the range of nanometers to a few micrometers.
Electrospinning has the unique ability to produce nanofibers
of different materials in various fibrous assemblies. The
relatively high production rate and simplicity of the setup
make electrospinning highly attractive to both academia
and industry [8]. In the basic process of electrospinning,
we need to consider two types of factors: (1) system
parameters—molecular weight, molecular weight distribution
and architecture (branched, linear etc) of the polymer
and solution properties (viscosity, conductivity and surface
tension); (2) process parameters—electric potential, flow
rate and concentration, distance between the capillary and
collector, ambient parameters (temperature, humidity and air
velocity in the chamber) and motion of the collector. By
varying the above parameters, it is possible to get some
variation in the morphology of the nanofibers. Nanofibers in
the range 10–2000 nm in diameter can be achieved by choosing
an appropriate polymer solvent system. The diameter
and parameters of electrospun fibers of select artificial and
biodegradable polymers, as examples, are listed in table 1.
Usually, we can decrease the concentration of polymer in the
(a)
(b)
Figure 1. Electrospun collagen I nanofibers (a), and seeding MSCs
on collagen nanofibers (b).
solution, and decrease the humidity in the chamber as well to
fabricate relatively smaller fibers.
The versatility of electrospinning also means that fibers
of different morphology and different materials can be
made directly or indirectly from electrospinning. Therefore,
different polymers, blends, mixtures or precursors can be made
into fibers to suit a specific application. Basic electrospinning
can only yield random nanofibers, but using a rotating mandrel
as a collector, aligned nanofibers can be successfully obtained,
such as aligned PGA fibers at 1000 rpm rotating speed [17]
and aligned type I collagen fibers at 4500 rpm rotating speed
[18]. If using the knife-edge disc as a collector, the alignment
degree of the fibers will increase [19]. To alter the electric
field such that more electric field lines converge toward the
auxiliary electrode, parallel knife-edged bars can be used
instead of strips. These were also found to improve on the
degree of alignment [20]. Tubular scaffolds or yarns, made of
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Table 1. Various electrospun nanofibers of synthetic and biodegradable polymers.
Polymer Solvent Concentration Diameter (nm) Reference
Poly(ε-caprolactone) 7:3 Dichloromethane 8 wt% 810 ± 150 [9]
(PCL) Mn = 80 000 (DCM):methanol
PCL Mn = 80 000 1:1 Tetrahydrofuran (THF): 0.14 g ml−1 700 ± 200 [10–12]
N, N-dimethylformamide (DMF)
Poly(L-lactic acid) Dichloromethane (DCM)/n,n- 2 wt% 150–500 [13]
(PLA) Mw = 300 000 dimethylformamide (DMF) (70:30) 5 wt% 800–3000
PLA Mw = 450 000 Hexafluoropropanol 5 wt% 290 (100–600) [14]
(HFIP) or chloroform
Poly(glycolic acid) PGA HFIP or chloroform 15 wt% 310 (50–650) [14]
Mw = 14 000–20 000
PLGA (l-lactide/glycolide = 50/50) Chloroform 8 wt% 760 (200–1800) [14]
Mw = 108 000
PLGA 85/15 1:1 THF and DMF 0.05 g ml−1 500–800 [15]
PLGA 10/90 HFIP 5–7% 3900 [16]
Table 2. Electrospun collagen fibers.
Material Solvent and concentration Parameter Diameter (nm) Reference
Collagen type I HFIP 0.083 g ml−1 Voltage = 25 kV, 100 ± 40 (calfskin) [18]
distance = 125 mm, 100–730 (human placenta)
feed rate = 5 ml h−1,
target mandrel
rotating = 4500 rpm
Collagen type I HFIP 8% Voltage = 15–20 kV, 460 (100–1200) [22]
distance = 80 mm,
feed rate = 0.02 ml min−1
Collagen type I HFIP 6.7% Voltage = 12 kV, 350 ± 250 Our lab
distance = 120 mm,
feed rate = 1.2 ml h−1
Collagen type II HFIP 40 mg ml−1 Voltage = 22 kV, 496 (110 ± 30) [24, 25]
feed rate = 2 ml h−1
Collagen type III HFIP 0.04 g ml−1 Voltage = 25 kV, 250 ± 150 [18]
distance = 125 mm,
feed rate = 5 ml h−1,
target mandrel
rotating = 4500 rpm
50% collagen type I: HFIP 0.06 g ml−1 Voltage = 25 kV, 390 ± 290 [18]
50% collagen type III distance = 125 mm,
feed rate = 5 ml h−1,
target mandrel
rotating = 4500 rpm
both aligned and random fibers, can be produced currently by
using specific parameters and setups [5].
3. Current electrospun nanofiber biomaterials
Mainly biomedical applications of nanofibers are used as
scaffolds for tissue engineering, which are aimed at tissue
regeneration. The detailed applied forms will be discussed
in section 4. Here, we described several representative
biomaterials, including natural and artificial polymers,
bioceramic-calcium phosphate and carbon. We hope that this
review will serve as a timely basis for further research on
developing biomedical applications of nanofibers.
3.1. Polymers
3.1.1. Natural polymers. Natural polymers that have been
electrospun are proteins and polysaccharides. One of the most
commonly used is collagen, naturally found in connective
tissue where it provides mechanical support as ECMs. It
is possible for electrospun collagen fibers to mimic the
extracellular matrix in the body. In vitro and in vivo studies
have shown that cells respond positively to scaffolds made of
electrospun collagen fibers [21–23]. Table 2 lists electrospun
collagen fibers obtained by different research groups.
Collagen I nanofibers before and after mesenchymal stem cell
(MSC) seeding are shown in figures 1(a) and (b) respectively.
Generally, collagen can be relatively strong and form stable
fibers after cross-linking or blending with other polymers such
as PEO for higher mechanical properties [24, 26]. A cheaper
alternative to collagen would be gelatin, which also can be
electrospun [27]. Another protein that is electrospun for use in
tissue engineering is fibrinogen [28].
The other typical naturally occurring polysaccharide is
hyaluronic acid (HYA) commonly found in specialized tissues
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Table 3. Electrospun hyaluronic acid fibers.
Material Solvent and concentration Parameter Diameter (nm) Reference
HYA HCl solution (pH = 1.5) 2.0–3.0% Voltage = 25–40 kV, 50–90 [29]
distance = 90 mm,
feed rate = 20–60 µl min−1,
air-blowing rate = 35–150 ft3 h−1
HYA HCl solution (pH = 1.5) 1.3–1.5% Voltage = 40 kV, 74 [30]
distance = 95 mm,
feed rate = 40 µl min−1,
air-blowing rate = 70 ft3 h−1 (57 ◦C)
HYA Water 1.3%, 1.5% DMF: Voltage = 22 kV, 120–250 [31]
water = 2,1.5,1,0.5, 1.5% distance = 150 mm,
feed rate = 60 µl min−1
HYA-DTPH (3,3′-dithiobis PEO/DMEM solution 2.0% (w/v) Voltage = 18 kV, 60–120 [32]
(propanoic dihydrazide)) distance = 100 mm, 0–400
feed rate = 20 µl min−1 (PEO extraction)
HYA-gelatin DMF:water = 1.5, 1.5% Voltage = 22 kV, 190–500 [33]
HYA 1.5–7.5% gelatin distance = 150 mm,
feed rate = 60 µl min−1
such as synovial fluid, dermis and cartilage. Electrospun pure
HYA fibers and those blended with other polymers are listed in
table 3. Due to extremely high biocompatibility, both collagen
and HYA have been used extensively in many biomedical
applications. Thus the optimal application of these electrospun
nanofibers could be achieved in the near future.
3.1.2. Synthetic polymers. Because there are several
limitations encountered in the use of naturally derived
polymers, including batch-to-batch (or source-to-source)
variation in materials isolated from tissues, restricted
flexibility in the range of accessible material properties, and
concerns about disease transmission associated with materials
isolated from mammalian sources, artificial polymers
were synthesized as alternative materials for biomedical
applications [2]. Current synthetic biodegradable polymers
for tissue regeneration include PLA, PGA, PLGA, PCL etc.
The electrospun fibers of these polymers are listed in table 1.
The other important advantages of these biodegradable
polymers are their relatively strong mechanical properties
and the fact that they are inexpensive. So the relatively
low biocompatibility of these polymers can be accepted for
practical applications.
3.2. Hydroxyapatite
As a major mineral component of human hard tissues,
hydroxyapatite (HA) possesses excellent biocompatibility
with bones, teeth, skin and muscles, both in vitro and
in vivo. Because of its bioactivity and osteoconductivity,
HA has found extensive applications in orthopedics and
dentistry [33]. Kim et al [34] describe an effective
method for HA nanofiber fabrication by combining the
electrospinning technique and sol–gel reaction. They used
10% polyvinyl butyral (PVB)/ethanol as a precursor for
electrospun nanofibers, subsequently heated to 700 ◦C in order
to remove the polymeric precursor and to bring about the
crystallization of HA. The parameters are as follows: feed
rate = 0.2 ml h−1, electrostatic voltage = 12 kV, distance =
8 cm. The diameter of the resultant fibers was exploited in
the range of 240 nm to 1.55 µm by means of adjusting the
concentration of the sols. By the same process and with NH4F
added into the sol solution, fluorhydroxyapatite (FHA) can
also be fabricated successfully.
3.3. Carbon
Carbon nanomaterials are arguably the most celebrated
products of nanotechnology to date, encompassing fullerenes,
nanotubes, nanofibers and a wide variety of related forms
[35]. Although there are no consistent opinions on the
biocompatibility of carbon nanomaterials, pilot studies showed
positive results on subcutaneous implantation and osteoblast
co-culture experiments [36–38]. Fabrication of carbon
nanofibers comprises electrospinning of polyacrylonitrile
(PAN) and carbonization of deposited nanofibers. Dzenis [39]
for the first time used this idea to fabricate carbon nanofiber
materials. Wang et al [40] prepared PAN/dimethylformamide
(DMF) solution by adding 600 mg PAN in 10 ml DMF at
room temperature, then electrospinning on 15 kV, 15 cm
distance, following carbonization at 560–1200 ◦C. The
resultant graphite domain size in carbon fibers was enlarged
from 1.5 to 2.6 nm with higher carbonization temperature.
As potential scaffolds, the carbon nanofibers needed to be
investigated on more aspects. The advantage of using a
carbon nanofiber is its high electroconductive property: it can
conduct electricity stimulus into the tissue healing process,
whereas other polymer or ceramic materials cannot achieve
this.
3.4. Electrospun nanofiber composites
The concept of nanocomposites exploited more optimal
choices for nanofibers with high mechanical properties
and high biocompatibility simultaneously. Regarding the
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electrospun nanofiber materials, we can not only electrospin
the blended polymer with nanoparticles, but also use coating or
immobilization technologies to functionalize the electrospun
nanofibers. For example, PCL/CaCO3 composite nanofibers
are fabricated under 20 kV voltages, 1.0 ml h−3 feeding rate
and 130 mm distance [41]. A nanocomposite with different
ratios of PCL and CaCO3 can be attained by the above
parameters, such as 75:25, 50:50 and 25:75. Two kinds of
PLLA-CL/collagen nanocomposites, the blended PLLA-CL
and collagen solution that can be electrospun at 0.5 ml h−1
feeding rate and 10 kV voltages and coated electrospun
PLLA-CL nanofibers by collagen, were designed for tissue
engineered vascular graft [42, 43]. The PCL nanofibers
grafted with gelatin are treated by air plasma to yield carboxyl
groups after electrospinning [44]. Apart from our lab’s work,
Patcharaporn Wutticharoenmongkol et al [45] also prepared
electrospun PCL/CaCO3 and PCL/HA composites by using
PCL solution containing nanoparticles of calcium carbonate
or hydroxyapatite. Cytotoxicity evaluation of the electrospun
PCL/CaCO3 and PCL/HA fibers based on human osteoblasts
(SaOS2) and mouse fibroblasts (L929) revealed that these
composite nanofibers posed no negative effect to the cells,
which corresponded to our results.
4. Potential tissue regeneration applications
From the structural viewpoint, almost all of the human tissues
consist of nanofibers, such as blood vessels, skin, cartilage
and bones. Enhanced cell growth on nanofibrous scaffolds
has been expected. But most fibrous materials used in tissue
engineering have no pertinence to a specific tissue/organ;
in fact different tissue regenerations have quite different
mechanisms, although their matrices are all fibrous scaffolds.
In this section, we summarize the nanofiber studies on tissue-
specific regeneration. Along these lines, electrospun nanofiber
biomaterials for tissue regeneration will be explored deeply for
biomimetic repairs in the form of natural tissue regeneration.
4.1. Blood vessel
Attempts have been made for many years to develop
small blood vessels, but all have encountered high failure
rates for one reason or another. In particular, it was
found that graft patency rates were greatly reduced when
synthetic grafts were used for small diameter arteries, such
as coronary and infragenicular vessels. Three-dimensional
nanomatrix scaffolds made of collagen or other cell-secreting
natural substances can be used to seed the smooth muscle
cells (SMCs) to mimic natural, small diameter vessels.
Studies suggested that muscle cells, once implanted in
the scaffold, could partly develop the function, shape,
morphology and cellular architecture of the normal vessel [46].
Poly(glycolide-co-ε-caprolactone) scaffolds possess elastic
mechanical properties and promote the SMC adhesion and
subsequent tissue formation [47]. Typical materials currently
used as vascular grafts include poly(ethylene terephthalate)
(PET) and poly(tetrafluoroethylene) (PTFE) etc. Surface
modification of electrospun PET fibers improved the spreading
and proliferation of endothelial cells (ECs) [48]. Furthermore,
not only the surface roughness of the nanofibers, but the
fiber alignment of the scaffold is also important [49, 50].
The aligned nanofiber scaffolds showed special favorable
interactions between SMCs and the scaffold as the orientation
of the fibers encouraged cell proliferation in that direction.
In natural blood vessels, the SMCs in the middle layer are
arranged in a concentric manner. If SMCs are cultured on the
electrospun nanofibers that are oriented in a concentric manner
to form a tubular scaffold, the cells are expected to grow in a
concentric manner resembling that of a natural blood vessel.
The alternative approach is to form tubular scaffolds made
of the electrospun nanofibers. By using a rotating collector
and controlling the electric field, it is possible to align the
electrospun nanofibers on the circumference of the small
diameter tube which can be extracted to give a tubular scaffold
[51]. Moreover, tubular scaffolds made of different materials
have also been made by multilayering and other mixing
electrospinning techniques [52]. In the near future, human
endothelial cells, smooth muscle cells and fibroblasts will be
used in the inner, middle and outer layers, respectively, of the
vascular constructs to achieve the ‘real’ synthetic blood vessel.
This is the greatest challenge in blood vessel regeneration.
4.2. Skin
As the outermost tissue of the human body, the passive and
active functions of skin are carried out by specialized cells
and structures located in the two main layers of skin: the
epidermis and dermis. The epidermis, composed primarily of
keratinocytes, is formed into a stratified squamous epithelium.
Proliferating cells in the basal layer of the epidermis anchor
the epidermis to the dermis and replenish the terminally
differentiated epithelial cells lost through normal sloughing
from the surface of the skin [53].
Collagen is a leading candidate for skin regeneration.
Experiments of open wound healing in rats showed
that collagen nanofibrous matrices were very effective as
wound-healing accelerators in early-stage wound healing.
Alternatively, coating type I collagen is also a good candidate
for wound dressing [21, 26]. This system has been
demonstrated by our group using electrospun PCL nanofibers
coating collagen I for fibroblast growth, proliferation and
migration inside the matrices [54]. Then this biodegradable
PCL/collagen composite nanofiber supported the attachment
and proliferation of human dermal fibroblasts and has
potential in tissue engineering as a dermal substitute for skin
regeneration.
Other non-biodegradable polymer nanofibers, such as
polystyrene and polyurethane, were also fabricated for
wound dressing by electrospinning [55, 56]. Although
it does not seem optimal material for tissue regeneration,
its unique results of cell co-culture are worth considering.
In the absence of serum, keratinocytes, fibroblasts and
endothelial cells did not grow when cultured alone. However,
when fibroblasts were co-cultured with keratinocytes and
endothelial cells, expansion of keratinocytes and endothelial
cells occurred even in the absence of serum, which was
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not consistent with the fibroblasts and keratinocytes cultured
on the electrospun silk fibroin (SF) nanofiber non-woven
membrane [57]. We hypothesized that when all three cell
types were introduced at random to the proper nanofiber
scaffold, the cells displayed native spatial three-dimensional
organization. As evidence, Huang [58] demonstrated
that co-culturing with fibroblasts enables keratinocytes and
endothelial cells to proliferate without serum, but also
to self-organize according to the native epidermal–dermal
structure given the symmetry-breaking field of an air–
liquid interface. Moreover, the electrospun nanofibrous
polyurethane membrane shows controlled evaporative water
loss, excellent oxygen permeability, promotes fluid drainage
ability, and inhibits exogenous microorganism invasion
because its pores are ultra-fine. Based upon the above
properties, the electrospun polyurethane membrane still has
potential applications for wound dressing [56].
The development of the electrospinning technique itself
certainly enhanced the potential applications. With a modified
coaxial electrospinning technique, a pencil-like, core-shell
composite nanofiber can be obtained. The drugs resveratrol
and gentamycin sulfate were encapsulated respectively into the
cores of biodegradable PCL ultra-fine fibers with diameters
down to a few hundred nanometers. Such composite
nanofibers will be useful in controlled drug release and in
the development of new medical devices as wound-dressing
materials [58]. As the most direct biomedical application
of electrospun nanofiber membranes, it is hoped that skin
regeneration will be realized by incorporating the drugs into
the nanofibers.
4.3. Cartilage
Cartilage is a dense connective tissue that is to a certain extent
pliable, making it resilient. These characteristics are due
to the nature of its matrix, which is rich in proteoglycans
consisting of a core protein attached by the repeating units
of disaccharides termed glycosaminoglycans (GAGs) mainly
consisting of HYA, chondroitin sulfate, collagen II and keratin
sulfate. Articular cartilages are important in load-bearing and
reducing friction of the articular surfaces. Due to the limited
capacity of articular cartilage to repair itself, and cartilage
defects resulting from aging, joint injury and developmental
disorders cause joint pain and loss of mobility [11]. As
promising candidates, the electrospun HYA or HYA-based
composite nanofibers have been fabricated successfully, but
the chondrocyte response on these fibers is still unknown,
which has a bearing on the efficiency of cartilage repair
[29–32].
Other nature-derived materials, the electrospinning of
collagen type II and subsequent seeding chondrocyte, were
investigated for potential use in cartilage tissue engineering.
The electrospinning parameters of this material were described
in section 3.1.1 (table 2) [24, 25]. Individual scaffold
specimens were evaluated as uncross-linked, cross-linked or
cross-linked/seeded in the study of Shields [24]. Scanning
electron microscopy of cross-linked scaffolds cultured with
chondrocytes demonstrated the ability of the cells to infiltrate
the scaffold surface and interior. Electrospun collagen type II
scaffolds produce a suitable environment for chondrocyte
growth, which establishes the foundation for the development
of articular cartilage repair.
As well as random nanofibers, oriented chitosan fibers
were studied for their biocompatibility with chondrocytes by
Subramanian et al [59]. As expected, the oriented electrospun
chitosan provides better chondrocyte biocompatibility than the
cast chitosan film. This electrospun membrane also has a
significantly higher elastic modulus (2.25 MPa) than that of the
cast film (1.19 MPa). Following this, the electrospun chitosan
still needs to be further processed into three-dimensional
scaffolds for cartilage tissue repair.
Synthetic biodegradable polymers are also studied for
chondrocyte scaffolds. Shin and colleagues [60] investigated
the potential of four different nanofiber-based types of
PLGA scaffolds (lactic acid/glycolic acid content ratio =
75:25, 50:50, or a blend of 75:25 and 50:50) to be used for
cartilage reconstruction. The mechanical properties of the
nanofiber scaffold were slightly lower than those of human
cartilage, which suggested that the nanofiber scaffold was
mechanically stable to withstand implantation and to support
regenerated cartilage. Proliferation of chondrocytes from
porcine articular cartilage and ECM formation in nanofiber
scaffolds were superior to those in the conventional cast
membrane, because of the intermittent hydrostatic pressure
applied to the cell-seeded nanofiber [60]. Nanofibrous PCL
was evaluated for its ability to maintain chondrocytes in
a functional state using fetal bovine chondrocytes (FBCs)
[12]. Gene expression analysis by a reverse transcription-
polymerase chain reaction showed that chondrocytes seeded
on the PCL nanofibrous scaffold continuously maintained
their chondrocytic phenotype by expressing cartilage-specific
extracellular matrix genes, including collagen types II and IX,
aggrecan, and cartilage oligomeric matrix protein. Expression
of the collagen type II splice variant transcript, which
is indicative of the mature chondrocyte phenotype, was
significantly up-regulated. The FBCs exhibited either a
spindle or round shape on the nanofibrous scaffolds, in contrast
to the flat, well-spread morphology seen in monolayer cultures
on TCP. In addition to promoting phenotypic differentiation,
the nanofibrous scaffold also supported cellular proliferation
as evidenced by a 21-fold increase in cell growth over 21 days
when the cultures were maintained in a serum-containing
medium. Thus, PCL nanofibers may be a suitable candidate
scaffold for cartilage tissue engineering.
4.4. Bone
As a connective tissue distinguished by the fact that its matrix
is mineralized by calcium phosphate, bone is both hard and
resilient, mainly consisting of collagen I and carbonated
hydroxyapatite. Ideally, scientists want to mimic the natural
process—collagen induces calcium, phosphate and hydroxide
to form hydroxyapatite crystallites within bone, which are
necessary for its structural rigidity [3]. Three strategies
were carried out: adding calcium phosphate into the scaffold,
seeding bone marrow stromal cells (BMSC) into the scaffold
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and combining with growth factors, which is described as
follows.
For bone tissue regeneration, biodegradable polymers are
commonly combined with bioceramics either before or after
the electrospinning process. Fujihara et al [41] prepared
the PCL/CaCO3 composite electrospun fibers as expected to
encourage osteoblast attachment from the in vitro experiments.
Alternatively, the electrospun nanofibrous film was soaked in
the simulated body fluid, as in the study of Ito [61]. The formed
HA changed the hydrophobic of the poly(3-hydroxybutyrate-
co-3-hydroxyvalerate) (PHBV) film to hydrophilic, as a result
increasing the degradation rate. However, the HA composition
did not significantly affect the cell adhesion. On replacing
the PHBV with silk/polyethylene oxide (PEO) containing
poly(L-aspartate) (poly-Asp), and changing SBF to CaCl2 and
Na2HPO4 solution, the apatite growth occurred preferentially
along the longitudinal direction of the fibers [62]. It is
highly possible to develop mineralized nanofibers, but it is still
necessary to investigate the osteoblast reactions on mineralized
nanofibers.
Mesenchymal stem cells (MSCs), derived from the bone
marrow of neonatal rats, were used for seeding on electrospun
PCL scaffolds by Yoshimoto et al [63]. The cell–polymer
constructs were cultured with osteogenic supplements under
dynamic culture. Ordinarily, the cell–polymer constructs
should maintain the size and shape of the original scaffolds
as it is necessary for space support in vivo implantation. At
4 weeks, the surfaces of the cell–polymer constructs were
covered with cell multilayers. In addition, type I collagen
secretion and cell mineralization both can be detected at that
time. Developed from PCL nanofiber material, gelatin/PCL
composite electrospun nanofibers were fabricated by mixing
the solution of 50% gelatin solution and 50% PCL solution,
in which gelatin concentration was ranging from 2.5% w/v to
12.5% w/v [64]. Contact-angle measurement and tensile tests
indicated that the gelatin/PCL complex fibrous membrane
exhibited improved mechanical properties as well as more
favorable wettability than that obtained from either gelatin
or PCL alone. BMSCs could not only favorably attach and
grow well on the surface of these scaffolds, but were also able
to migrate inside the scaffold up to 114 µm within 1 week
of culture, which shows better biocompatibility than PCL
nanofibrous material. The positive reactions of MSC on the
nanofibers matrix also showed up on PLA and silk electrospun
nanofibers [10, 65].
Bone growth factors such as BMP-2, OP-1 etc gradually
became attractive clinical drugs for bone defect repair. The
previous mineralized collagen/PLA 3-D scaffold with BMP-2
had already shown some exciting healing effects in vivo [66].
In principle, the nanofiber materials will more easily absorb
growth factors for a high surface area, and then possibly
result in more optimal healing effect. The silk fibroin
nanofiber scaffolds containing BMP-2 and/or nanoparticles
of hydroxyapatite (nHA) prepared via electrospinning were
selected as a matrix for in vitro bone formation from human
bone marrow derived mesenchymal stem cells (hMSCs)
[67]. The scaffolds with the coprocessed BMP-2 supported
higher calcium deposition, higher crystallinity apatite and
enhanced transcript levels of bone-specific markers than in the
controls (without BMP-2), indicating that these nanofibrous
electrospun silk scaffolds were an efficient delivery system
for BMP-2. The coexistence of BMP-2 and nHA in the
electrospun silk fibroin fibers resulted in the highest calcium
deposition and up-regulation of BMP-2 transcript levels when
compared with other systems. Fortunately, the mild aqueous
process required to electrospin the fibers offers an important
option for delivery of labile cytokines and other biomolecules
into the system.
5. Improvement of electrospun nanofibers
With a greater understanding of electrospinning, we may be
able to have greater control over its resultant fibers with
the desired morphology and structure. Although there have
been many breakthroughs in electrospinning technology, as
previous sections mentioned, the fundamental experimental
and theoretical analysis of the process needs to develop
the flexibility and reliability of its assemblies and
nanocomposites [68]. We discuss the developing directions
of electrospun nanofibers related to tissue regeneration
application in this section.
5.1. Functionalization of nanofibers
After fabrication of nanofibers by electrospinning, we may
consider the possible functionalization of these nanofibers.
The polymeric nanofiber matrix has a similar structure to
nanoscaled non-woven fibrous extracellular matrix proteins,
and surface modification of nanofibers improved the
biocompatibility. Collagen-coated PLA-CL has demonstrated
higher cell attachment, spreading and viability than the
unmodified nanofibers by endothelial cell culture [43]. This
gives rise to the possibility of composites with the advantages
of both artificial polymer and natural protein, maintaining the
nanofiber form at the same time.
In addition to coating or blending for composite nanofiber
fabrication, the covalently grafted protein on the nanofiber
surface is another choice for functionalization, which has
long been used for surface modification for conventional
biomaterials. However, not all surface modification
methods developed have been appropriate for functionalizing
nanofibers, because only moderate methods can possibly be
useful for modification of nanofibers, otherwise the nanofibers
will be themselves destroyed. Moreover, we do not know
whether this functionalization will have effect on in vivo
tissue repair or not; the study of in vivo implantation is too
limited. A specific and systemic functionalizing technique
with electrospinning needs to be established through further
investigations.
5.2. Three-dimensional extension
Electrospinning technology enables the production of
continuous nanofibers. Then most people will think about
yarns and textiles, where it is possible to fabricate three-
dimensional (3D) textile fabrics for bridging the gap from
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the nano- to microscales. Previous studies of non-nanofibrous
polymer scaffolds showed that the 3D form reacted differently
from the 2D materials based on in vitro and in vivo
experiments. If we want to extend the biomimetic nanofibers
as optimal scaffolds for tissue regeneration, 3D extension of
nanofibers has to be done as soon as possible. Up to now,
electrospinning technology has enhanced continuous fibers
to continuous yarns. Then the definite pattern structure of
the nanofibers will become the second attraction of nanofiber
technology.
In an attempt to obtain a continuous yarn made of
aligned fibers, fiber bundles were fabricated by collecting the
electrospun fibers on a rotating drum. The collected nanofibers
were linked and twisted into yarns [69]. Moreover, Khil et al
[70] designed a particular setup for yarn collection: they used
a water bath for deposition of the electrospun fibers, then the
deposited fibers were drawn out of the water as a bundle from
one side of the bath using a filament guide bar and collected
onto a roller in the form of a yarn. If we replace the parallel
electrodes of straight bars with rings, with one of the rings
rotated, twisting of the aligned fiber bundle is achieved [71].
Although by using the above methods it is possible to get a
twisted fiber bundle, a significant drawback is that the length
of the twisted fiber bundle is limited to the space between the
fibers, and the distance outside the range would result in a poor
profile of the fibers on the rings with fibers either depositing
mainly at the top of the ring or at the bottom of it.
5.3. Mechanical strength
From the material science viewpoint, the effect of size on
the properties of a single fiber should be an interesting
topic. There are as yet few scientific papers discussing the
mechanical properties of electrospun single nanofibers. At
present, three testing apparatuses are available to measure
tensile and bending properties of a single nanofiber: the
cantilever technique, the AFM-based nanoindentation system
and the nanotensile tester [71–75]. Using the AFM-based
nanoindentation system, a bending test of a PLLA single
fiber was conducted by suspending a fiber over the etched
groove in a silicon wafer of 4 µm width and 2.5 µm
depth [73]. The crosshead speed of the cantilever tip was
1.8 µm s−1 and the applied maximum load to a single PLLA
nanofiber was 15 nN. We have described only this method
in detail because it can measure the mechanical properties of
cultured cells, and therefore make it possible for us to co-
consider mechanical properties of an electrospun nanofiber to
the natural ECM fibers in situ. The stress stimulus effect to cell
and tissue growth is still to be understood; this nanotechnique
possibly gives us a new tool to investigate this aspect. Research
on the relationship between cell behavior and stress provided
by nanofibers is still in its infancy when the electrospun
nanofibers are selected as a matrix for cell culture.
On the macroscale, as a basic property for practical
biomedical application, the traditional tensile testing method
has been applied to test the nanofibrous membrane and
nanoyarns. However, even for the most widely used PLGA
polymer, systemic research is limited. Zong et al [76] obtained
6 MPa and 4.9 MPa of tensile stress from 400 nm and 1000 nm
PLGA (LA:GA = 10:90) fibers, and from the study of Li
et al [77], it is 22.67 MPa of 500–800 nm PLGA (LA:GA =
85:15) nanofibers. For aligned nanofiber membranes, the
tensile property in each drum rotating direction and transverse
direction should be considered. Actually, even if nanofibers
are collected with a rotating drum, there is no certainty that
their alignment can be unidirectionally oriented. In order to
get more precise fiber alignment, the current fiber collection
system using a rotating drum still needs further improvement.
6. Future prospects
Polymeric nanofibers can be processed by a number of
techniques such as drawing, templated synthesis, phase
separation, self-assembly and electrospinning. The significant
advantage of electrospinning is that long and continuous
nanofibers can be produced in a cost-effective way, which
makes it a potential application for industrial processing. But
the disadvantage it shares with other nanotechniques is its low
productivity. In order for electrospinning to be commercially
viable, it is necessary to increase the production rate of the
nanofibers. To do so, we try to use a multiple-spinning setup
to increase the product yield, such as using eight needles
at one syringe pump and a 24 ml h−1 feed rate for PCL
nanofiber fabrication [5]. Even now, we still need to investigate
the corresponding parameters of electrospun nanofibers with
optimal and stable properties.
In addition to single-electrospinning technology for
obtaining nanofibers, other variations of electrospinning
exist in order to absorb both advantages of other modern
nanotechniques, such as the combined electrospinning process
[78, 79]. Further assembly of nanofibers will be possible
with a combination of self-assemblies, which generally occurs
throughout nature.
Most current nanofibrous scaffold research is at the
experimental stage. The trend is heading to animal
study with or without seeded cells, aimed at achieving
biomedical applications. Potential therapies include stem cell
implantation with nanofibers. In this respect, it can be said that
the biomedical application of nanofibers has a bright future,
and can certainly progress rapidly by collaboration between
biomaterials researchers and clinicians.
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THE MOST IMPORTANT REASON for the long-term fail-ure of small-diameter (6-mm) vascular grafts is in-
timal hyperplasia, which is characterized by a cascade of
immunoreactions caused by contact between the blood
and foreign materials.1–3 These immunoreactions, in-
cluding formation of thrombus; infiltration of macro-
phages, neutrophils, and monocytes; secretion of cyto-
kines; ingrowth and proliferation of smooth muscle cells
(SMCs) and production of extracellular matrix (ECM);
and so on, lead to abnormal tissue growth inside the vas-
cular grafts, thereby blocking blood flow and finally caus-
ing the failure of the grafts.
A blood vessel tissue-engineering scaffold fabricated
with biodegradable materials provides an excellent ap-
proach to obtain a vascular substitute with long-term pa-
tency. However, methods still need to be taken to pre-
vent intimal hyperplasia during the early phase after
implantation of the scaffold. An effective approach is en-
dothelialization of the blood-facing surface of the scaf-
fold, would prevent thrombosis and enhance graft sur-
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Grafting of Gelatin on Electrospun Poly(caprolactone)
Nanofibers to Improve Endothelial Cell Spreading and
Proliferation and to Control Cell Orientation
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ABSTRACT
We modified the surface of electrospun poly(caprolactone) (PCL) nanofibers to improve their com-
patibility with endothelial cells (ECs) and to show the potential application of PCL nanofibers as a
blood vessel tissue-engineering scaffold. Nonwoven PCL nanofibers (PCL NF) and aligned PCL
nanofibers (APCL NF) were fabricated by electrospinning technology. To graft gelatin on the
nanofiber surface, PCL nanofibers were first treated with air plasma to introduce –COOH groups
on the surface, followed by covalent grafting of gelatin molecules, using water-soluble carbodiimide
as the coupling agent. The chemical change in the material surface during surface modification was
confirmed by X-ray photoelectron spectroscopy and quantified by colorimetric methods. ECs were
cultured to evaluate the cytocompatibility of surface-modified PCL NF and APCL NF. Gelatin graft-
ing can obviously enhance EC spreading and proliferation compared with the original material.
Moreover, gelatin-grafted APCL NF readily orients ECs along the fibers whereas unmodified APCL
NF does not. Immunostaining micrographs showed that ECs cultured on gelatin-grafted PCL NF
were able to maintain the expression of three characteristic markers: platelet–endothelial cell ad-
hesion molecule 1 (PECAM-1), intercellular adhesion molecule 1 (ICAM-1), and vascular cell ad-
hesion molecule 1 (VCAM-1). The surface-modified PCL nanofibrous material is a potential candi-
date material in blood vessel tissue engineering.
1Nanoscience and Nanotechnology Initiative, National University of Singapore, Singapore.
2Division of Bioengineering, National University of Singapore, Singapore.
3Department of Mechanical Engineering, National University of Singapore, Singapore.
vival.4–6 Therefore, an ideal blood vessel tissue-engi-
neering scaffold should have a confluent endothelial cell
lining and the cells should be able to resist the shear stress
of the blood flow and possess desirable physiologic func-
tions such as anticoagulation abilities.
Polymeric nanofibers produced by electrospinning
technology have been of interest because the nanoscaled
morphology of the nanofibers is analogous to the struc-
ture of protein fibrils/fibers in natural ECM. Studies on
the use of electrospun nanofibers as tissue-engineering
scaffolds for the regeneration of bone,7 cartilage,8 blood
vessels,9–11 and cardiac tissue12 have been reported. In
particular, a two-dimensional polymer nanofiber mat is
similar in structure to the natural basal lamina, which 
lies under the endothelial cells in blood vessels and 
consists of collagen IV and laminin-1 fibrils/fibers with
nanoscaled diameters.13,14 It therefore makes sense to use
the two-dimensional polymer nanofiber mat as a basal
lamina-mimicking material to construct the inner surface
of tissue-engineering scaffolds.
In this work, electrospun poly(caprolactone) (PCL)
nanofiber mats were fabricated and surface modified to
create an artificial basal lamina with both ECM-mimic-
king structures and cell-compatible surfaces. Both non-
woven PCL nanofiber mats (PCL NF) and aligned PCL
nanofiber mats (APCL NF) were prepared and surface
modified. PCL NF can be prepared much more easily
than APCL NF. Therefore this article describes how PCL
NF was used for surface modification, and then how the
same surface modification method was employed to mod-
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ify APCL NF. Endothelial cell behavior on both materi-
als was studied in terms of cell morphology, prolifera-
tion, and phenotype. The ability of APCL NF to control
cell orientation is described.
EXPERIMENTS
Materials and reagents
Poly(caprolactone) (PCL, Mn  80,000; Sigma-Aldrich,
St. Louis, MO), 2-(N-morpholino)ethanesulfonic acid
(MES; Sigma, St. Louis, MO), 1-ethyl-3-(3-dimethy-
laminopropyl)carbodiimide hydrochloride (EDAC; Sigma),
N-hydroxysuccinimide (NHS; Sigma), and gelatin (Sigma-
Aldrich) were all used as received.
Preparation of PCL nanofiber
PCL nanofiber mats were produced by an electrospin-
ning method, using the instruments schematically shown
in Fig. 1 and described in detail in Xu et al.9 and Mo et
al.11. Briefly, 2 mL of PCL solution (10 w%) in a mix-
ture of chloroform and N,N-dimethylformamide (DMF)
(70:30, w/w) was placed in a 20-mL syringe. A syringe
pump was used to squeeze out the polymer solution at
0.5 mL/h through a needle with an inner diameter of 0.21
mm. Directly below the needle an aluminum plate was
placed at a distance of 15 cm from the needle. Voltage
(15 kV) was loaded between the needle and the aluminum
plate. The polymer solution was drawn into the fibers by
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FIG. 1. Schematic representations of the fabrication process for nonwoven PCL nanofiber mat (PCL NF) and aligned PCL
nanofiber mat (APCL NF). SEM images of PCL NF and APCL NF are also shown.
the high voltage and deposited on the aluminum plate to
give a nonwoven PCL nanofiber mat (PCL NF).
To make aligned PCL nanofibers (APCL NF), fiber was
collected with a rotating aluminum wheel (1000 rpm) in-
stead of the static aluminum plate (Fig. 1). The wheel has
a sharpened edge that is capable of strengthening the elec-
tric field near the collector. The distance between the nee-
dle and the wheel edge is 15 cm and a round glass cover-
slip (diameter, 15 mm) was fixed to the wheel edge with
its surface normal to the wheel. The fibers collected on the
coverslips were aligned along the direction of the wheel
edge to form APCL NF mats. Other conditions were the
same as used to prepare PCL NF, as described above.
Surface modification
The surface modification reaction scheme is shown in
Fig. 2. Air plasma treatment of PCL nanofiber was carried
out in an electrodeless, inductively coupled radio-fre-
quency glow discharge (RFGD) plasma cleaner (PDC-001;
Harrick Plasma, Ithaca, NY). The air plasma treatment
lasted for 5 min with the radio-frequency power set at 30
W. Air plasma-treated PCL nanofiber mats were immersed
into MES buffer solution (0.1 M, pH 5.0) containing
EDAC (5 mg/mL) and NHS (5 mg/mL) at 4°C for 2 h.
The material was then rinsed with MES buffer, immersed
into gelatin solution (4 mg/mL in MES buffer), and re-
acted for 24 h at 4°C. The gelatin-grafted material was fi-
nally rinsed with deionized water for 24 h to remove the
physically adsorbed gelatin, and dried under vacuum.
Surface characterization
Scanning electron microscopy (SEM) images of PCL
NF and APCL NF were taken with a JSM-5800LV scan-
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ning electron microscope (JEOL, Tokyo, Japan). X-ray
photoelectron spectra of control and modified PCL NF
were taken on a VG ESCALAB 2201-XL base system
(Thermo VG Scientific, East Grinstead, UK) with a take-
off angle of 90°. The binding energy was referenced to
the C1S of saturated hydrocarbon at 285.0 eV. The C1s:
O1s: N1s intensity ratio of the equipment is 1:2.85:1.7.
COOH groups on air plasma-treated PCL NF was mea-
sured by the toluidine blue O (TBO) method described
in detail by Ying et al.15 and Gupta et al.16 The mea-
surement is based on the formation of complexes between
carboxyl groups and TBO molecules. The amount of
gelation on the gelatin-grafted PCL NF surface was mea-
sured by the Coomassie Brilliant Blue G (CBBG; Sigma)
staining method,17,18 which is based on the combination
between protein molecules and the CBBG molecule.
Wettability of original and modified PCL NF was stud-
ied by sessile drop water contact angle measurement, us-
ing a surface contact angle tester (VCA Optima, AST
Products, Billerica, MA). Water (7.5 L) was dropped
on the material surface and the water drop shape was
recorded over 30 s. The sessile drop water contact angle
was calculated with software provided by the manufac-
turer.
Endothelial cell culture
For endothelial cell (EC) culturing, PCL NF and APCL
NF were deposited on round coverslips (diameter, 15
mm) Assistent; Glaswarenfabrik Karl Hecht, Sondheim,
Germany), which exactly covered the well bottoms of 24-
well tissue culture plates. Fiber collecting time was con-
trolled at 40 min. ECs were seeded onto original and mod-
ified PCL NF or APCL NF with tissue culture polystyrene
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FIG. 2. Reaction scheme of the surface modification process for PCL nanofiber. Air plasma treatment was used to introduce
carboxyl groups onto the PCL nanofiber surface, followed by the covalent attachment of gelatin molecules, using EDAC as the
coupling agent. RFGD, Radio-frequency glow discharge.
(TCPS) set as a control. Ethanol solution (75%, v/v) was
used to sterilize the samples.
Human coronary artery endothelial cells (HCAECs;
Cambrex Bio Science, Walkersville, MD) were pur-
chased at passage 3. The cells were cultured in endothe-
lial cell basal medium 2 containing growth factors (EGM-
2; Cambrex Bio Science) supplemented with penicillin
(100 U/mL) and streptomycin (100 U/mL). During cell
culture, the culture medium was changed every 4 days.
ECs at passage 9 were used in this work.
Cell morphology
Cell morphology was studied by fluorescence mi-
croscopy (Leica Microsystems, Bensheim, Germany) and
SEM (JSM-5800LV; JEOL). Living cells were stained
with chloromethyl fluorescein diacetate (CMFDA; Mo-
lecular Probes, Eugene, OR) and observed directly by flu-
orescence microscopy without fixation.19 A stock solution
of CMFDA (25 M/mL in dimethyl sulfoxide [DMSO])
was diluted with cell culture medium to obtain a 2.5
M/mL working solution. Working solution (200 L) was
added to every well and cells were observed 4 h later. For
SEM, cells were fixed with 2.5% (v/v) glutaraldehyde so-
lution for 30 min and dried under vacuum. To observe the
cytoskeleton, cells were fixed with 2.5% (v/v) glutaralde-
hyde solution for 30 min, extracted with 0.1% Triton X-
100 in phosphate-buffered saline (PBS), incubated in phal-
loidin–tetramethylrhodamine B isothiocyanate (5 g/mL
in PBS) for 1 h at 37°C, rinsed with PBS repeatedly, and
observed under a laser scanning confocal microscope
(LSCM) (TCS SP2; Leica Microsystems).
Cell proliferation
Cell proliferation on original and surface-modified PCL
NF was studied by 3-(4,5-dimethylthiazol-2-yl)-5-(3-car-
boxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium
(MTS) colorimetric assay. The kit (CellTiter 96 AQueous
One Solution cell proliferation assay; Promega, Madison,
WI) was used according to the manufacturer’s directions.
Before MTS testing, old culture medium was pipetted from
the 24-well tissue culture plate and 500 L of fresh 
culture medium was added to every well. CellTiter 96
AQueous One Solution reagent (100 L) was then added to
every well. After culturing for 4 h, the deeply colored cul-
ture medium was pipetted out and added to a 96-well plate
(100 L/well), and the absorbance at 490 nm was recorded
using an enzyme-linked immunosorbent assay (ELISA)
plate reader. Samples with culture medium but without
cells were set as the control, to determine background ab-
sorbance to be subtracted.
Cell phenotypic study
Three typical cell surface markers of ECs (platelet–en-
dothelial cell adhesion molecule 1 [PECAM-1 or CD31],
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vascular cell adhesion molecule 1 [VCAM-1 or CD106],
and intercellular adhesion molecule 1 [ICAM-1 or
CD54]) were studied. After fixation with 2.5% parafor-
maldehyde and blocking with 2% bovine serum albumin
(BSA), cells were incubated for 2 h at 37°C with a 200-
L/well concentration of primary antibody (mouse anti-
human PECAM-1, mouse anti-human VCAM-1, or
mouse anti-human ICAM-1; BD Biosciences Pharmin-
gen, San Diego, CA) diluted 1:60 with PBS–2% BSA.
After washing, fluorescein isothiocyanate (FITC)-labeled
rabbit anti-mouse IgG (BD Biosciences Pharmingen) di-
luted 1:60 with PBS–2% BSA was added (200 L/well)
and incubated for 2 h at 37°C, followed by washing and
counterstaining with propidium iodide (PI, 2 g/mL, 100
L/well) for 10 min. The immunostained ECs were then
viewed under a laser scanning confocal microscope (Le-
ica TCS SP2). Control experiments showed that sec-
ondary antibody alone cannot specifically stain cells.
RESULTS AND DISCUSSION
PCL nanofiber
SEM images of PCL NF and APCL NF are shown in
Fig. 1. PCL NF is a highly porous nonwoven fabric ma-
terial. From the higher magnification image in Fig. 1 it
can be seen that the fiber diameter has a wide distribu-
tion, mainly between 200 nm and 1 m. The thickness
of PCL NF mats can be controlled by adjusting the elec-
trospinning time. In this work PCL NF with a thickness
of 25  3 and 100  10 m was obtained after electro-
spinning for 40 min or 3 h, respectively.
APCL NF was obtained by depositing the nanofiber
on the edge of a rotating plate (1000 rpm) instead of a
static collector. As shown in Fig. 1, the fiber diameter of
APCL NF is about 200–500 nm, which is smaller than
that of PCL NF. The smaller fiber diameter for APCL
NF may be attributed to the stretching force loaded on
the fiber, produced by the rotating plate during electro-
spinning. After electrospinning for 40 min, APCL NF
mat with a width of 5 mm was obtained on the cover-
slip (Fig. 1).
Plasma treatment of PCL NF
Radio-frequency glow discharge (RFGD) treatment
using air or oxygen as reactive gas is a traditional method
to introduce oxygen-containing groups (such as carboxyl
and hydroxyl groups) onto polymer surfaces. This sim-
ple method was used in this work to introduce carboxyl
groups on PCL nanofiber surfaces. The air plasma used
here was produced by an electrodeless, inductively cou-
pled RFGD instrument (PDC-001; Harrick Plasma),
which is different from the more commonly used captive
coupled RFGD instruments employing two planar elec-
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trodes. The plasma produced by the inductively coupled
RFGD is more uniform, and therefore more appropriate
for the surface modification of three-dimensional poly-
mer scaffolds. The surface chemical composition of PCL
NF before and after air plasma treatment was studied by
X-ray photoelectron spectroscopy (XPS). Figure 3a
shows the survey scan spectra of original PCL NF and
air plasma-treated PCL NF. The atomic ratio of C to O
(shown in the Fig. 3a) on the material surface can be cal-
culated from the peak area ratio of C1s to O1s and the
corresponding intensity factors. After air plasma treat-
ment, the proportion of oxygen is increased, due obvi-
ously to the introduction of oxygen atoms. From the C1s
core level scan spectra of the original and air plasma-
treated PCL NF shown in Fig. 3a, it can be seen that the
percentage of the saturated hydrocarbon C1s peak at
285.0 eV decreased after the plasma treatment because
of the introduction of oxygen atoms.
The oxygen-containing groups introduced by the air
plasma treatment are not specific and have great variety.
Therefore, TBO, a dye that can specifically combine with
carboxyl groups,15,16 was used to verify the existence of
the –COOH group and to quantitatively measure its
amount on air plasma-treated PCL NF. Figure 4 shows
the COOH density as a function of plasma treatment time
and fiber mat thickness. The number of COOH groups
clearly increased with treatment time. Increasing thick-
ness of PCL NF produced greater amounts of COOH, in-
dicating that the surface modification occurred not only
on the outer surface, but deeper in the whole three-di-
mensional mat.
Gelatin grafting on PCL NF
For gelatin grafting, the air plasma treatment time was
set at 5 min to yield enough COOH groups. Water-solu-
ble carbodiimide was used to activate the COOH groups,
which were subsequently reacted with gelatin molecules.
GRAFTING OF GELATIN ON ELECTROSPUN PCL NANOFIBERS
The existence of gelatin can be confirmed by the ap-
pearance of the N1s peak in the XPS of gelatin-grafted
PCL NF (Fig. 3b). Using the CBBR staining method,17,18
the amount of gelatin grafted on PCL NF with thicknesses
of 25 and 100 m was measured as 0.22 and 0.72
mg/cm2, respectively.
Wettability
The wettability of original and modified PCL NF mat
was studied by water contact angle test (Table 1). Plain
PCL film with a smooth surface was used as a control.
Original PCL NF has a much higher water contact angle
than original plain PCL film because of high surface
roughness. Air plasma treatment effectively increased the
hydrophilicity of the PCL film surface, whereas for air
plasma-treated PCL NF, the water drop was suddenly
sucked into the nanofiber mat, giving a contact angle of
0°. Here the notable difference between the wettability
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FIG. 3. (a) Survey scan XPS and C1s core level scan spectra of original and plasma-treated PCL NF. Atomic ratio of carbon
to oxygen (C:O) are shown. (b) Survey scan XPS of gelatin-grafted PCL NF and APCL NF. N1s peaks directly verified the ex-
istence of gelatin on the nanofiber surface.
A
B
FIG. 4. Density of COOH groups yielded by air plasma treat-
ment of PCL NF, plotted against treatment time.
of plain PCL film and PCL NF is in agreement with com-
mon experience20, that is, the water contact angle in-
creases with surface roughness for a hydrophobic mate-
rial, and decreases with surface roughness for a
hydrophilic material. PCL NF has much higher surface
roughness than does PCL film, so it has a higher water
contact angle before air plasma treatment and a lower
contact angle (0°) after air plasma treatment. Gelatin-
grafted PCL NF also showed a water contact angle of 0°.
EC morphology on PCL NF
Figure 5 shows a set of fluorescence and SEM micro-
graphs of ECs on original and gelatin-grafted PCL NF
taken after various times in culture. In the fluorescence
micrographs the ECs were stained with CMFDA, which
stains only living cells.19 ECs cultured on unmodified
PCL NF always kept a rounded shape from the begin-
MA ET AL.
ning of cell seeding and never spread with increasing cul-
ture time, whereas on gelatin-grafted PCL NF the ECs
adopted a rounded shape at an early stage after cell seed-
ing (6 h), but become fully spread by days 2 and 4. The
SEM images of single ECs (Fig. 5d and h) show that the
pseudopods of ECs can be formed along gelatin-grafted
nanofiber, but not along unmodified nanofiber. Cell mor-
phology is an important parameter to be considered when
tissue engineering blood vessel scaffolds. A confluent
EC monolayer covering the foreign material surfaces
may prevent the development of intimal hyperblasia by
preventing the thrombosis and immunoreactions caused
by direct contact between the blood and the foreign 
material.
EC proliferation on PCL NF
Cell growth behavior on original and gelatin-modified
PCL NF was measured by MTS cell proliferation analy-
sis. EC growth curves are shown in Fig. 6, with TCPS
set as control. The grafting of gelatin on PCL NF clearly
improves cell proliferation, compared with the poor cell
growth on unmodified PCL NF. However, the difference
in cell growth rate between gelatin-modified PCL NF and
TCPS implies that there is still room for improvement
for the material.
APCL NF and its ability to control EC orientation
Aligned PCL nanofiber was also prepared in this work
to obtain a controllable orientation of ECs, because for-
mer studies9,21 have shown that aligned electrospun
nanofiber is capable of controlling the orientation of
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FIG. 5. Fluorescence and SEM micrographs of ECs cultured on original PCL NF (a–d) and gelatin-grafted PCL NF (e–h) for
various cell-culturing times. Cell-culturing times: (a and e) 6 h; (b and f) 2 days; (c, d, g, and h) 4 days. Cell-seeding density,
30,000 per well.




Original PCL film 85  3
Original PCL NF 131  2
Air plasma-treated PCL filma 43  1
Air plasma-treated PCL NFa 0
Gelatin-grafted PCL NFa 0
aAir plasma treatment time, 5 min.
smooth muscle cells and neurons by a mechanism called
“contact guidance.” Large APCL NF meshes with uni-
form thickness were not available because of limitations
of the technique (Fig. 1), making some quantitative sur-
face chemistry analysis and cell compatibility study of
the APCL NF impossible. However, the ability of APCL
GRAFTING OF GELATIN ON ELECTROSPUN PCL NANOFIBERS
NF to control cell orientation could be verified, as is de-
scribed below.
The same surface modification strategy for PCL NF
was used to covalently immobilize gelatin molecules on
APCL NF, which was confirmed by the N1s peak ap-
pearing in the XPS of gelatin-grafted APCL NF (Fig. 3b).
Figure 7 shows the appearance of ECs on original and
gelatin-grafted APCL NF after various times in culture.
As on PCL NF, ECs cultured on unmodified APCL NF
always kept a rounded shape from the beginning of cell
seeding. On gelatin-grafted APCL NF, however, ECs
adopted spread shapes shortly (6h) after cell seeding, with
the cells oriented along the nanofibers. The orientation
of the cells parallel to the nanofibers became more ob-
vious with increasing culturing time (2 and 4 days). In-
stead of the polygonal shape observed on gelatin-grafted
PCL NF (Fig. 5), the ECs adopted a spindle shape, with
the long axes parallel to each other on gelatin-grafted
APCL NF. The orientation of ECs on APCL NF was more
obviously demonstrated after cell skeletons were visual-
ized by staining with rhodamine-labeled phalloidin. Fig-
ure 7i and j show that cell skeletons were organized par-
allel to the fibers on gelatin-grafted APCL NF, but were
randomly oriented on gelatin-grafted PCL NF.
In the human body, shear stress caused by blood flow
in vivo can orient endothelial cells in the direction of
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FIG. 6. EC proliferation, determined by MTS assay, on
TCPS, original PCL NF, and gelatin-grafted PCL NF. Cell-
seeding density, 30,000 per well.
FIG. 7. Fluorescence and SEM micrographs of ECs cultured on original APCL NF (a–d) and gelatin-grafted APCL NF (e–h)
for various cell-culturing times. (i and j) LSCM images of rhodamine–phalloidin-stained ECs on gelatin-grafted APCL NF and
gelatin-grafted PCL NF, respectively. Cells were stained with rhodamine-labeled phalloidin to visualize actin in the cytoskele-
tons. Cell-culturing times: (a and e) 6 h; (b and f) 2 days; (c,d, and g–j) 4 days. Cell-seeding density, 30,000 per well. Double-
headed arrows point out the direction of the aligned nanofibers.
blood flow.22–24 The elongated endothelial cell shape is
speculated to be important in preventing the atheroscle-
rotic process because atherosclerosis develops preferen-
tially in regions where ECs are round shaped, whereas
arterial regions largely resistant to atherosclerosis are
characterized by elongated ECs.25 It is therefore impor-
tant to control EC orientation in blood vessel scaffolds
to mimic the natural situation. Moreover, the orientation
of ECs in the direction of flow may be able to increase
the ability of ECs to resist shear stress and to decrease
the desquamation of ECs from material surfaces.
Surface-modified APCL NF provides a convenient
strategy to obtain cells with controlled orientation by sta-
tic cell culturing instead of dynamic culturing, which ne-
cessitates a complicated fluid system. Although other ap-
proaches to control EC orientation without a fluid field
have been developed, such as grooved surfaces produced
via lithography26 or physical grinding27 or micropat-
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terned surfaces produced via self-assembly mono-
layer,28,29 these techniques are relatively more compli-
cated and, above all, are not practical to apply to tissue-
engineering scaffolds.
Phenotypic study of ECs on PCL NF and APCL NF
Three important surface markers expressed by ECs cul-
tured on gelatin-grafted PCL NF and APCL NF were stud-
ied by immunostaining, using TCPS as control. The sur-
face markers studied, PECAM-1 (CD31), VCAM-1
(CD106), and ICAM-1 (CD54), are all adhesion proteins
characteristically expressed on cell membranes of blood
vessel endothelial cells. Figure 8 shows LCSM images of
immunostained ECs cultured on TCPS, gelatin-grafted
PCL NF, and APCL NF. ECs on TCPS strongly expressed
three surface markers. ECs cultured on gelatin-grafted PCL
NF and APCL NF also expressed all three markers.
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FIG. 8. Expression of PECAM-1 (CD31), VCAM-1 (CD106), and ICAM-1 (CD54) on membranes of ECs cultured on TCPS,
gelatin-grafted PCL NF, and gelatin-grafted APCL NF. Cells were first immunostained with the appropriate primary antibody
and then with FITC-labeled secondary antibody, and finally counterstained with PI to visualize cell nuclei. Representative LSCM
micrographs are shown. Double-headed arrows point out the direction of the aligned nanofibers.
CD31 occurs on the EC membrane close to intercel-
lular junctions and regulates EC–EC adhesion and
EC–leukocyte adhesion. It is usually believed that in-
creased expression of CD31 favors endothelialization,30
whereas decreased expression of CD31 by ECs is an im-
plication of cell damages.31 CD106 and CD56 belong to
EC surface markers that are up-regulated in the case of
inflammation. CD106 and CD56 can mediate the adhe-
sion of leukocytes on endothelial cells, and the migration
of leukocytes out of the endothelial cell layer and into
the surrounding tissue to kill invading bacteria or
viruses.30,32–34 Expression of the three surface markers
on gelatin-modified PCL NF and APCL NF indicated that
the novel nanofibrous biomaterials can successfully
maintain the phenotype of ECs and therefore the corre-
sponding important cell functions described above.
CONCLUSION
Electrospun PCL nanofiber was surface modified with
gelatin to improve cell compatibility. Inductively coupled
radio-frequency glow discharge plasma treatment with air
as the reaction gas can effectively introduce –COOH
groups on PCL nanofiber surfaces. The COOH groups
were further utilized to covalently graft gelatin mole-
cules, using water-soluble carbodiimide as the coupling
agent. Gelatin grafting can significantly improve EC
spreading and growth on PCL nanofiber. Moreover,
aligned gelatin grafted PCL nanofiber showed a strong
ability to control the orientation of ECs in the direction
of the fibers, thus providing an effective way to control
EC orientation without using a fluid field. ECs cultured
on gelatin-grafted PCL nanofiber can maintain their phe-
notypic character.
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Abstracts
Non-woven polyethylene terephthalate nanoﬁber mats (PET NFM) were prepared by electrospinning technology and were
surface modiﬁed to mimic the ﬁbrous proteins in native extracellular matrix towards constructing a biocompatible surface for
endothelial cells (ECs). The electrospun PET NFM was ﬁrst treated in formaldehyde to yield hydroxyl groups on the surface,
followed by the grafting polymerization of methacrylic acid (MAA) initiated by Ce(IV). Finally, the PMAA-grafted PET NFM was
grafted with gelatin using water-soluble carbodiimide as coupling agent. Plane PET ﬁlm was also surface modiﬁed and characterized
for basic understanding of the surface modiﬁcation process. The grafting of PMAA and gelatin on PET surface was conﬁrmed by
XPS spectroscopy and quantitatively analyzed by colorimetric methods. ECs were cultured on the original and gelatin-modiﬁed
PET NFM and the cell morphology, proliferation and viability were studied. Three characteristic surface makers expressed by ECs
were studied using immuno-ﬂorescent microscopy. The gelatin grafting method can obviously improve the spreading andf the ECs on the PET NFM, and moreover, can preserve the EC’s phenotype.
ier Ltd. All rights reserved.
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1. Introduction
Blood vessel disease such as atherosclerosis is one of
the major causes of human death in modern society. The
malfunctioning blood vessel can be replaced by auto-
logous veins or arteries, but at the cost of other healthysearch for vascular graft substitute has thus
-century endeavor. Although PTFE and
terephthalate (PET) (DacronMT) have been
fully in treating the pathology of large-
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diameter arteries (46mm, inner diameter), no materials
have been proven to be successful in replacing small-
diameter blood vessels (o6mm). The main reason for the
long-term failure of the small-diameter vascular graft is
the incomplete cover of endothelial cells (ECs) on the
vascular graft surfaces and the subsequent myointimal
hyperplasia [1,2]. One approach to solve this problem
called endothelialization [3] is to seed autologous ECs
onto the luminal surface of the vascular grafts to allow
the formation of a monolayer of ECs prior to implanta-
tion. This approach has been proven to be able to
increase patency of the vascular grafts obviously [4].
The inner layer closest to blood ﬂow in the blood
vessel is formed by an EC monolayer attached onto a
connective tissue bed of basement membrane, which is a
ﬂexible thin (40–120 nm thick) mat underlying all
IN
erialsepithelial or EC sheets to separate them from the
underlying connective tissues. The basement membrane
is mainly composed of type IV collagen and laminin
ﬁbers embedded in heparan sulfate proteoglycan hydro-
gels. The protein ﬁbers in the basement membrane have
nanoscaled diameters, ranging from several to several
tens of nanometers [5].
A technology to fabricate polymeric nanoﬁber called
electrospinning [6] had already been known for more
than a half century, but received extensively renewed
interests in recent years due to the similarity between the
electrospun non-woven nanoﬁber and the nanoscaled
protein ﬁbers/ﬁbrils in native extracellular matrix
(ECM). The desire to build an artiﬁcial analogue of
native ECM for tissue regeneration stimulated extensive
studies on the possibility of applying the polymeric
nanoﬁber as tissue engineering scaffolds [7–13].
It has been demonstrated that nanoscaled surface
texture has signiﬁcant inﬂuence on cell behaviors.
Nanoscaled random surface roughness has been found
to enhance cell adhesion and functions [14]. Cells attach
and organize well around ﬁbers with diameters smaller
than the cells [15]. Recent study reported that osteoblast
adhesion, proliferation, alkaline phosphatase activity
and ECM secretion on carbon nanoﬁbers increased with
deceasing ﬁber diameter in the range of 60–200 nm [16].
In this work, a conventional polymer used in vascular
graft, PET, was processed into non-woven nanoﬁber
mat (NFM) via electrospinning. To overcome the
ARTICLE
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gelatin was covalently grafted onto the PET NFM
surface. The surface-modiﬁed PET NFM may be a new
kind of material for blood vessel tissue engineering.
2. Experiments
2.1. Materials and reagents
PET particles ([Z]=0.82+0.02) were kindly donated
by Mitsui Chemicals, Inc. (Japan). Methacrylic acid
(MAA, Sigma-Aldrich) was puriﬁed by distillation
before use. Triﬂuoroacetic acid (TFA, Merck), Ammo-
nium cerium(IV) nitrate (Fluka), 1-ethyl-3-(3-dimethy-
laminopropyl) carbodiimide hydrochloride (EDAC,
Sigma), N-hydroxysuccinimide (NHS, Sigma) and Ge-
latin (Sigma-Aldrich) were all used as received.
2.2. Preparation of PET film and PET NFM
PET ﬁlms with a thickness of 50 mm were prepared
by heat-pressing of PET particles under 260 1C. Non-
woven PET NFMs were prepared by electrospinning
technology using equipments described in [7] in detail.
Brieﬂy, PET particles were dissolved in TFA to get a
solution (0.2 g/ml). The solution was added into a 20mlsyringe and induced to ﬂow out freely through a needle
with an inner diameter of 0.21mm. The polymer
solution was deposited on an aluminum foil under a
15 kV DC voltage (Gamma High-Voltage Research)
that was loaded between the needle and the aluminum
foil which was at 15 cm distance from the needle. Glass
pieces were put on the aluminum foil to collect the PET
nanoﬁbers. The deposition time was controlled to get
PET NFMs with different thickness. The thickness of
the PET NFM was measured by a micrometer and its
apparent density and porosity were calculated using the
following equations:
NFM apparent density ðg=cm3Þ
¼ NFMMass ðmgÞ  10
NFM thickness ðmmÞ NFM area ðcm2Þ ;
NFM porosity
¼ 1 NFM apparent density ðg=cm
3Þ
bulk density of PET ðg=cm3Þ
 
100%;
where the bulk density of the PET is 1.3 g cm3.
2.3. Surface modification of the PET film and PET NFM
Glue (SilbioneR, MED ADH 4300 RTV, Rhodia,
USA) was used to ﬁx the edge of the PET NFM on the
glass piece to prevent it from being deformed during the
surface modiﬁcation. The NFM was ﬁrst pre-wetted
with ethanol and then immersed into deionized water to
exchange the ethanol with water. For the ﬁlm, there is
no need for the pre-wetting process.
The whole chemical reaction scheme for PET surface
modiﬁcation is shown in Fig. 1.
The PET ﬁlm or NFM was exposed to 18.5 vol%
formaldehyde in 1M acetic acid solution for 24 h at
room temperature to yield hydroxyl groups on the PET
surface [17]. The formaldehyde-treated PET ﬁlm or
NFM was then rinsed with deionized water for 24 h. The
hydroxylated PET ﬁlm/NFM was placed into a glass
tube containing 10ml MAA aqueous solution with a
given concentration, 0.4 M H2SO4 and 0.007M Ce(IV).
The tube was sealed and purged with nitrogen, and the
grafting polymerization of MMA was conducted under
80 1C. The PMAA-grafted PET ﬁlm/NFM was rinsed in
NaOH solution (pH=10) for 3 h and then in deionized
water for 24 h to remove the unreacted monomer and
homopolymer of PMAA.
For gelatin grafting, PET ﬁlm/NFM was ﬁrst grafted
with PMAA as described above, with the MAA
concentration being 10 vol% and the grafting time being
4 h. The PMAA-grafted PET ﬁlm/NFM was immersed
PRESS
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Sigma) buffer solution (0.1 M, pH=5.0) containing
5mg/ml EDAC and 5mg/ml NHS under 4 1C for 2 h.
The material was then rinsed with deionized water,
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and reacted for 24 h under 4 1C. The material was ﬁnally
rinsed with deionized water for 24 h to remove the
physically adsorbed gelatin, and dried under vacuum.
2.4. Surface characterization of PET NFM
SEM images of the PET NFM were obtained on a
JEOL JSM-5800LV scanning electron microscope. XPS
spectra of the control and modiﬁed PET surfaces were
obtained on a VG ESCALAB 2201-XL Base System
with a takeoff angle of 901. The binding energy was
referenced to the C1S of saturated hydrocarbon at
285.0 eV. Advancing, receding and static sessile drop
water contact angle of the control and modiﬁed PET
surface was measured using a VCA Optima (AST
Products INC) surface contact angle tester.
COOH surface density on the PMAA-grafted PET
ﬁlm or NFM was measured using toluidine blue O
(TBO) method [18–20] and the surface density of the
gelation grafted on the PET ﬁlm/NFM was measured
with a modiﬁed Coomassie brilliant blue staining
method [21]. For both measurements control tests with
unmodiﬁed material were performed to eliminate the
effects of physically adsorbed dye molecules on the
material surfaces.
2.5. Endothelial cell culturing
Human coronary artery ECs at passage 3 were
purchased from American Type Culture Association
(ATCC; Arlington, VA). The cells were cultured in EC
Basal Medium-2 (EBM-2, CloneticsTM) supplemented
Fig. 1. Schematic representation owith 100U/ml penicillin and 100U/ml streptomycin.
During the cell culture, the culture medium was changed
every 4 days. ECs at passage 9 were used in this work.
The PET nanoﬁber was deposited on round cover slips(15mmf, Assistant, Germany), which can be put into
the wells of 24-well tissue culture plate and exactly
covered the well bottom. A little amount of an implant
grade silicon adhesive (Silbiones, MED ADH 4300
RTV, Rhodia, USA) was used along the edge of the
PET nanoﬁber sheet to immobilize it on the glass
surface. Experiments had been conducted in our lab to
show that the high inert silicon adhesive has no toxic
effects on the cells. Ethanol solution (75 vol%) was used
to sterilize the samples and was removed by exchanging
with PBS. ECs were seeded onto the original and
modiﬁed PET NFM at a seeding density of 30000/well.
TCPS was set as control. Cell morphology was observed
on SEM (JEOL JSM-5800LV) and AFM (Dimension
3100, Digital Instruments) after 5 days’ culturing and
ﬁxing with 2.5 vol% glutaraldehyde.
2.6. Cell proliferation and viability
It was found in this study that the ECs cultured on the
nanoﬁber surfaces bonded strongly with the materials
and could not be completely detached by a trypsin
digestion. Therefore, cell number was measured by
directly counting the cells on the material surface. The
ECs were ﬁrst immobilized by glutaraldehyde (2.5% in
PBS). After a staining with PI (2 mg/ml, 100 ml per well),
the cells were counted under a ﬂorescence microscope.
The cell number per well was calculated by multiplying
the measured cell surface densities with the total area of
one well (1.8 cm2) of the 24-well TCPS plate. On each
sample, six different points were selected randomly and
the cell numbers were averaged to calculate the cell
surface density on the sample.
PET surface modiﬁcation process.Cell viability was measured using the 3-(4,5-di-
methylthiazol-2-yl)-5-(3-carboxymeth-oxyphenyl)-2-(4-
sulfophenyl)-2H-tetrazolium (MTS) colorimetric assay.
The kit (CellTiter 96s Aqueous One Solution Cell
IN
erialsProliferation Assay) was purchased from Promega and
the measurement was conducted according to the
manufacturer’s directions. Before the MTS testing, the
culture medium was pipetted out from the 24-well tissue
culture plate and 500 ml new fresh culture medium was
added into every well. Hundred microliters of CellTiter
96s Aqueous One Solution reagent was added into
every well. After culturing for 4 h, the deep colored
culture medium was pipetted out and added into a 96-
well plate (100 ml/well) and the absorbance at 490 nm
ARTICLE
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3.2. Grafting polymerization of MAA
Different methods like plasma treatment [22,23],
UV irradiation [24,25] and UV-induced grafting
Table 1
The thickness, apparent density and porosity of the PET NFM













(%)with culture medium but without cells were set as
control to get background absorbance to be subtracted
from the absorbance of the cell-containing wells.
2.7. Cell phenotype study
After 5 days’ culturing, the ECs were washed with
PBS, ﬁxed with 2.5% paraformaldehyde and blocked by
BSA. The cells were then incubated for 2 h at 37 1C with
200 ml/well primary antibody (mouse anti-human plate-
let EC adhesion molecule (PECAM-1), mouse anti-
human vascular cell adhesion molecule-1 (VCAM-1);
mouse anti-human intercellular adhesion molecule-1
(ICAM-1), BD Biosciences, USA) diluted 1:60 with
PBS/0.02% BSA. After washing, ﬂuorescein isothiocya-
nate (FITC) labeled rabbit anti-mouse IgG (BD
Biosciences, USA) diluted 1:60 with PBS/0.02% BSA
was added (200 ml/well) and incubated for 2 h at 37 1C,
followed by washing and counterstaining with PI (2 mg/
ml, 100 ml per well) for 10min. The immuno-stained ECs
were then viewed under a laser scanning confocal
microscope (Leica TCS SP2).
Fig. 2. SEM images of the original (a,b) an3. Results and discussion
3.1. Preparation of PET NFM
Morphology of the PET NFM obtained from
electrospinning was shown in Fig. 2. The diameter of
the nanoﬁber was in the range 200–600 nm. The
nanoscaled ﬁbers were randomly distributed to form a
non-woven mat with good integrity. In this work, mats of
different NFM thicknesses were obtained by controlling
the deposition time in the electrospinning (Table 1). The
electrospun PET NFM is a highly porous material. With
the known bulk density of PET (1.3 g/cm3), the porosity
of the PET NFM can be calculated by measuring its
apparent density, the results of which were summarized
in Table 1. It can be seen that the thickness of the NFM
increased with the deposition time while its porosity
remained a constant value of about 82%.
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30 6 0.15 0.25 80.7
60 12 0.27 0.23 82.3
120 35 0.78 0.22 83.1
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Fig. 4. COOH density on the PMAA-grafted PET ﬁlm and PET NFM
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modify polymers towards improving biocompatibility
for EC. However, for surface modiﬁcation of polymer
nanoﬁbers, strong reaction conditions like irradiation
and plasma should be avoided because the ultraﬁne
polymeric nanoﬁbers are not as strong as bulk materials
and can be easily destroyed. For example, our recent
work showed plasma treatment could destroy PET
nanoﬁbers severely. Therefore, Ce(IV) was used in this
work to initiate grafting polymerization of MAA on
PET surfaces. Fig. 2 showed that the morphology of the
PET NFM was very well preserved after the gelatin
grafting.
Although the purpose of this work is to surface
modify the PET NFM; plane PET ﬁlm was also surface
modiﬁed to obtain a fundamental understanding of the
surface modiﬁcation process.
As the ﬁrst step, the PET ﬁlm/NFM was treated with
formaldehyde to introduce hydroxyl groups [17], which
can be oxidized by Ce(IV) to produce radicals to initiate
the grafting polymerization (Fig. 1). The grafting of
PMAA on PET surface yielded COOH groups, of which
the density was quantitatively measured by TBO
methods. Fig. 3 showed the COOH density on the
PMAA-grafted PET ﬁlm as a function of the monomer
concentration. Obviously, the COOH density increased
with the monomer concentration. To test the effective-
ness of the formaldehyde treatment, surface grafting of
non-formaldehyde-treated PET ﬁlm was also conducted.
It can be found that even the PET ﬁlms without
formaldehyde treatment have COOH groups yielded on
the surface. The reason is the PET ﬁlm surface can be
hydrolyzed under the acidic reaction environment,
producing some hydroxyl groups to be oxidized by
ARTICLE
Z. Ma et al. / BiomatCe(IV) to initiate the grafting polymerization. The
hydrolysis can also directly produce some COOH
groups. Even so, treatment by formaldehyde can
obviously increase the grafting degree and is necessary.





















 non-treated PET film
 formaldehyde treated PET film
Fig. 3. COOH density on the PMAA-grafted PET ﬁlm as a function of
the monomer (MAA) concentration. Grafting time is 4 h.For the surface modiﬁcation of the PET NFM, the
formaldehyde treatment was always used.
The COOH density grafted on the PET ﬁlm/NFM
increased with the grafting time, as shown in Fig. 4.
Here the COOH density was expressed as COOH
amount per unit area of the PET NFM because it is a
straightforward way to show how many COOH groups
exist in a piece of nanoﬁber sheet with a given area. The
amount of the COOH groups grafted on the PET NFM
was much higher than on the PET ﬁlm, which can be
traced to the much higher surface area of the PET
NFM. It is worthy to point out that PET NFM
with high thickness produced higher COOH density
than the thinner PET NFM, as shown in Fig. 4,
indicating that the grafting polymerization of MAA not
only occurred on the outer surface, but also went deep
into the NFM.
The grafting of PMAA on the PET ﬁlm/NFM surface
was further veriﬁed by XPS spectroscopy. Fig. 5 showed
the C1S core-level scan spectra of the original and
PMAA-grafted PET ﬁlm/NFM. The introduction of
PMAA on the PET surface increased the percentage of
peak (I) at 285 eV that corresponds to saturated
hydrocarbon and decreased the percentage of peak (II)
at 286.8 eV that corresponds to the carbon atoms
connected with only one oxygen atom by a single bond.
Such changes are in accordance with the chemical
structure of the PMAA, which has more saturated
hydrocarbon atoms than PET, and contains no carbon
atoms connected with only one oxygen atom by a single
bond. Table 2 showed the atomic ration of C and O on
as a function of the grafting time. The monomer (MAA) concentration
is 10 vol%. Note the change of vertical scale at 12.the original and PMAA-grafted PET surface. It can be
found that due to the similar C/O ratios in PMAA (2:1)
and PET (2.5:1), there were no big changes in the atomic
ratios of C and O after the PMAA grafting.
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PET 71.1 — 28.9
PMAA-grafted PET ﬁlm 69.3 — 30.7
PMAA-grafted PET NFM 73.3 — 26.7




aFor the grafting of PMAA in the ﬁrst step, the MAA concentration
is 10% and the grafting time is 4 h.
Fig. 5. C1S core level scan spectra of (a) original PET surface, (b)
PMAA-grafted PET ﬁlm and (c) PMAA-grafted PET NFM. The
numbers in the ﬁgure indicate the percentage of the single peak area in
the total C1S peak area.
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EDAC/NHS chemistry, a commonly used approach
to covalently immobilize protein molecules on –COOH-
containing surfaces, was used to graft gelatin on the
PET ﬁlm and NFM. The gelatin grafting was directly
veriﬁed by the appearance of the N1S peak in the XPS
spectra of the gelatin-grafted PET ﬁlm and NFM (Table
2). The amount of gelatin grafted on the PET ﬁlm and
NFM was quantitatively measured by CBBR-staining
method (Table 3). Again, due to the higher surface area,
the PET NFM had a much higher gelatin content than
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was the gelatin content, implying that gelatin grafting
was not limited only on the outer surface of the PET
NFM.
3.4. Wettability
Water contact angle of the original and modiﬁed PET
ﬁlm/NFM were summarized in Table 4. PET NFM
showed totally different water contact angle from the
PET ﬁlm. The original PET NFM has a much higher
advancing and sessile drop angle than the original PET
ﬁlm, while its receding angle is unusually much smaller.
This is because the PET NFM has a highly rough
surface compared with the relatively smooth PET ﬁlm.
The surface modiﬁcation obviously increased the
Table 3
Amount of the gelatin grafted on the PET ﬁlm and PET NFM with
different thicknessesa
Sample Amount of the gelatin
grafted on the PET NFM
(mg/cm2)
Gelatin-grafted PET ﬁlm 20
Gelatin-grafted PET NFM (6mm)b 105
Gelatin-grafted PET NFM (12mm)b 200
Gelatin-grafted PET NFM (35mm)b 370
aSample preparing condition is the same as in Table 2.
bThe number in the brackets is the thickness of the PET NFM.
Table 4








Original PET ﬁlm 9773 5374 8072
PMAA-grafted PET ﬁlm 7472 1971 5372
Gelatin-grafted PET ﬁlm 7173 1772 5073
Original PET NFM 14473 1572 12873
PMAA-grafted PET NFM — — 0
Gelatin-grafted PET NFM — — 0
aSample preparing condition is the same as in Table 2.
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Z. Ma et al. / Biomaterials 26 (2005) 2527–2536 2533hydrophilicity of the PET surface. Interestingly,
although the original PET NFM showed very high
advancing and sessile drop water contact angle, after
surface modiﬁcation either by PMAA grafting or by
gelatin grafting, it becomes a highly wettable material.
The water drop, upon contact with the surface-modiﬁed
PET NFM, was suddenly sucked into the NFM, giving
a zero water contact angle.
The big difference of the PET NFM’s wettability
before and after the surface modiﬁcation can be
explained by the following experience [28]. The water
contact angle of a solid surface is affected by surface
roughness in such a manner: If the material is
intrinsically hydrophobic, the water will not be able to
penetrate into the hollows and pores on the rough
surface and can be regarded as resting on a semi-solid
and semi-air plane surface, which will increase the
contact angle signiﬁcantly. In contrast, the water will
penetrate and ﬁll up most of the hollows and pores
formed by an intrinsically hydrophilic material, forming
a surface which is partly solid and partly liquid and
Fig. 6. SEM images of ECs cultured on (a) TCPS, (b) original PET N







ahighly rough surface, the PET NFM experienced a big
improvement in wettability after it was surface modiﬁed
from hydrophobic to hydrophilic.4. EC morphology
Cell morphology is an important parameter to be
considered for EC in vascular graft. A spreading shape
7day5day3day1day
Fig. 7. EC growth curve (a) and MTT viability (b) on TCPS, the
original and gelatin-modiﬁed PET NFM. Cell seeding density is
30,000/well (24-well tissue culture plate).
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erialsis of particular importance since it is needed for the neo-
endothelium formation. The spreading cells can form a
monolayer covering the foreign material surfaces to
prevent direct contact between the blood and the foreign
material; therefore, preventing immuno-reactions and
thrombosis. Cell morphology on TCPS, the original
and the gelatin-grafted PET NFM was checked by
SEM and shown in Fig. 6. The ECs were extensively
spread on TCPS. The ECs on the original PET NFM
were round shaped and did not spread, while on the
gelatin-grafted NFM the ECs adopted a spreading
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image shown in Fig. 6(d), the proﬁle of some nanoﬁbers
beneath the extensively spreading cells can be easily
observed.
Fig. 8. Expression of PECAM-1 (CD31), VCAM-1 (CD106) and ICAM-1 (C
Cells were immuno-stained with respective primary antibody and FITC labele
micrographs are shown.4.1. EC proliferation and viability
The cell proliferation was measured by counting the
cells directly on the material surface because it was
found that the ECs seeded on the nanoﬁber surface
bonded strongly with the ﬁber and could not be
completely detached by trypsinization. Fig. 7a showed
the proliferation curves of the ECs seeded on the TCPS,
original PET NFM and gelatin-grafted PET NFM. On
TCPS the cell number kept increasing throughout the
whole cell culture time. The ECs cultured on both the
PRESS
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the 3rd day compared with the ﬁrst day, followed by an
increase on the 5th day. This decrease of the cell number
on the 3rd day might indicate a damage of the ECs to
D54) by the ECs cultured on TCPS and the gelatin-grafted PET NFM.
d secondary antibody, and counterstained by PI. Representative LCSM
improve the spreading and proliferation of ECs on
IN
erialssome extent on the original and the surface-modiﬁed
PET NFM. Fig. 7b showed the cell MTT viability
curves, which were roughly in accordance with the cell
proliferation curves shown in Fig. 7b. It can be
concluded from Fig. 7 that on the one hand, surface
grafting of gelatin on the PET NFM can obviously
improve the cell growth behaviors compared with the
poor cell growth on the unmodiﬁed PET NFM. While
on the other hand, the difference of cell number and cell
viability between the gelatin-modiﬁed PET NFM and
the TCPS implies a necessary further improvement of
the material in the future.
4.2. EC phenotype analysis
Three typical surface adhesion proteins characteristi-
cally expressed by ECs, i.e., PECAM (or CD31),
VCAM-1 (or CD106) and ICAM-1 (or CD54) were
studied using immuno-ﬂorescent microscopy. Fig. 8
showed the LCSM images of the immuno-stained ECs
cultured on TCPS and on the gelatin-grafted PET
NFM. There were positively stained cells for all the
three surface makers on both materials. The ECs on
TCPS have an obviously stronger expression of CD31
than on the gelatin-grafted PET NFM. CD31 belongs to
the superfamily of the immunoglobulin and occurs to
regulate EC–EC adhesion and EC–leukocyte adhesion.
It is usually believed that an increased expression of
CD31 is in favor of endothelialization [29], while a
decreased expression of CD31 by EC is a possible
implication of cell damage [30]. CD106 and CD54
belong to the immunoglobulin superfamily as well, and
mainly regulate EC–leukocyte adhesion [29,31–33]. The
expression of all three surface makers by the ECs
cultured on the gelatin-modiﬁed PET NFM indicates
the preservation of EC’s characteristic phenotype.
However, the weaker expression of CD31 on the
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lization than on TCPS. This result is also in agreement
with the cell proliferation and viability test results shown
in Fig. 7.
5. Conclusion
After the PET NFM is treated with formaldehyde,
MAA can be polymerized on the PET NFM surface
using Ce(IV) as initiator. The PMAA grafting degree
increased with monomer concentration and grafting
time. The amount of the carboxyl groups grafted on the
PET NFM also increased with the mat thickness,
indicating that the surface modiﬁcation occurred not
only on the outer layer but also throughout the whole
nanoﬁber matrix. Using EDAC/NHS chemistry gelatin
can be covalently attached to the PMAA-grafted PET
NFM. The gelatin grafting method can obviouslyPRESS
26 (2005) 2527–2536 2535PET NFM, and the gelatin-grafted PET NFM can
preserve the EC’s phenotype.
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